BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Radtke F, Raj K. The role of Notch in tumorigenesis: oncogene or tumour suppressor? Nat Rev Cancer. 2003;3:756-767. [PMID: 14570040 DOI: 10.1038/nrc1186] [Cited by in Crossref: 566] [Cited by in F6Publishing: 528] [Article Influence: 29.8] [Reference Citation Analysis]
Number Citing Articles
1 Simutis FJ, Sanderson TP, Pilcher GD, Graziano MJ. Nonclinical Safety Assessment of the γ-Secretase Inhibitor Avagacestat. Toxicological Sciences 2018;163:525-42. [DOI: 10.1093/toxsci/kfy048] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
2 Soltanian S, Matin MM. Cancer stem cells and cancer therapy. Tumour Biol. 2011;32:425-440. [PMID: 21318290 DOI: 10.1007/s13277-011-0155-8] [Cited by in Crossref: 97] [Cited by in F6Publishing: 89] [Article Influence: 8.8] [Reference Citation Analysis]
3 Huang HJ, Ping FY, Hu JA, Zhao SF. Downregulation of Notch1 and its potential correlation with epidermal growth factor receptor signalling in tongue squamous cell carcinoma. Br J Oral Maxillofac Surg 2010;48:30-6. [PMID: 19398252 DOI: 10.1016/j.bjoms.2009.03.008] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
4 Ahn S, Hyeon J, Park CK. Notch1 and Notch4 are markers for poor prognosis of hepatocellular carcinoma. Hepatobiliary Pancreat Dis Int. 2013;12:286-294. [PMID: 23742774 DOI: 10.1016/s1499-3872(13)60046-6] [Cited by in Crossref: 30] [Cited by in F6Publishing: 20] [Article Influence: 3.8] [Reference Citation Analysis]
5 Funahashi Y, Hernandez SL, Das I, Ahn A, Huang J, Vorontchikhina M, Sharma A, Kanamaru E, Borisenko V, Desilva DM, Suzuki A, Wang X, Shawber CJ, Kandel JJ, Yamashiro DJ, Kitajewski J. A notch1 ectodomain construct inhibits endothelial notch signaling, tumor growth, and angiogenesis. Cancer Res. 2008;68:4727-4735. [PMID: 18559519 DOI: 10.1158/0008-5472.can-07-6499] [Cited by in Crossref: 114] [Cited by in F6Publishing: 74] [Article Influence: 8.1] [Reference Citation Analysis]
6 Ferretti E, Tosi E, Po A, Scipioni A, Morisi R, Espinola MS, Russo D, Durante C, Schlumberger M, Screpanti I, Filetti S, Gulino A. Notch Signaling Is Involved in Expression of Thyrocyte Differentiation Markers and Is Down-Regulated in Thyroid Tumors. The Journal of Clinical Endocrinology & Metabolism 2008;93:4080-7. [DOI: 10.1210/jc.2008-0528] [Cited by in Crossref: 50] [Cited by in F6Publishing: 51] [Article Influence: 3.6] [Reference Citation Analysis]
7 Zhao K, Li X, Wang J, Liu J, Gong W, Xu H, Wang J, Jiang L, Dan H, Li J, Zeng X, Chen Q. Correlation between prostate stem cell antigen gene expression and oral squamous cell carcinoma. Oncol Lett 2018;15:9151-61. [PMID: 29844822 DOI: 10.3892/ol.2018.8468] [Reference Citation Analysis]
8 Ma Y, Li MD. Establishment of a Strong Link Between Smoking and Cancer Pathogenesis through DNA Methylation Analysis. Sci Rep 2017;7:1811. [PMID: 28500316 DOI: 10.1038/s41598-017-01856-4] [Cited by in Crossref: 37] [Cited by in F6Publishing: 32] [Article Influence: 7.4] [Reference Citation Analysis]
9 Kamakura S, Oishi K, Yoshimatsu T, Nakafuku M, Masuyama N, Gotoh Y. Hes binding to STAT3 mediates crosstalk between Notch and JAK-STAT signalling. Nat Cell Biol. 2004;6:547-554. [PMID: 15156153 DOI: 10.1038/ncb1138] [Cited by in Crossref: 293] [Cited by in F6Publishing: 283] [Article Influence: 16.3] [Reference Citation Analysis]
10 Giovannini C, Fornari F, Piscaglia F, Gramantieri L. Notch Signaling Regulation in HCC: From Hepatitis Virus to Non-Coding RNAs. Cells 2021;10:521. [PMID: 33804511 DOI: 10.3390/cells10030521] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
11 Nowell C, Radtke F. Cutaneous Notch signaling in health and disease. Cold Spring Harb Perspect Med 2013;3:a017772. [PMID: 24296353 DOI: 10.1101/cshperspect.a017772] [Cited by in Crossref: 48] [Cited by in F6Publishing: 45] [Article Influence: 5.3] [Reference Citation Analysis]
12 Wierstra I, Alves J. The c‐myc Promoter: Still MysterY and Challenge. Elsevier; 2008. pp. 113-333. [DOI: 10.1016/s0065-230x(07)99004-1] [Cited by in Crossref: 133] [Cited by in F6Publishing: 79] [Article Influence: 9.5] [Reference Citation Analysis]
13 Saksena S, Emr SD. ESCRTs and human disease. Biochem Soc Trans 2009;37:167-72. [PMID: 19143624 DOI: 10.1042/BST0370167] [Cited by in Crossref: 69] [Cited by in F6Publishing: 49] [Article Influence: 5.3] [Reference Citation Analysis]
14 Cui H, Kong Y, Xu M, Zhang H. Notch3 functions as a tumor suppressor by controlling cellular senescence. Cancer Res 2013;73:3451-9. [PMID: 23610446 DOI: 10.1158/0008-5472.CAN-12-3902] [Cited by in Crossref: 67] [Cited by in F6Publishing: 41] [Article Influence: 7.4] [Reference Citation Analysis]
15 Kamdje AHN, Krampera M. Notch signaling in acute lymphoblastic leukemia: any role for stromal microenvironment? Blood 2011;118:6506-14. [DOI: 10.1182/blood-2011-08-376061] [Cited by in Crossref: 25] [Cited by in F6Publishing: 27] [Article Influence: 2.3] [Reference Citation Analysis]
16 Lasky JL, Wu H. Notch signaling, brain development, and human disease. Pediatr Res 2005;57:104R-9R. [PMID: 15817497 DOI: 10.1203/01.PDR.0000159632.70510.3D] [Cited by in Crossref: 91] [Cited by in F6Publishing: 52] [Article Influence: 5.4] [Reference Citation Analysis]
17 Qu N, Xu M, Mizoguchi I, Furusawa J, Kaneko K, Watanabe K, Mizuguchi J, Itoh M, Kawakami Y, Yoshimoto T. Pivotal roles of T-helper 17-related cytokines, IL-17, IL-22, and IL-23, in inflammatory diseases. Clin Dev Immunol. 2013;2013:968549. [PMID: 23956763 DOI: 10.1155/2013/968549] [Cited by in Crossref: 82] [Cited by in F6Publishing: 90] [Article Influence: 9.1] [Reference Citation Analysis]
18 Engin F, Yao Z, Yang T, Zhou G, Bertin T, Jiang MM, Chen Y, Wang L, Zheng H, Sutton RE. Dimorphic effects of Notch signaling in bone homeostasis. Nat Med. 2008;14:299-305. [PMID: 18297084 DOI: 10.1038/nm1712] [Cited by in Crossref: 286] [Cited by in F6Publishing: 260] [Article Influence: 20.4] [Reference Citation Analysis]
19 Sarmento LM, Barata JT. Therapeutic potential of Notch inhibition in T-cell acute lymphoblastic leukemia: rationale, caveats and promises. Expert Rev Anticancer Ther 2011;11:1403-15. [PMID: 21929314 DOI: 10.1586/era.11.73] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 1.8] [Reference Citation Analysis]
20 Ding H, Yu X, Hang C, Gao K, Lao X, Jia Y, Yan Z. Ailanthone: A novel potential drug for treating human cancer. Oncol Lett 2020;20:1489-503. [PMID: 32724391 DOI: 10.3892/ol.2020.11710] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
21 Han L, Shi S, Gong T, Zhang Z, Sun X. Cancer stem cells: therapeutic implications and perspectives in cancer therapy. Acta Pharmaceutica Sinica B 2013;3:65-75. [DOI: 10.1016/j.apsb.2013.02.006] [Cited by in Crossref: 78] [Cited by in F6Publishing: 29] [Article Influence: 8.7] [Reference Citation Analysis]
22 Henken FE, De-Castro Arce J, Rösl F, Bosch L, Meijer CJ, Snijders PJ, Steenbergen RD. The functional role of Notch signaling in HPV-mediated transformation is dose-dependent and linked to AP-1 alterations. Cell Oncol (Dordr) 2012;35:77-84. [PMID: 22271085 DOI: 10.1007/s13402-011-0062-4] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 1.2] [Reference Citation Analysis]
23 Byrum SD, Washam CL, Montgomery CO, Tackett AJ, Suva LJ. Proteomic technologies for the study of osteosarcoma. Sarcoma 2012;2012:169416. [PMID: 22550414 DOI: 10.1155/2012/169416] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
24 Harbuzariu A, Oprea-Ilies GM, Gonzalez-Perez RR. The Role of Notch Signaling and Leptin-Notch Crosstalk in Pancreatic Cancer. Medicines (Basel) 2018;5:E68. [PMID: 30004402 DOI: 10.3390/medicines5030068] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
25 Ferrer-Luna R, Mata M, Núñez L, Calvar J, Dasí F, Arias E, Piquer J, Cerdá-Nicolás M, Taratuto AL, Sevlever G, Celda B, Martinetto H. Loss of heterozygosity at 1p-19q induces a global change in oligodendroglial tumor gene expression. J Neurooncol 2009;95:343-54. [PMID: 19597701 DOI: 10.1007/s11060-009-9944-y] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 1.1] [Reference Citation Analysis]
26 Kim GC, Lee CG, Verma R, Rudra D, Kim T, Kang K, Nam JH, Kim Y, Im SH, Kwon HK. ETS1 Suppresses Tumorigenesis of Human Breast Cancer via Trans-Activation of Canonical Tumor Suppressor Genes. Front Oncol 2020;10:642. [PMID: 32477936 DOI: 10.3389/fonc.2020.00642] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
27 Tuluhong D, Chen T, Wang J, Zeng H, Li H, Dunzhu W, Li Q, Wang S. FZD2 promotes TGF-β-induced epithelial-to-mesenchymal transition in breast cancer via activating notch signaling pathway. Cancer Cell Int 2021;21:199. [PMID: 33832493 DOI: 10.1186/s12935-021-01866-3] [Reference Citation Analysis]
28 Garnis C, Campbell J, Davies JJ, Macaulay C, Lam S, Lam WL. Involvement of multiple developmental genes on chromosome 1p in lung tumorigenesis. Hum Mol Genet 2005;14:475-82. [PMID: 15615770 DOI: 10.1093/hmg/ddi043] [Cited by in Crossref: 41] [Cited by in F6Publishing: 36] [Article Influence: 2.3] [Reference Citation Analysis]
29 Jin H, Gong W, Zhang C, Wang S. Epigallocatechin gallate inhibits the proliferation of colorectal cancer cells by regulating Notch signaling. Onco Targets Ther. 2013;6:145-153. [PMID: 23525843 DOI: 10.2147/ott.s40914] [Cited by in Crossref: 30] [Cited by in F6Publishing: 21] [Article Influence: 3.3] [Reference Citation Analysis]
30 Revandkar A, Perciato ML, Toso A, Alajati A, Chen J, Gerber H, Dimitrov M, Rinaldi A, Delaleu N, Pasquini E, D'Antuono R, Pinton S, Losa M, Gnetti L, Arribas A, Fraering P, Bertoni F, Nepveu A, Alimonti A. Inhibition of Notch pathway arrests PTEN-deficient advanced prostate cancer by triggering p27-driven cellular senescence. Nat Commun 2016;7:13719. [PMID: 27941799 DOI: 10.1038/ncomms13719] [Cited by in Crossref: 24] [Cited by in F6Publishing: 22] [Article Influence: 4.0] [Reference Citation Analysis]
31 Curry CL, Reed LL, Nickoloff BJ, Miele L, Foreman KE. Notch-independent regulation of Hes-1 expression by c-Jun N-terminal kinase signaling in human endothelial cells. Lab Invest 2006;86:842-52. [DOI: 10.1038/labinvest.3700442] [Cited by in Crossref: 66] [Cited by in F6Publishing: 66] [Article Influence: 4.1] [Reference Citation Analysis]
32 Rodrigues AB, Moses K. Growth and specification: flyPax6 homologseyegone andeyeless have distinct functions. Bioessays 2004;26:600-3. [DOI: 10.1002/bies.20055] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 0.9] [Reference Citation Analysis]
33 Ali-Seyed M, Laycock N, Karanam S, Xiao W, Blair ET, Moreno CS. Cross-platform expression profiling demonstrates that SV40 small tumor antigen activates Notch, Hedgehog, and Wnt signaling in human cells. BMC Cancer 2006;6:54. [PMID: 16522205 DOI: 10.1186/1471-2407-6-54] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 0.8] [Reference Citation Analysis]
34 Collins BJ, Kleeberger W, Ball DW. Notch in lung development and lung cancer. Semin Cancer Biol 2004;14:357-64. [PMID: 15288261 DOI: 10.1016/j.semcancer.2004.04.015] [Cited by in Crossref: 91] [Cited by in F6Publishing: 92] [Article Influence: 5.4] [Reference Citation Analysis]
35 Zheng MZ, Zheng LM, Zeng YX. SCC-112 gene is involved in tumor progression and promotes the cell proliferation in G2/M phase. J Cancer Res Clin Oncol 2008;134:453-62. [PMID: 17846787 DOI: 10.1007/s00432-007-0306-x] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 0.8] [Reference Citation Analysis]
36 Tan MJ, White EA, Sowa ME, Harper JW, Aster JC, Howley PM. Cutaneous β-human papillomavirus E6 proteins bind Mastermind-like coactivators and repress Notch signaling. Proc Natl Acad Sci U S A 2012;109:E1473-80. [PMID: 22547818 DOI: 10.1073/pnas.1205991109] [Cited by in Crossref: 94] [Cited by in F6Publishing: 85] [Article Influence: 9.4] [Reference Citation Analysis]
37 Liu SH, Patel S, Gingras MC, Nemunaitis J, Zhou G, Chen C, Li M, Fisher W, Gibbs R, Brunicardi FC. PDX-1: demonstration of oncogenic properties in pancreatic cancer. Cancer 2011;117:723-33. [PMID: 20886630 DOI: 10.1002/cncr.25629] [Cited by in Crossref: 29] [Cited by in F6Publishing: 32] [Article Influence: 2.4] [Reference Citation Analysis]
38 Pinnix CC, Herlyn M. The many faces of Notch signaling in skin-derived cells. Pigment Cell Res. 2007;20:458-465. [PMID: 17935489 DOI: 10.1111/j.1600-0749.2007.00410.x] [Cited by in Crossref: 48] [Cited by in F6Publishing: 38] [Article Influence: 3.4] [Reference Citation Analysis]
39 Liu SH, Zhou G, Yu J, Wu J, Nemunaitis J, Senzer N, Dawson D, Li M, Fisher WE, Brunicardi FC. Notch1 activation up-regulates pancreatic and duodenal homeobox-1. Genes (Basel) 2013;4:358-74. [PMID: 24705209 DOI: 10.3390/genes4030358] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
40 Lobry C, Oh P, Mansour MR, Look AT, Aifantis I. Notch signaling: switching an oncogene to a tumor suppressor. Blood. 2014;123:2451-2459. [PMID: 24608975 DOI: 10.1182/blood-2013-08-355818] [Cited by in Crossref: 140] [Cited by in F6Publishing: 138] [Article Influence: 17.5] [Reference Citation Analysis]
41 Su Y, Cheng R, Zhang J, Qian J, Diao C, Ran J, Zhang H, Li L. Interferon-α2b gene-modified human bone marrow mesenchymal stem cells inhibit hepatocellular carcinoma by reducing the Notch1 levels. Life Sci 2015;143:18-26. [PMID: 26518164 DOI: 10.1016/j.lfs.2015.10.031] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.1] [Reference Citation Analysis]
42 Ong CT, Cheng HT, Chang LW, Ohtsuka T, Kageyama R, Stormo GD, Kopan R. Target selectivity of vertebrate notch proteins. Collaboration between discrete domains and CSL-binding site architecture determines activation probability. J Biol Chem 2006;281:5106-19. [PMID: 16365048 DOI: 10.1074/jbc.M506108200] [Cited by in Crossref: 157] [Cited by in F6Publishing: 111] [Article Influence: 9.2] [Reference Citation Analysis]
43 Cai H, Gupta S, Rath P, Ai N, Baudis M. arrayMap 2014: an updated cancer genome resource. Nucleic Acids Res 2015;43:D825-30. [PMID: 25428357 DOI: 10.1093/nar/gku1123] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 2.0] [Reference Citation Analysis]
44 Li T, Xu XH, Guo X, Yuan T, Tang ZH, Jiang XM, Xu YL, Zhang LL, Chen X, Zhu H, Shi JJ, Lu JJ. Activation of notch 3/c-MYC/CHOP axis regulates apoptosis and promotes sensitivity of lung cancer cells to mTOR inhibitor everolimus. Biochem Pharmacol 2020;175:113921. [PMID: 32201213 DOI: 10.1016/j.bcp.2020.113921] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
45 Sun P, Xia S, Lal B, Eberhart CG, Quinones-Hinojosa A, Maciaczyk J, Matsui W, Dimeco F, Piccirillo SM, Vescovi AL, Laterra J. DNER, an epigenetically modulated gene, regulates glioblastoma-derived neurosphere cell differentiation and tumor propagation. Stem Cells 2009;27:1473-86. [PMID: 19544453 DOI: 10.1002/stem.89] [Cited by in Crossref: 61] [Cited by in F6Publishing: 57] [Article Influence: 4.7] [Reference Citation Analysis]
46 Bao B, Prasad AS. Targeting CSC in a Most Aggressive Subtype of Breast Cancer TNBC. In: Ahmad A, editor. Breast Cancer Metastasis and Drug Resistance. Cham: Springer International Publishing; 2019. pp. 311-34. [DOI: 10.1007/978-3-030-20301-6_17] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 3.7] [Reference Citation Analysis]
47 Ren B, Rose JB, Liu Y, Jaskular-Sztul R, Contreras C, Beck A, Chen H. Heterogeneity of Vascular Endothelial Cells, De Novo Arteriogenesis and Therapeutic Implications in Pancreatic Neuroendocrine Tumors. J Clin Med 2019;8:E1980. [PMID: 31739580 DOI: 10.3390/jcm8111980] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
48 Zhou W, Tian Y, Gong H, Guo S, Luo C. Oncogenic role and therapeutic target of leptin signaling in colorectal cancer. Expert Opin Ther Targets 2014;18:961-71. [PMID: 24946986 DOI: 10.1517/14728222.2014.926889] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.4] [Reference Citation Analysis]
49 Jin N, Lubner SJ, Mulkerin DL, Rajguru S, Carmichael L, Chen H, Holen KD, LoConte NK. A Phase II Trial of a Histone Deacetylase Inhibitor Panobinostat in Patients With Low-Grade Neuroendocrine Tumors. Oncologist 2016;21:785-6. [PMID: 27261467 DOI: 10.1634/theoncologist.2016-0060] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 3.0] [Reference Citation Analysis]
50 Ramakrishnan S, Hu Q, Krishnan N, Wang D, Smit E, Granger V, Rak M, Attwood K, Johnson C, Morrison C, Pili R, Chatta G, Guru K, Gueron G, McNally L, Wang J, Woloszynska-Read A. Decitabine, a DNA-demethylating agent, promotes differentiation via NOTCH1 signaling and alters immune-related pathways in muscle-invasive bladder cancer. Cell Death Dis 2017;8:3217. [PMID: 29242529 DOI: 10.1038/s41419-017-0024-5] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 2.2] [Reference Citation Analysis]
51 Moeini A, Cornellà H, Villanueva A. Emerging signaling pathways in hepatocellular carcinoma. Liver Cancer 2012;1:83-93. [PMID: 24159576 DOI: 10.1159/000342405] [Cited by in Crossref: 111] [Cited by in F6Publishing: 111] [Article Influence: 13.9] [Reference Citation Analysis]
52 Dumont AG, Yang Y, Reynoso D, Katz D, Trent JC, Hughes DP. Anti-tumor effects of the Notch pathway in gastrointestinal stromal tumors. Carcinogenesis. 2012;33:1674-1683. [PMID: 22764137 DOI: 10.1093/carcin/bgs221] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 1.4] [Reference Citation Analysis]
53 Sail V, Hadden MK. Notch Pathway Modulators as Anticancer Chemotherapeutics. Annual Reports in Medicinal Chemistry Volume 47. Elsevier; 2012. pp. 267-80. [DOI: 10.1016/b978-0-12-396492-2.00018-7] [Cited by in Crossref: 6] [Article Influence: 0.6] [Reference Citation Analysis]
54 de Almeida Sassi F, Lunardi Brunetto A, Schwartsmann G, Roesler R, Abujamra AL. Glioma revisited: from neurogenesis and cancer stem cells to the epigenetic regulation of the niche. J Oncol. 2012;2012:537861. [PMID: 22973309 DOI: 10.1155/2012/537861] [Cited by in Crossref: 20] [Cited by in F6Publishing: 23] [Article Influence: 2.0] [Reference Citation Analysis]
55 Roos-Weil D, Nguyen-Khac F, Bernard OA. Chronic lymphocytic leukemia: Time to go past genomics? Am J Hematol 2016;91:518-28. [PMID: 26800490 DOI: 10.1002/ajh.24301] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.7] [Reference Citation Analysis]
56 Kunnimalaiyaan M, Chen H. Tumor suppressor role of Notch-1 signaling in neuroendocrine tumors. Oncologist. 2007;12:535-542. [PMID: 17522241 DOI: 10.1634/theoncologist.12-5-535] [Cited by in Crossref: 119] [Cited by in F6Publishing: 119] [Article Influence: 7.9] [Reference Citation Analysis]
57 Nagao H, Setoguchi T, Kitamoto S, Ishidou Y, Nagano S, Yokouchi M, Abematsu M, Kawabata N, Maeda S, Yonezawa S, Komiya S. RBPJ is a novel target for rhabdomyosarcoma therapy. PLoS One 2012;7:e39268. [PMID: 22792167 DOI: 10.1371/journal.pone.0039268] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 1.2] [Reference Citation Analysis]
58 Teider N, Scott DK, Neiss A, Weeraratne SD, Amani VM, Wang Y, Marquez VE, Cho YJ, Pomeroy SL. Neuralized1 causes apoptosis and downregulates Notch target genes in medulloblastoma. Neuro Oncol 2010;12:1244-56. [PMID: 20847082 DOI: 10.1093/neuonc/noq091] [Cited by in Crossref: 28] [Cited by in F6Publishing: 26] [Article Influence: 2.3] [Reference Citation Analysis]
59 Schachter NF, Adams JR, Skowron P, Kozma KJ, Lee CA, Raghuram N, Yang J, Loch AJ, Wang W, Kucharczuk A, Wright KL, Quintana RM, An Y, Dotzko D, Gorman JL, Wojtal D, Shah JS, Leon-Gomez P, Pellecchia G, Dupuy AJ, Perou CM, Ben-Porath I, Karni R, Zacksenhaus E, Woodgett JR, Done SJ, Garzia L, Sorana Morrissy A, Reimand J, Taylor MD, Egan SE. Single allele loss-of-function mutations select and sculpt conditional cooperative networks in breast cancer. Nat Commun 2021;12:5238. [PMID: 34475389 DOI: 10.1038/s41467-021-25467-w] [Reference Citation Analysis]
60 Yan R, Zhang L, Li M, Liu X, Yang X, Chen L. Hes1 negatively regulates neurogenesis in the adult mouse dentate gyrus following traumatic brain injury. Exp Ther Med 2018;16:2267-74. [PMID: 30186467 DOI: 10.3892/etm.2018.6450] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
61 Wong H, Soh J, Gordon PM, Yu T, Sensen CW, Parr E, Johnston RN. Genomic compartmentalization of gene families encoding core components of metazoan signaling systems. Genome 2013;56:215-25. [PMID: 23706074 DOI: 10.1139/gen-2013-0021] [Cited by in Crossref: 2] [Article Influence: 0.2] [Reference Citation Analysis]
62 Bin Hafeez B, Adhami VM, Asim M, Siddiqui IA, Bhat KM, Zhong W, Saleem M, Din M, Setaluri V, Mukhtar H. Targeted knockdown of Notch1 inhibits invasion of human prostate cancer cells concomitant with inhibition of matrix metalloproteinase-9 and urokinase plasminogen activator. Clin Cancer Res 2009;15:452-9. [PMID: 19147749 DOI: 10.1158/1078-0432.CCR-08-1631] [Cited by in Crossref: 100] [Cited by in F6Publishing: 70] [Article Influence: 7.7] [Reference Citation Analysis]
63 Hu J, Markowitz GJ, Wang X. Noncoding RNAs Regulating Cancer Signaling Network. In: Song E, editor. The Long and Short Non-coding RNAs in Cancer Biology. Singapore: Springer; 2016. pp. 297-315. [DOI: 10.1007/978-981-10-1498-7_11] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
64 Tseng YC, Tsai YH, Tseng MJ, Hsu KW, Yang MC, Huang KH, Li AF, Chi CW, Hsieh RH, Ku HH. Notch2-induced COX-2 expression enhancing gastric cancer progression. Mol Carcinog. 2012;51:939-951. [PMID: 21976141 DOI: 10.1002/mc.20865] [Cited by in Crossref: 33] [Cited by in F6Publishing: 39] [Article Influence: 3.0] [Reference Citation Analysis]
65 Saranyadevi S. Multifaceted targeting strategies in cancer against the human notch 3 protein: a computational study. In Silico Pharmacol 2021;9:53. [PMID: 34631360 DOI: 10.1007/s40203-021-00112-y] [Reference Citation Analysis]
66 Liao W, Li G, You Y, Wan H, Wu Q, Wang C, Lv N. Antitumor activity of Notch‑1 inhibition in human colorectal carcinoma cells. Oncol Rep 2018;39:1063-71. [PMID: 29286145 DOI: 10.3892/or.2017.6176] [Cited by in Crossref: 3] [Cited by in F6Publishing: 11] [Article Influence: 0.6] [Reference Citation Analysis]
67 Xu P, Qiu M, Zhang Z, Kang C, Jiang R, Jia Z, Wang G, Jiang H, Pu P. The oncogenic roles of Notch1 in astrocytic gliomas in vitro and in vivo. J Neurooncol. 2010;97:41-51. [PMID: 19771395 DOI: 10.1007/s11060-009-0007-1] [Cited by in Crossref: 56] [Cited by in F6Publishing: 58] [Article Influence: 4.3] [Reference Citation Analysis]
68 Court H, Ahearn IM, Amoyel M, Bach EA, Philips MR. Regulation of NOTCH signaling by RAB7 and RAB8 requires carboxyl methylation by ICMT. J Cell Biol 2017;216:4165-82. [PMID: 29051265 DOI: 10.1083/jcb.201701053] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
69 Bai H, Wang C, Qi Y, Xu J, Li N, Chen L, Jiang B, Zhu X, Zhang H, Li X, Yang Q, Ma J, Xu Y, Ben J, Chen Q. Major vault protein suppresses lung cancer cell proliferation by inhibiting STAT3 signaling pathway. BMC Cancer 2019;19:454. [PMID: 31092229 DOI: 10.1186/s12885-019-5665-6] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
70 Bradl M, Lassmann H. Oligodendrocytes: biology and pathology. Acta Neuropathol 2010;119:37-53. [PMID: 19847447 DOI: 10.1007/s00401-009-0601-5] [Cited by in Crossref: 426] [Cited by in F6Publishing: 409] [Article Influence: 32.8] [Reference Citation Analysis]
71 Bailey JM, Singh PK, Hollingsworth MA. Cancer metastasis facilitated by developmental pathways: Sonic hedgehog, Notch, and bone morphogenic proteins. J Cell Biochem. 2007;102:829-839. [PMID: 17914743 DOI: 10.1002/jcb.21509] [Cited by in Crossref: 149] [Cited by in F6Publishing: 142] [Article Influence: 10.6] [Reference Citation Analysis]
72 Nickoloff BJ, Hendrix MJ, Pollock PM, Trent JM, Miele L, Qin JZ. Notch and NOXA-related pathways in melanoma cells. J Investig Dermatol Symp Proc 2005;10:95-104. [PMID: 16363061 DOI: 10.1111/j.1087-0024.2005.200404.x] [Cited by in Crossref: 46] [Cited by in F6Publishing: 41] [Article Influence: 2.7] [Reference Citation Analysis]
73 Tsao PN, Vasconcelos M, Izvolsky KI, Qian J, Lu J, Cardoso WV. Notch signaling controls the balance of ciliated and secretory cell fates in developing airways. Development 2009;136:2297-307. [PMID: 19502490 DOI: 10.1242/dev.034884] [Cited by in Crossref: 236] [Cited by in F6Publishing: 226] [Article Influence: 18.2] [Reference Citation Analysis]
74 Zhang TH, Liu HC, Zhu LJ, Chu M, Liang YJ, Liang LZ, Liao GQ. Activation of Notch signaling in human tongue carcinoma. J Oral Pathol Med 2011;40:37-45. [PMID: 20819128 DOI: 10.1111/j.1600-0714.2010.00931.x] [Cited by in Crossref: 41] [Cited by in F6Publishing: 35] [Article Influence: 3.4] [Reference Citation Analysis]
75 Larrayoz IM, Ochoa-Callejero L, García-Sanmartín J, Vicario-Abejón C, Martínez A. Role of adrenomedullin in the growth and differentiation of stem and progenitor cells. Int Rev Cell Mol Biol 2012;297:175-234. [PMID: 22608560 DOI: 10.1016/B978-0-12-394308-8.00005-4] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
76 Poppleton H, Gilbertson RJ. Stem cells of ependymoma. Br J Cancer 2007;96:6-10. [PMID: 17179988 DOI: 10.1038/sj.bjc.6603519] [Cited by in Crossref: 62] [Cited by in F6Publishing: 50] [Article Influence: 3.9] [Reference Citation Analysis]
77 Kumamoto H, Ohki K. Detection of Notch signaling molecules in ameloblastomas: Notch signaling in ameloblastoma. Journal of Oral Pathology & Medicine 2008;37:228-34. [DOI: 10.1111/j.1600-0714.2007.00629.x] [Cited by in Crossref: 18] [Cited by in F6Publishing: 14] [Article Influence: 1.3] [Reference Citation Analysis]
78 Moeini A, Cornellà H, Villanueva A. Emerging signaling pathways in hepatocellular carcinoma. Liver Cancer. 2012;1:83-93. [PMID: 24159576 DOI: 10.1159/0003424-05] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
79 Fiaschetti G, Schroeder C, Castelletti D, Arcaro A, Westermann F, Baumgartner M, Shalaby T, Grotzer MA. NOTCH ligands JAG1 and JAG2 as critical pro-survival factors in childhood medulloblastoma. Acta Neuropathol Commun 2014;2:39. [PMID: 24708907 DOI: 10.1186/2051-5960-2-39] [Cited by in Crossref: 24] [Cited by in F6Publishing: 23] [Article Influence: 3.0] [Reference Citation Analysis]
80 Olsauskas-Kuprys R, Zlobin A, Osipo C. Gamma secretase inhibitors of Notch signaling. Onco Targets Ther 2013;6:943-55. [PMID: 23901284 DOI: 10.2147/OTT.S33766] [Cited by in Crossref: 27] [Cited by in F6Publishing: 67] [Article Influence: 3.0] [Reference Citation Analysis]
81 Pei Z, Baker NE. Competition between Delta and the Abruptex domain of Notch. BMC Dev Biol 2008;8:4. [PMID: 18208612 DOI: 10.1186/1471-213X-8-4] [Cited by in Crossref: 34] [Cited by in F6Publishing: 21] [Article Influence: 2.4] [Reference Citation Analysis]
82 Yeh JJ, Der CJ. Targeting signal transduction in pancreatic cancer treatment. Expert Opin Ther Targets 2007;11:673-94. [PMID: 17465725 DOI: 10.1517/14728222.11.5.673] [Cited by in Crossref: 38] [Cited by in F6Publishing: 41] [Article Influence: 2.5] [Reference Citation Analysis]
83 Iwai A, Takegami T, Shiozaki T, Miyazaki T. Hepatitis C virus NS3 protein can activate the Notch-signaling pathway through binding to a transcription factor, SRCAP. PLoS One. 2011;6:e20718. [PMID: 21673954 DOI: 10.1371/journal.pone.0020718] [Cited by in Crossref: 25] [Cited by in F6Publishing: 25] [Article Influence: 2.3] [Reference Citation Analysis]
84 Ahlborn GJ, Nelson GM, Ward WO, Knapp G, Allen JW, Ouyang M, Roop BC, Chen Y, O'brien T, Kitchin KT, Delker DA. Dose response evaluation of gene expression profiles in the skin of K6/ODC mice exposed to sodium arsenite. Toxicology and Applied Pharmacology 2008;227:400-16. [DOI: 10.1016/j.taap.2007.10.029] [Cited by in Crossref: 40] [Cited by in F6Publishing: 35] [Article Influence: 2.9] [Reference Citation Analysis]
85 Lee S, Kumano K, Masuda S, Hangaishi A, Takita J, Nakazaki K, Kurokawa M, Hayashi Y, Ogawa S, Chiba S. Mutations of the Notch1 gene in T-cell acute lymphoblastic leukemia: analysis in adults and children. Leukemia 2005;19:1841-3. [DOI: 10.1038/sj.leu.2403896] [Cited by in Crossref: 44] [Cited by in F6Publishing: 41] [Article Influence: 2.6] [Reference Citation Analysis]
86 Rowland BD, Peeper DS. KLF4, p21 and context-dependent opposing forces in cancer. Nat Rev Cancer 2006;6:11-23. [PMID: 16372018 DOI: 10.1038/nrc1780] [Cited by in Crossref: 381] [Cited by in F6Publishing: 367] [Article Influence: 23.8] [Reference Citation Analysis]
87 Kim SH, Hahm ER, Arlotti JA, Samanta SK, Moura MB, Thorne SH, Shuai Y, Anderson CJ, White AG, Lokshin A, Lee J, Singh SV. Withaferin A inhibits in vivo growth of breast cancer cells accelerated by Notch2 knockdown. Breast Cancer Res Treat 2016;157:41-54. [PMID: 27097807 DOI: 10.1007/s10549-016-3795-y] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 2.8] [Reference Citation Analysis]
88 Hai L, Zhang C, Li T, Zhou X, Liu B, Li S, Zhu M, Lin Y, Yu S, Zhang K, Ren B, Ming H, Huang Y, Chen L, Zhao P, Zhou H, Jiang T, Yang X. Notch1 is a prognostic factor that is distinctly activated in the classical and proneural subtype of glioblastoma and that promotes glioma cell survival via the NF-κB(p65) pathway. Cell Death Dis 2018;9:158. [PMID: 29410396 DOI: 10.1038/s41419-017-0119-z] [Cited by in Crossref: 28] [Cited by in F6Publishing: 25] [Article Influence: 7.0] [Reference Citation Analysis]
89 Igarashi S, Matsubara T, Harada K, Ikeda H, Sato Y, Sasaki M, Matsui O, Nakanuma Y. Bile duct expression of pancreatic and duodenal homeobox 1 in perihilar cholangiocarcinogenesis. Histopathology. 2012;61:266-276. [PMID: 22594685 DOI: 10.1111/j.1365-2559.2012.04218.x] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
90 Ristorcelli E, Lombardo D. Targeting Notch signaling in pancreatic cancer. Expert Opin Ther Targets. 2010;14:541-552. [PMID: 20392166 DOI: 10.1517/14728221003769895] [Cited by in Crossref: 33] [Cited by in F6Publishing: 30] [Article Influence: 2.8] [Reference Citation Analysis]
91 Dhar S, Kumar A, Zhang L, Rimando AM, Lage JM, Lewin JR, Atfi A, Zhang X, Levenson AS. Dietary pterostilbene is a novel MTA1-targeted chemopreventive and therapeutic agent in prostate cancer. Oncotarget 2016;7:18469-84. [PMID: 26943043 DOI: 10.18632/oncotarget.7841] [Cited by in Crossref: 43] [Cited by in F6Publishing: 37] [Article Influence: 8.6] [Reference Citation Analysis]
92 Vauclair S, Nicolas M, Barrandon Y, Radtke F. Notch1 is essential for postnatal hair follicle development and homeostasis. Dev Biol 2005;284:184-93. [PMID: 15978571 DOI: 10.1016/j.ydbio.2005.05.018] [Cited by in Crossref: 93] [Cited by in F6Publishing: 85] [Article Influence: 5.5] [Reference Citation Analysis]
93 Bertrand FE. The cross-talk of NOTCH and GSK-3 signaling in colon and other cancers. Biochim Biophys Acta Mol Cell Res 2020;1867:118738. [PMID: 32389646 DOI: 10.1016/j.bbamcr.2020.118738] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
94 Serra A, Schackert HK, Mohr B, Weise A, Liehr T, Fitze G. t(11;19)(q21;p12~p13.11) and MECT1-MAML2 fusion transcript expression as a prognostic marker in infantile lung mucoepidermoid carcinoma. J Pediatr Surg 2007;42:E23-9. [PMID: 17618868 DOI: 10.1016/j.jpedsurg.2007.04.031] [Cited by in Crossref: 21] [Cited by in F6Publishing: 17] [Article Influence: 1.4] [Reference Citation Analysis]
95 Liu Z, Xiao M, Balint K, Soma A, Pinnix CC, Capobianco AJ, Velazquez OC, Herlyn M, Liu Z, Xiao M, Balint K, Soma A, Pinnix CC, Capobianco AJ, Velazquez OC, Herlyn M. Inhibition of endothelial cell proliferation by Notch1 signaling is mediated by repressing MAPK and PI3K/Akt pathways and requires MAML1. FASEB j 2006;20:1009-11. [DOI: 10.1096/fj.05-4880fje] [Cited by in Crossref: 81] [Cited by in F6Publishing: 74] [Article Influence: 5.1] [Reference Citation Analysis]
96 Lee LA, Farris AD. Photosensitivity Diseases: Cutaneous Lupus Erythematosus. Journal of Investigative Dermatology Symposium Proceedings 1999;4:73-8. [DOI: 10.1038/sj.jidsp.5640186] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 0.8] [Reference Citation Analysis]
97 Kim HG, Hwang SY, Aaronson SA, Mandinova A, Lee SW. DDR1 receptor tyrosine kinase promotes prosurvival pathway through Notch1 activation. J Biol Chem 2011;286:17672-81. [PMID: 21398698 DOI: 10.1074/jbc.M111.236612] [Cited by in Crossref: 59] [Cited by in F6Publishing: 43] [Article Influence: 5.4] [Reference Citation Analysis]
98 Hayward P, Balayo T, Martinez Arias A. Notch synergizes with axin to regulate the activity of armadillo in Drosophila. Dev Dyn 2006;235:2656-66. [DOI: 10.1002/dvdy.20902] [Cited by in Crossref: 25] [Cited by in F6Publishing: 25] [Article Influence: 1.6] [Reference Citation Analysis]
99 Lubman OY, Kopan R, Waksman G, Korolev S. The crystal structure of a partial mouse Notch-1 ankyrin domain: repeats 4 through 7 preserve an ankyrin fold. Protein Sci 2005;14:1274-81. [PMID: 15802643 DOI: 10.1110/ps.041184105] [Cited by in Crossref: 25] [Cited by in F6Publishing: 25] [Article Influence: 1.5] [Reference Citation Analysis]
100 Pear WS, Simon MC. Lasting longer without oxygen: The influence of hypoxia on Notch signaling. Cancer Cell 2005;8:435-7. [PMID: 16338655 DOI: 10.1016/j.ccr.2005.11.016] [Cited by in Crossref: 31] [Cited by in F6Publishing: 31] [Article Influence: 1.9] [Reference Citation Analysis]
101 Leilei Y, Bing L, Yang L, Shaoxia W, Yuan X, Dongping W, Huahu Y, Shichen S, Guangzhou Z, Ruiyun P, Lin Z, Wenlong L. iRhom2 mutation leads to aberrant hair follicle differentiation in mice. PLoS One 2014;9:e115114. [PMID: 25546423 DOI: 10.1371/journal.pone.0115114] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 1.6] [Reference Citation Analysis]
102 Engin F, Bertin T, Ma O, Jiang MM, Wang L, Sutton RE, Donehower LA, Lee B. Notch signaling contributes to the pathogenesis of human osteosarcomas. Hum Mol Genet 2009;18:1464-70. [PMID: 19228774 DOI: 10.1093/hmg/ddp057] [Cited by in Crossref: 124] [Cited by in F6Publishing: 112] [Article Influence: 9.5] [Reference Citation Analysis]
103 Charles N, Ozawa T, Squatrito M, Bleau AM, Brennan CW, Hambardzumyan D, Holland EC. Perivascular nitric oxide activates notch signaling and promotes stem-like character in PDGF-induced glioma cells. Cell Stem Cell. 2010;6:141-152. [PMID: 20144787 DOI: 10.1016/j.stem.2010.01.001] [Cited by in Crossref: 349] [Cited by in F6Publishing: 320] [Article Influence: 29.1] [Reference Citation Analysis]
104 Zhou W, Wang G, Guo S. Regulation of angiogenesis via Notch signaling in breast cancer and cancer stem cells. Biochim Biophys Acta. 2013;1836:304-320. [PMID: 24183943 DOI: 10.1016/j.bbcan.2013.10.003] [Cited by in Crossref: 12] [Cited by in F6Publishing: 23] [Article Influence: 1.3] [Reference Citation Analysis]
105 Lin JT, Chen MK, Yeh KT, Chang CS, Chang TH, Lin CY, Wu YC, Su BW, Lee KD, Chang PJ. Association of high levels of Jagged-1 and Notch-1 expression with poor prognosis in head and neck cancer. Ann Surg Oncol. 2010;17:2976-2983. [PMID: 20517681 DOI: 10.1245/s10434-010-1118-9] [Cited by in Crossref: 59] [Cited by in F6Publishing: 49] [Article Influence: 4.9] [Reference Citation Analysis]
106 Souilhol C, Cormier S, Tanigaki K, Babinet C, Cohen-Tannoudji M. RBP-Jkappa-dependent notch signaling is dispensable for mouse early embryonic development. Mol Cell Biol. 2006;26:4769-4774. [PMID: 16782866 DOI: 10.1128/MCB.00319-06] [Cited by in Crossref: 38] [Cited by in F6Publishing: 13] [Article Influence: 2.4] [Reference Citation Analysis]
107 Karpathakis A, Dibra H, Thirlwell C. Neuroendocrine tumours: cracking the epigenetic code. Endocr Relat Cancer. 2013;20:R65-R82. [PMID: 23429748 DOI: 10.1530/erc-12-0338] [Cited by in Crossref: 42] [Cited by in F6Publishing: 21] [Article Influence: 4.7] [Reference Citation Analysis]
108 Bao B, Azmi AS, Ali S, Ahmad A, Li Y, Banerjee S, Kong D, Sarkar FH. The biological kinship of hypoxia with CSC and EMT and their relationship with deregulated expression of miRNAs and tumor aggressiveness. Biochim Biophys Acta. 2012;1826:272-296. [PMID: 22579961 DOI: 10.1016/j.bbcan.2012.04.008] [Cited by in Crossref: 38] [Cited by in F6Publishing: 80] [Article Influence: 3.8] [Reference Citation Analysis]
109 Robert-moreno A, Espinosa L, de la Pompa JL, Bigas A. RBPjκ-dependent Notch function regulates Gata2 and is essential for the formation of intra-embryonic hematopoietic cells. Development 2005;132:1117-26. [DOI: 10.1242/dev.01660] [Cited by in Crossref: 183] [Cited by in F6Publishing: 176] [Article Influence: 10.8] [Reference Citation Analysis]
110 Piana S, Zanetti E, Bisagni A, Ciarrocchi A, Giordano D, Torricelli F, Rossi T, Ragazzi M. Expression of NOTCH1 in thyroid cancer is mostly restricted to papillary carcinoma. Endocr Connect 2019;8:1089-96. [PMID: 31265994 DOI: 10.1530/EC-19-0303] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
111 Giovannini C, Gramantieri L, Minguzzi M, Fornari F, Chieco P, Grazi GL, Bolondi L. CDKN1C/P57 Is Regulated by the Notch Target Gene Hes1 and Induces Senescence in Human Hepatocellular Carcinoma. The American Journal of Pathology 2012;181:413-22. [DOI: 10.1016/j.ajpath.2012.04.019] [Cited by in Crossref: 42] [Cited by in F6Publishing: 39] [Article Influence: 4.2] [Reference Citation Analysis]
112 Villanueva A, Llovet JM. Targeted therapies for hepatocellular carcinoma. Gastroenterology 2011;140:1410-26. [PMID: 21406195 DOI: 10.1053/j.gastro.2011.03.006] [Cited by in Crossref: 310] [Cited by in F6Publishing: 310] [Article Influence: 28.2] [Reference Citation Analysis]
113 Jagani Z, Khosravi-far R. Cancer Stem Cells and Impaired Apoptosis. Programmed Cell Death in Cancer Progression and Therapy. Dordrecht: Springer Netherlands; 2008. pp. 331-44. [DOI: 10.1007/978-1-4020-6554-5_15] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 0.7] [Reference Citation Analysis]
114 Du H, Taylor HS. Stem cells and female reproduction. Reprod Sci 2009;16:126-39. [PMID: 19208782 DOI: 10.1177/1933719108329956] [Cited by in Crossref: 51] [Cited by in F6Publishing: 45] [Article Influence: 3.9] [Reference Citation Analysis]
115 Tiberi L, Bonnefont J, van den Ameele J, Le bon S, Herpoel A, Bilheu A, Baron B, Vanderhaeghen P. A BCL6/BCOR/SIRT1 Complex Triggers Neurogenesis and Suppresses Medulloblastoma by Repressing Sonic Hedgehog Signaling. Cancer Cell 2014;26:797-812. [DOI: 10.1016/j.ccell.2014.10.021] [Cited by in Crossref: 60] [Cited by in F6Publishing: 55] [Article Influence: 7.5] [Reference Citation Analysis]
116 Dontu G, Jackson KW, McNicholas E, Kawamura MJ, Abdallah WM, Wicha MS. Role of Notch signaling in cell-fate determination of human mammary stem/progenitor cells. Breast Cancer Res. 2004;6:R605-R615. [PMID: 15535842 DOI: 10.1186/bcr920] [Cited by in Crossref: 529] [Cited by in F6Publishing: 488] [Article Influence: 29.4] [Reference Citation Analysis]
117 Zacksenhaus E, Liu J, Jiang Z, Yao Y, Xia L, Shrestha M, Ben-david Y. Transcription Factors in Breast Cancer—Lessons From Recent Genomic Analyses and Therapeutic Implications. Chromatin Proteins and Transcription Factors as Therapeutic Targets. Elsevier; 2017. pp. 223-73. [DOI: 10.1016/bs.apcsb.2016.10.003] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 1.2] [Reference Citation Analysis]
118 Piazzi G, Fini L, Selgrad M, Garcia M, Daoud Y, Wex T, Malfertheiner P, Gasbarrini A, Romano M, Meyer RL, Genta RM, Fox JG, Boland CR, Bazzoli F, Ricciardiello L. Epigenetic regulation of Delta-Like1 controls Notch1 activation in gastric cancer. Oncotarget 2011;2:1291-301. [PMID: 22249198 DOI: 10.18632/oncotarget.414] [Cited by in Crossref: 41] [Cited by in F6Publishing: 39] [Article Influence: 4.1] [Reference Citation Analysis]
119 Polychronidou G, Kotoula V, Manousou K, Kostopoulos I, Karayannopoulou G, Vrettou E, Bobos M, Raptou G, Efstratiou I, Dionysopoulos D, Chatzopoulos K, Lakis S, Chrisafi S, Tsolakidis D, Papanikolaou A, Dombros N, Fountzilas G. Mismatch repair deficiency and aberrations in the Notch and Hedgehog pathways are of prognostic value in patients with endometrial cancer. PLoS One 2018;13:e0208221. [PMID: 30521558 DOI: 10.1371/journal.pone.0208221] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
120 Baumgart A, Mazur PK, Anton M, Rudelius M, Schwamborn K, Feuchtinger A, Behnke K, Walch A, Braren R, Peschel C, Duyster J, Siveke JT, Dechow T. Opposing role of Notch1 and Notch2 in a Kras(G12D)-driven murine non-small cell lung cancer model. Oncogene 2015;34:578-88. [PMID: 24509876 DOI: 10.1038/onc.2013.592] [Cited by in Crossref: 47] [Cited by in F6Publishing: 43] [Article Influence: 5.9] [Reference Citation Analysis]
121 McCright B, Lozier J, Gridley T. Generation of new Notch2 mutant alleles. Genesis 2006;44:29-33. [PMID: 16397869 DOI: 10.1002/gene.20181] [Cited by in Crossref: 72] [Cited by in F6Publishing: 73] [Article Influence: 4.5] [Reference Citation Analysis]
122 Zoccoli A, Iuliani M, Pantano F, Imperatori M, Intagliata S, Vincenzi B, Marchetti P, Papapietro N, Denaro V, Tonini G, Santini D. Premetastatic niche: ready for new therapeutic interventions? Expert Opin Ther Targets 2012;16 Suppl 2:S119-29. [PMID: 22443277 DOI: 10.1517/14728222.2012.656092] [Cited by in Crossref: 27] [Cited by in F6Publishing: 26] [Article Influence: 2.7] [Reference Citation Analysis]
123 Xu Y, Xue S, Zhou J, Voorhees JJ, Fisher GJ. Notch and TGF-β pathways cooperatively regulate receptor protein tyrosine phosphatase-κ (PTPRK) gene expression in human primary keratinocytes. Mol Biol Cell 2015;26:1199-206. [PMID: 25609089 DOI: 10.1091/mbc.E14-12-1591] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 1.4] [Reference Citation Analysis]
124 Yoo KW, Kim EH, Jung SH, Rhee M, Koo BK, Yoon KJ, Kong YY, Kim CH. Snx5, as a Mind bomb-binding protein, is expressed in hematopoietic and endothelial precursor cells in zebrafish. FEBS Lett 2006;580:4409-16. [PMID: 16857196 DOI: 10.1016/j.febslet.2006.07.009] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 1.1] [Reference Citation Analysis]
125 Vooijs M, Schroeter EH, Pan Y, Blandford M, Kopan R. Ectodomain Shedding and Intramembrane Cleavage of Mammalian Notch Proteins Are Not Regulated through Oligomerization. Journal of Biological Chemistry 2004;279:50864-73. [DOI: 10.1074/jbc.m409430200] [Cited by in Crossref: 54] [Cited by in F6Publishing: 40] [Article Influence: 3.0] [Reference Citation Analysis]
126 Lundkvist J, Zhu S, Hansson EM, Schweinhardt P, Miao Q, Beatus P, Dannaeus K, Karlström H, Johansson CB, Viitanen M, Rozell B, Spenger C, Mohammed A, Kalimo H, Lendahl U. Mice carrying a R142C Notch 3 knock-in mutation do not develop a CADASIL-like phenotype. Genesis 2005;41:13-22. [PMID: 15645445 DOI: 10.1002/gene.20091] [Cited by in Crossref: 32] [Cited by in F6Publishing: 28] [Article Influence: 1.9] [Reference Citation Analysis]
127 Xu Y, Xu S, Cai Y, Liu L. Qingyihuaji Formula Inhibits Pancreatic Cancer and Prolongs Survival by Downregulating Hes-1 and Hey-1. Evid Based Complement Alternat Med 2015;2015:145016. [PMID: 26783407 DOI: 10.1155/2015/145016] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
128 Pyrzynska B, Pilecka I, Miaczynska M. Endocytic proteins in the regulation of nuclear signaling, transcription and tumorigenesis. Mol Oncol 2009;3:321-38. [PMID: 19577966 DOI: 10.1016/j.molonc.2009.06.001] [Cited by in Crossref: 43] [Cited by in F6Publishing: 45] [Article Influence: 3.3] [Reference Citation Analysis]
129 Quillard T, Devalliere J, Chatelais M, Coulon F, Séveno C, Romagnoli M, Barillé Nion S, Charreau B. Notch2 signaling sensitizes endothelial cells to apoptosis by negatively regulating the key protective molecule survivin. PLoS One 2009;4:e8244. [PMID: 20011512 DOI: 10.1371/journal.pone.0008244] [Cited by in Crossref: 44] [Cited by in F6Publishing: 45] [Article Influence: 3.4] [Reference Citation Analysis]
130 Giakoustidis A, Giakoustidis D, Mudan S, Sklavos A, Williams R. Molecular signalling in hepatocellular carcinoma: Role of and crosstalk among WNT/ß-catenin, Sonic Hedgehog, Notch and Dickkopf-1. Can J Gastroenterol Hepatol 2015;29:209-17. [PMID: 25965442 DOI: 10.1155/2015/172356] [Cited by in Crossref: 34] [Cited by in F6Publishing: 33] [Article Influence: 5.7] [Reference Citation Analysis]
131 Zhang P, Yang Y, Zweidler-McKay PA, Hughes DP. Critical role of notch signaling in osteosarcoma invasion and metastasis. Clin Cancer Res 2008;14:2962-9. [PMID: 18483362 DOI: 10.1158/1078-0432.CCR-07-1992] [Cited by in Crossref: 114] [Cited by in F6Publishing: 58] [Article Influence: 8.1] [Reference Citation Analysis]
132 Wakabayashi N, Shin S, Slocum SL, Agoston ES, Wakabayashi J, Kwak MK, Misra V, Biswal S, Yamamoto M, Kensler TW. Regulation of notch1 signaling by nrf2: implications for tissue regeneration. Sci Signal. 2010;3:ra52. [PMID: 20628156 DOI: 10.1126/scisignal.2000762] [Cited by in Crossref: 135] [Cited by in F6Publishing: 140] [Article Influence: 11.3] [Reference Citation Analysis]
133 Li G, Zhou Z, Zhou H, Zhao L, Chen D, Chen H, Zou H, Qi Y, Jia W, Pang L. The expression profile and clinicopathological significance of Notch1 in patients with colorectal cancer: a meta-analysis. Future Oncol 2017;13:2103-18. [PMID: 28984154 DOI: 10.2217/fon-2017-0178] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
134 Fukuda K, Yuasa S. Stem cells as a source of regenerative cardiomyocytes. Circ Res 2006;98:1002-13. [PMID: 16645150 DOI: 10.1161/01.RES.0000218272.18669.6e] [Cited by in Crossref: 95] [Cited by in F6Publishing: 35] [Article Influence: 5.9] [Reference Citation Analysis]
135 Mysliwiec P, Boucher MJ. Targeting Notch signaling in pancreatic cancer patients--rationale for new therapy. Adv Med Sci 2009;54:136-42. [PMID: 19758972 DOI: 10.2478/v10039-009-0026-3] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 1.4] [Reference Citation Analysis]
136 Munro D, Ghersi D, Singh M. Two critical positions in zinc finger domains are heavily mutated in three human cancer types. PLoS Comput Biol 2018;14:e1006290. [PMID: 29953437 DOI: 10.1371/journal.pcbi.1006290] [Cited by in Crossref: 19] [Cited by in F6Publishing: 11] [Article Influence: 4.8] [Reference Citation Analysis]
137 Belandia B, Parker MG. Nuclear receptor regulation gears up another Notch. Nucl Recept Signal 2006;4:e001. [PMID: 16604164 DOI: 10.1621/nrs.04001] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.4] [Reference Citation Analysis]
138 Gallardo F, Sandoval J, Díaz-lagares A, Garcia R, D'altri T, González J, Alegre V, Servitje O, Crujeiras A, Stefánsson Ó, Espinet B, Hernández M, Bellosillo B, Esteller M, Pujol R, Bigas A, Espinosa L. Notch1 Pathway Activation Results from the Epigenetic Abrogation of Notch-Related MicroRNAs in Mycosis Fungoides. Journal of Investigative Dermatology 2015;135:3144-52. [DOI: 10.1038/jid.2015.328] [Cited by in Crossref: 22] [Cited by in F6Publishing: 21] [Article Influence: 3.1] [Reference Citation Analysis]
139 Collins M, Michot JM, Bellanger C, Mussini C, Benhadji K, Massard C, Carbonnel F. Notch inhibitors induce diarrhea, hypercrinia and secretory cell metaplasia in the human colon. EXCLI J 2021;20:819-27. [PMID: 34121974 DOI: 10.17179/excli2021-3572] [Reference Citation Analysis]
140 Yang SA, Deng WM. Serrate/Notch Signaling Regulates the Size of the Progenitor Cell Pool in Drosophila Imaginal Rings. Genetics 2018;209:829-43. [PMID: 29773559 DOI: 10.1534/genetics.118.300963] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
141 Román-trufero M, Méndez-gómez HR, Pérez C, Hijikata A, Fujimura Y, Endo T, Koseki H, Vicario-abejón C, Vidal M. Maintenance of Undifferentiated State and Self-Renewal of Embryonic Neural Stem Cells by Polycomb Protein Ring1B. Stem Cells 2009;27:1559-70. [DOI: 10.1002/stem.82] [Cited by in Crossref: 49] [Cited by in F6Publishing: 49] [Article Influence: 3.8] [Reference Citation Analysis]
142 Lever J, Zhao EY, Grewal J, Jones MR, Jones SJM. CancerMine: a literature-mined resource for drivers, oncogenes and tumor suppressors in cancer. Nat Methods 2019;16:505-7. [DOI: 10.1038/s41592-019-0422-y] [Cited by in Crossref: 49] [Cited by in F6Publishing: 37] [Article Influence: 16.3] [Reference Citation Analysis]
143 Hezel AF, Ryan DP. Emerging therapies for colorectal cancer. Expert Opin Investig Drugs 2007;16:867-76. [PMID: 17501698 DOI: 10.1517/13543784.16.6.867] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
144 Kwon OJ, Zhang L, Wang J, Su Q, Feng Q, Zhang XH, Mani SA, Paulter R, Creighton CJ, Ittmann MM, Xin L. Notch promotes tumor metastasis in a prostate-specific Pten-null mouse model. J Clin Invest 2016;126:2626-41. [PMID: 27294523 DOI: 10.1172/JCI84637] [Cited by in Crossref: 37] [Cited by in F6Publishing: 23] [Article Influence: 6.2] [Reference Citation Analysis]
145 Saw PE, Xu X, Chen J, Song EW. Non-coding RNAs: the new central dogma of cancer biology. Sci China Life Sci 2021;64:22-50. [PMID: 32930921 DOI: 10.1007/s11427-020-1700-9] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
146 Manier S, Sacco A, Leleu X, Ghobrial IM, Roccaro AM. Bone marrow microenvironment in multiple myeloma progression. J Biomed Biotechnol. 2012;2012:157496. [PMID: 23093834 DOI: 10.1155/2012/157496] [Cited by in Crossref: 169] [Cited by in F6Publishing: 173] [Article Influence: 16.9] [Reference Citation Analysis]
147 Mo JS, Kim MY, Han SO, Kim IS, Ann EJ, Lee KS, Seo MS, Kim JY, Lee SC, Park JW, Choi EJ, Seong JY, Joe CO, Faessler R, Park HS. Integrin-linked kinase controls Notch1 signaling by down-regulation of protein stability through Fbw7 ubiquitin ligase. Mol Cell Biol 2007;27:5565-74. [PMID: 17526737 DOI: 10.1128/MCB.02372-06] [Cited by in Crossref: 40] [Cited by in F6Publishing: 22] [Article Influence: 2.7] [Reference Citation Analysis]
148 Bhagwandin VJ, Shay JW. Pancreatic cancer stem cells: fact or fiction? Biochim Biophys Acta 2009;1792:248-59. [PMID: 19233264 DOI: 10.1016/j.bbadis.2009.02.007] [Cited by in Crossref: 26] [Cited by in F6Publishing: 29] [Article Influence: 2.0] [Reference Citation Analysis]
149 Ma B, Simala-grant JL, Taylor DE. Fucosylation in prokaryotes and eukaryotes. Glycobiology 2006;16:158R-84R. [DOI: 10.1093/glycob/cwl040] [Cited by in Crossref: 284] [Cited by in F6Publishing: 268] [Article Influence: 17.8] [Reference Citation Analysis]
150 Sun L, Yang Q, Wang P, Liu D, Liang W, Lin S, Yuan S. The influence of YS-1 on the Dll4-Notch1 signaling pathway. Acta Biochim Biophys Sin (Shanghai) 2014;46:56-64. [PMID: 24274976 DOI: 10.1093/abbs/gmt125] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
151 Jin HY, Zhang HY, Wang X, Xu J, Ding Y. Expression and clinical significance of Notch signaling genes in colorectal cancer. Tumour Biol 2012;33:817-24. [PMID: 22219033 DOI: 10.1007/s13277-011-0301-3] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 0.9] [Reference Citation Analysis]
152 García Campelo MR, Alonso Curbera G, Aparicio Gallego G, Grande Pulido E, Antón Aparicio LM. Stem cell and lung cancer development: blaming the Wnt, Hh and Notch signalling pathway. Clin Transl Oncol 2011;13:77-83. [PMID: 21324794 DOI: 10.1007/s12094-011-0622-0] [Cited by in Crossref: 32] [Cited by in F6Publishing: 34] [Article Influence: 2.9] [Reference Citation Analysis]
153 Nowell CS, Radtke F. Notch as a tumour suppressor. Nat Rev Cancer 2017;17:145-59. [PMID: 28154375 DOI: 10.1038/nrc.2016.145] [Cited by in Crossref: 173] [Cited by in F6Publishing: 163] [Article Influence: 34.6] [Reference Citation Analysis]
154 Madonna R, Pieragostino D, Cufaro MC, Doria V, Del Boccio P, Deidda M, Pierdomenico SD, Dessalvi CC, De Caterina R, Mercuro G. Ponatinib Induces Vascular Toxicity through the Notch-1 Signaling Pathway. J Clin Med 2020;9:E820. [PMID: 32197359 DOI: 10.3390/jcm9030820] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
155 Büchler P, Gazdhar A, Schubert M, Giese N, Reber HA, Hines OJ, Giese T, Ceyhan GO, Müller M, Büchler MW, Friess H. The Notch signaling pathway is related to neurovascular progression of pancreatic cancer. Ann Surg 2005;242:791-800, discussion 800-1. [PMID: 16327489 DOI: 10.1097/01.sla.0000189115.94847.f1] [Cited by in Crossref: 65] [Cited by in F6Publishing: 61] [Article Influence: 4.1] [Reference Citation Analysis]
156 Müller CSL. Notch Signaling and Malignant Melanoma. In: Reichrath J, Reichrath S, editors. Notch Signaling in Embryology and Cancer. New York: Springer US; 2012. pp. 258-64. [DOI: 10.1007/978-1-4614-0899-4_19] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 1.5] [Reference Citation Analysis]
157 Ma D, Dong X, Zang S, Ma R, Zhao P, Guo D, Dai J, Chen F, Ye J, Ji C. Aberrant expression and clinical correlation of Notch signaling molecules in breast cancer of Chinese population. Asia Pac J Clin Oncol 2011;7:385-91. [PMID: 22151989 DOI: 10.1111/j.1743-7563.2011.01433.x] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 1.2] [Reference Citation Analysis]
158 Balint K, Xiao M, Pinnix CC, Soma A, Veres I, Juhasz I, Brown EJ, Capobianco AJ, Herlyn M, Liu ZJ. Activation of Notch1 signaling is required for beta-catenin-mediated human primary melanoma progression. J Clin Invest 2005;115:3166-76. [PMID: 16239965 DOI: 10.1172/JCI25001] [Cited by in Crossref: 244] [Cited by in F6Publishing: 135] [Article Influence: 14.4] [Reference Citation Analysis]
159 Estella C, Baonza A. Cell proliferation control by Notch signalling during imaginal discs development in Drosophila. AIMS Genetics 2021;02:070-96. [DOI: 10.3934/genet.2015.1.70] [Cited by in Crossref: 6] [Cited by in F6Publishing: 1] [Article Influence: 6.0] [Reference Citation Analysis]
160 Qian CJ, Yao J, Si JM. Nuclear JAK2: form and function in cancer. Anat Rec (Hoboken) 2011;294:1446-59. [PMID: 21809458 DOI: 10.1002/ar.21443] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 0.8] [Reference Citation Analysis]
161 Mertins SD. Cancer stem cells: a systems biology view of their role in prognosis and therapy. Anticancer Drugs. 2014;25:353-367. [PMID: 24418909 DOI: 10.1097/CAD.0000000000000075] [Cited by in Crossref: 25] [Cited by in F6Publishing: 16] [Article Influence: 3.1] [Reference Citation Analysis]
162 Vázquez-Ulloa E, Ramos-Cruz AC, Prada D, Avilés-Salas A, Chávez-Blanco AD, Herrera LA, Lizano M, Contreras-Paredes A. Loss of nuclear NOTCH1, but not its negative regulator NUMB, is an independent predictor of cervical malignancy. Oncotarget 2018;9:18916-28. [PMID: 29721172 DOI: 10.18632/oncotarget.24828] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
163 Quillard T, Devallière J, Coupel S, Charreau B. Inflammation dysregulates Notch signaling in endothelial cells: implication of Notch2 and Notch4 to endothelial dysfunction. Biochem Pharmacol 2010;80:2032-41. [PMID: 20643108 DOI: 10.1016/j.bcp.2010.07.010] [Cited by in Crossref: 55] [Cited by in F6Publishing: 58] [Article Influence: 4.6] [Reference Citation Analysis]
164 Rose SL, Kunnimalaiyaan M, Drenzek J, Seiler N. Notch 1 signaling is active in ovarian cancer. Gynecol Oncol 2010;117:130-3. [PMID: 20060575 DOI: 10.1016/j.ygyno.2009.12.003] [Cited by in Crossref: 72] [Cited by in F6Publishing: 66] [Article Influence: 6.0] [Reference Citation Analysis]
165 Ryeom SW. The cautionary tale of side effects of chronic Notch1 inhibition. J Clin Invest 2011;121:508-9. [DOI: 10.1172/jci45976] [Cited by in Crossref: 31] [Cited by in F6Publishing: 25] [Article Influence: 2.8] [Reference Citation Analysis]
166 Yu XM, Jaskula-Sztul R, Georgen MR, Aburjania Z, Somnay YR, Leverson G, Sippel RS, Lloyd RV, Johnson BP, Chen H. Notch1 Signaling Regulates the Aggressiveness of Differentiated Thyroid Cancer and Inhibits SERPINE1 Expression. Clin Cancer Res 2016;22:3582-92. [PMID: 26847059 DOI: 10.1158/1078-0432.CCR-15-1749] [Cited by in Crossref: 22] [Cited by in F6Publishing: 17] [Article Influence: 3.7] [Reference Citation Analysis]
167 Koçer SS, Djurić PM, Bugallo MF, Simon SR, Matic M. Transcriptional profiling of putative human epithelial stem cells. BMC Genomics 2008;9:359. [PMID: 18667080 DOI: 10.1186/1471-2164-9-359] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 0.9] [Reference Citation Analysis]
168 Hong KJ, Wu DC, Cheng KH, Chen LT, Hung WC. RECK inhibits stemness gene expression and tumorigenicity of gastric cancer cells by suppressing ADAM-mediated Notch1 activation. J Cell Physiol 2014;229:191-201. [PMID: 23881612 DOI: 10.1002/jcp.24434] [Cited by in Crossref: 35] [Cited by in F6Publishing: 43] [Article Influence: 3.9] [Reference Citation Analysis]
169 Chang H, Gwack Y, Kingston D, Souvlis J, Liang X, Means RE, Cesarman E, Hutt-Fletcher L, Jung JU. Activation of CD21 and CD23 gene expression by Kaposi's sarcoma-associated herpesvirus RTA. J Virol 2005;79:4651-63. [PMID: 15795251 DOI: 10.1128/JVI.79.8.4651-4663.2005] [Cited by in Crossref: 26] [Cited by in F6Publishing: 20] [Article Influence: 1.5] [Reference Citation Analysis]
170 Shi W, Harris AL. Notch signaling in breast cancer and tumor angiogenesis: cross-talk and therapeutic potentials. J Mammary Gland Biol Neoplasia. 2006;11:41-52. [PMID: 16947085 DOI: 10.1007/s10911-006-9011-7] [Cited by in Crossref: 51] [Cited by in F6Publishing: 54] [Article Influence: 3.4] [Reference Citation Analysis]
171 Sethi N, Kang Y. Notch signaling: mediator and therapeutic target of bone metastasis. Bonekey Rep 2012;1:3. [PMID: 23951415 DOI: 10.1038/bonekey.2012.2] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 0.9] [Reference Citation Analysis]
172 Huntly BJ, Gilliland DG. Leukaemia stem cells and the evolution of cancer-stem-cell research. Nat Rev Cancer. 2005;5:311-321. [PMID: 15803157 DOI: 10.1038/nrc1592] [Cited by in Crossref: 400] [Cited by in F6Publishing: 357] [Article Influence: 23.5] [Reference Citation Analysis]
173 Jia D, Underwood J, Xu Q, Xie Q. NOTCH2/NOTCH3/DLL3/MAML1/ADAM17 signaling network is associated with ovarian cancer. Oncol Lett 2019;17:4914-20. [PMID: 31186700 DOI: 10.3892/ol.2019.10170] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
174 Lee JM, Lee KH, Farrell CJ, Ling PD, Kempkes B, Park JH, Hayward SD. EBNA2 is required for protection of latently Epstein-Barr virus-infected B cells against specific apoptotic stimuli. J Virol 2004;78:12694-7. [PMID: 15507659 DOI: 10.1128/JVI.78.22.12694-12697.2004] [Cited by in Crossref: 28] [Cited by in F6Publishing: 19] [Article Influence: 1.6] [Reference Citation Analysis]
175 Chang H, Dittmer DP, Shin YC, Hong Y, Jung JU. Role of Notch signal transduction in Kaposi's sarcoma-associated herpesvirus gene expression. J Virol 2005;79:14371-82. [PMID: 16254371 DOI: 10.1128/JVI.79.22.14371-14382.2005] [Cited by in Crossref: 55] [Cited by in F6Publishing: 39] [Article Influence: 3.4] [Reference Citation Analysis]
176 Kang H, An HJ, Song JY, Kim TH, Heo JH, Ahn DH, Kim G. Notch3 and Jagged2 contribute to gastric cancer development and to glandular differentiation associated with MUC2 and MUC5AC expression. Histopathology. 2012;61:576-586. [PMID: 22691042 DOI: 10.1111/j.1365-2559.2012.04274.x] [Cited by in Crossref: 33] [Cited by in F6Publishing: 38] [Article Influence: 5.5] [Reference Citation Analysis]
177 Hu J, Yu J, Gan J, Song N, Shi L, Liu J, Zhang Z, Du J. Notch1/2/3/4 are prognostic biomarker and correlated with immune infiltrates in gastric cancer. Aging (Albany NY) 2020;12:2595-609. [PMID: 32028262 DOI: 10.18632/aging.102764] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 4.5] [Reference Citation Analysis]
178 Su Q, Zhang B, Zhang L, Dang T, Rowley D, Ittmann M, Xin L. Jagged1 upregulation in prostate epithelial cells promotes formation of reactive stroma in the Pten null mouse model for prostate cancer. Oncogene 2017;36:618-27. [PMID: 27345403 DOI: 10.1038/onc.2016.232] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 3.3] [Reference Citation Analysis]
179 Copeland JN, Feng Y, Neradugomma NK, Fields PE, Vivian JL. Notch signaling regulates remodeling and vessel diameter in the extraembryonic yolk sac. BMC Dev Biol 2011;11:12. [PMID: 21352545 DOI: 10.1186/1471-213X-11-12] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 1.4] [Reference Citation Analysis]
180 Chu D, Wang W, Xie H, Li Y, Dong G, Xu C, Chen D, Zheng J, Li M, Lu Z, Ji G. Notch1 expression in colorectal carcinoma determines tumor differentiation status. J Gastrointest Surg. 2009;13:253-260. [PMID: 18777195 DOI: 10.1007/s11605-008-0689-2] [Cited by in Crossref: 25] [Cited by in F6Publishing: 23] [Article Influence: 1.8] [Reference Citation Analysis]
181 Zarebczan B, Chen H. Signaling mechanisms in neuroendocrine tumors as targets for therapy. Endocrinol Metab Clin North Am 2010;39:801-10. [PMID: 21095546 DOI: 10.1016/j.ecl.2010.08.002] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.0] [Reference Citation Analysis]
182 Kang W, Zhang J, Huang T, Zhou Y, Wong CC, Chan RCK, Dong Y, Wu F, Zhang B, Wu WKK, Chan MWY, Cheng ASL, Yu J, Wong N, Lo KW, To KF. NOTCH3, a crucial target of miR-491-5p/miR-875-5p, promotes gastric carcinogenesis by upregulating PHLDB2 expression and activating Akt pathway. Oncogene 2021;40:1578-94. [PMID: 33452458 DOI: 10.1038/s41388-020-01579-3] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
183 Khandelwal A, Chandu D, Roe CM, Kopan R, Quatrano RS. Moonlighting activity of presenilin in plants is independent of gamma-secretase and evolutionarily conserved. Proc Natl Acad Sci U S A 2007;104:13337-42. [PMID: 17684101 DOI: 10.1073/pnas.0702038104] [Cited by in Crossref: 47] [Cited by in F6Publishing: 41] [Article Influence: 3.1] [Reference Citation Analysis]
184 Ren K, Li T, Zhang W, Ren J, Li Z, Wu G. miR-199a-3p inhibits cell proliferation and induces apoptosis by targeting YAP1, suppressing Jagged1-Notch signaling in human hepatocellular carcinoma. J Biomed Sci. 2016;23:79. [PMID: 27832779 DOI: 10.1186/s12929-016-0295-7] [Cited by in Crossref: 30] [Cited by in F6Publishing: 34] [Article Influence: 5.0] [Reference Citation Analysis]
185 Niimi H, Pardali K, Vanlandewijck M, Heldin CH, Moustakas A. Notch signaling is necessary for epithelial growth arrest by TGF-beta. J Cell Biol 2007;176:695-707. [PMID: 17325209 DOI: 10.1083/jcb.200612129] [Cited by in Crossref: 102] [Cited by in F6Publishing: 95] [Article Influence: 6.8] [Reference Citation Analysis]
186 Catalano V, Gaggianesi M, Spina V, Iovino F, Dieli F, Stassi G, Todaro M. Colorectal cancer stem cells and cell death. Cancers (Basel) 2011;3:1929-46. [PMID: 24212789 DOI: 10.3390/cancers3021929] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 1.2] [Reference Citation Analysis]
187 Kim HA, Koo BK, Cho JH, Kim YY, Seong J, Chang HJ, Oh YM, Stange DE, Park JG, Hwang D. Notch1 counteracts WNT/β-catenin signaling through chromatin modification in colorectal cancer. J Clin Invest. 2012;122:3248-3259. [PMID: 22863622 DOI: 10.1172/jci61216] [Cited by in Crossref: 81] [Cited by in F6Publishing: 62] [Article Influence: 8.1] [Reference Citation Analysis]
188 Panaroni C, Yee AJ, Raje NS. Myeloma and Bone Disease. Curr Osteoporos Rep 2017;15:483-98. [DOI: 10.1007/s11914-017-0397-5] [Cited by in Crossref: 23] [Cited by in F6Publishing: 20] [Article Influence: 4.6] [Reference Citation Analysis]
189 Roese-Koerner B, Stappert L, Berger T, Braun NC, Veltel M, Jungverdorben J, Evert BO, Peitz M, Borghese L, Brüstle O. Reciprocal Regulation between Bifunctional miR-9/9(∗) and its Transcriptional Modulator Notch in Human Neural Stem Cell Self-Renewal and Differentiation. Stem Cell Reports 2016;7:207-19. [PMID: 27426040 DOI: 10.1016/j.stemcr.2016.06.008] [Cited by in Crossref: 28] [Cited by in F6Publishing: 24] [Article Influence: 4.7] [Reference Citation Analysis]
190 Nemir M, Pedrazzini T. Functional role of Notch signaling in the developing and postnatal heart. J Mol Cell Cardiol. 2008;45:495-504. [PMID: 18410944 DOI: 10.1016/j.yjmcc.2008.02.273] [Cited by in Crossref: 53] [Cited by in F6Publishing: 56] [Article Influence: 3.8] [Reference Citation Analysis]
191 Lu J, Song G, Tang Q, Yin J, Zou C, Zhao Z, Xie X, Xu H, Huang G, Wang J, Lee DF, Khokha R, Yang H, Shen J. MiR-26a inhibits stem cell-like phenotype and tumor growth of osteosarcoma by targeting Jagged1. Oncogene 2017;36:231-41. [PMID: 27270422 DOI: 10.1038/onc.2016.194] [Cited by in Crossref: 49] [Cited by in F6Publishing: 57] [Article Influence: 8.2] [Reference Citation Analysis]
192 Zhao WX, Lin JH. Notch signaling pathway and human placenta. Int J Med Sci 2012;9:447-52. [PMID: 22859905 DOI: 10.7150/ijms.4593] [Cited by in Crossref: 23] [Cited by in F6Publishing: 22] [Article Influence: 2.3] [Reference Citation Analysis]
193 Blumenberg M, Gao S, Dickman K, Grollman AP, Bottinger EP, Zavadil J. Chromatin Structure Regulation in Transforming Growth Factor-β-Directed Epithelial-Mesenchymal Transition. Cells Tissues Organs 2007;185:162-74. [DOI: 10.1159/000101317] [Cited by in Crossref: 18] [Cited by in F6Publishing: 13] [Article Influence: 1.2] [Reference Citation Analysis]
194 Hansson EM, Strömberg K, Bergstedt S, Yu G, Näslund J, Lundkvist J, Lendahl U. Aph-1 interacts at the cell surface with proteins in the active γ-secretase complex and membrane-tethered Notch: Aph-1 and Notch at the cell surface. Journal of Neurochemistry 2005;92:1010-20. [DOI: 10.1111/j.1471-4159.2004.02926.x] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 1.1] [Reference Citation Analysis]
195 Lee SM, Jung CK, Ko YH, Choi JY, Lee KY, Kang CS. Expression of Notch 1 and 3 is related to inhibition of lymph node metastasis and progression in non-small cell lung carcinomas. Basic and Applied Pathology 2008;1:93-7. [DOI: 10.1111/j.1755-9294.2008.00020.x] [Cited by in Crossref: 8] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
196 Kostianovsky AM, Maier LM, Baecher-allan C, Anderson AC, Anderson DE. Up-Regulation of Gene Related to Anergy in Lymphocytes Is Associated with Notch-Mediated Human T Cell Suppression. J Immunol 2007;178:6158-63. [DOI: 10.4049/jimmunol.178.10.6158] [Cited by in Crossref: 32] [Cited by in F6Publishing: 28] [Article Influence: 2.1] [Reference Citation Analysis]
197 Herranz H, Pérez L, Martín FA, Milán M. A Wingless and Notch double-repression mechanism regulates G1-S transition in the Drosophila wing. EMBO J 2008;27:1633-45. [PMID: 18451803 DOI: 10.1038/emboj.2008.84] [Cited by in Crossref: 79] [Cited by in F6Publishing: 80] [Article Influence: 5.6] [Reference Citation Analysis]
198 Mourikis P, Tajbakhsh S. Distinct contextual roles for Notch signalling in skeletal muscle stem cells. BMC Dev Biol 2014;14:2. [PMID: 24472470 DOI: 10.1186/1471-213X-14-2] [Cited by in Crossref: 78] [Cited by in F6Publishing: 49] [Article Influence: 9.8] [Reference Citation Analysis]
199 Drenzek JG, Seiler NL, Jaskula-Sztul R, Rausch MM, Rose SL. Xanthohumol decreases Notch1 expression and cell growth by cell cycle arrest and induction of apoptosis in epithelial ovarian cancer cell lines. Gynecol Oncol 2011;122:396-401. [PMID: 21616523 DOI: 10.1016/j.ygyno.2011.04.027] [Cited by in Crossref: 54] [Cited by in F6Publishing: 55] [Article Influence: 4.9] [Reference Citation Analysis]
200 Halani SH, Yousefi S, Velazquez Vega J, Rossi MR, Zhao Z, Amrollahi F, Holder CA, Baxter-Stoltzfus A, Eschbacher J, Griffith B, Olson JJ, Jiang T, Yates JR, Eberhart CG, Poisson LM, Cooper LAD, Brat DJ. Multi-faceted computational assessment of risk and progression in oligodendroglioma implicates NOTCH and PI3K pathways. NPJ Precis Oncol 2018;2:24. [PMID: 30417117 DOI: 10.1038/s41698-018-0067-9] [Cited by in Crossref: 19] [Cited by in F6Publishing: 15] [Article Influence: 4.8] [Reference Citation Analysis]
201 Krikelis D, Pentheroudakis G, Goussia A, Siozopoulou V, Bobos M, Petrakis D, Stoyianni A, Golfinopoulos V, Cervantes A, Ciuleanu T, Fountzilas G, Malamou-mitsi V, Pavlidis N. Profiling immunohistochemical expression of NOTCH1–3, JAGGED1, cMET, and phospho-MAPK in 100 carcinomas of unknown primary. Clin Exp Metastasis 2012;29:603-14. [DOI: 10.1007/s10585-012-9474-4] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 1.2] [Reference Citation Analysis]
202 Sun L, Ke J, He Z, Chen Z, Huang Q, Ai W, Wang G, Wei Y, Zou X, Zhang S, Lan P, Hong C. HES1 Promotes Colorectal Cancer Cell Resistance To 5-Fu by Inducing Of EMT and ABC Transporter Proteins. J Cancer 2017;8:2802-8. [PMID: 28928869 DOI: 10.7150/jca.19142] [Cited by in Crossref: 28] [Cited by in F6Publishing: 34] [Article Influence: 5.6] [Reference Citation Analysis]
203 Lockwood WW, Coe BP, Williams AC, MacAulay C, Lam WL. Whole genome tiling path array CGH analysis of segmental copy number alterations in cervical cancer cell lines. Int J Cancer 2007;120:436-43. [PMID: 17096350 DOI: 10.1002/ijc.22335] [Cited by in Crossref: 29] [Cited by in F6Publishing: 29] [Article Influence: 1.9] [Reference Citation Analysis]
204 Katoh M. Networking of WNT, FGF, Notch, BMP, and Hedgehog signaling pathways during carcinogenesis. Stem Cell Rev 2007;3:30-8. [PMID: 17873379 DOI: 10.1007/s12015-007-0006-6] [Cited by in Crossref: 201] [Cited by in F6Publishing: 195] [Article Influence: 13.4] [Reference Citation Analysis]
205 Bae Y, Yang T, Zeng HC, Campeau PM, Chen Y, Bertin T, Dawson BC, Munivez E, Tao J, Lee BH. miRNA-34c regulates Notch signaling during bone development. Hum Mol Genet 2012;21:2991-3000. [PMID: 22498974 DOI: 10.1093/hmg/dds129] [Cited by in Crossref: 162] [Cited by in F6Publishing: 151] [Article Influence: 16.2] [Reference Citation Analysis]
206 Ercan C, Vermeulen JF, Hoefnagel L, Bult P, van der Groep P, van der Wall E, van Diest PJ. HIF-1α and NOTCH signaling in ductal and lobular carcinomas of the breast. Cell Oncol 2012;35:435-42. [DOI: 10.1007/s13402-012-0102-8] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.1] [Reference Citation Analysis]
207 Yasui H, Hideshima T, Richardson PG, Anderson KC. Novel therapeutic strategies targeting growth factor signalling cascades in multiple myeloma. Br J Haematol. 2006;132:385-397. [PMID: 16412014 DOI: 10.1111/j.1365-2141.2005.05860.x] [Cited by in Crossref: 3] [Cited by in F6Publishing: 25] [Article Influence: 0.2] [Reference Citation Analysis]
208 Kawano Y, Moschetta M, Manier S, Glavey S, Görgün GT, Roccaro AM, Anderson KC, Ghobrial IM. Targeting the bone marrow microenvironment in multiple myeloma. Immunol Rev 2015;263:160-72. [PMID: 25510276 DOI: 10.1111/imr.12233] [Cited by in Crossref: 183] [Cited by in F6Publishing: 181] [Article Influence: 26.1] [Reference Citation Analysis]
209 Ishii H, Saito T. Cancer metastasis as disrupted developmental phenotype. Curr Genomics 2008;9:25-8. [PMID: 19424481 DOI: 10.2174/138920208783884919] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
210 Guo S, Liu M, Wang G, Torroella-Kouri M, Gonzalez-Perez RR. Oncogenic role and therapeutic target of leptin signaling in breast cancer and cancer stem cells. Biochim Biophys Acta. 2012;1825:207-222. [PMID: 22289780 DOI: 10.1016/j.bbcan.2012.01.002.oncogenic] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
211 Egloff AM, Grandis JR. Molecular pathways: context-dependent approaches to Notch targeting as cancer therapy. Clin Cancer Res 2012;18:5188-95. [PMID: 22773520 DOI: 10.1158/1078-0432.CCR-11-2258] [Cited by in Crossref: 45] [Cited by in F6Publishing: 27] [Article Influence: 4.5] [Reference Citation Analysis]
212 Bertrand FE, McCubrey JA, Angus CW, Nutter JM, Sigounas G. NOTCH and PTEN in prostate cancer. Adv Biol Regul 2014;56:51-65. [PMID: 24933481 DOI: 10.1016/j.jbior.2014.05.002] [Cited by in Crossref: 36] [Cited by in F6Publishing: 33] [Article Influence: 4.5] [Reference Citation Analysis]
213 Sethi N, Kang Y. Notch signalling in cancer progression and bone metastasis. Br J Cancer 2011;105:1805-10. [PMID: 22075946 DOI: 10.1038/bjc.2011.497] [Cited by in Crossref: 60] [Cited by in F6Publishing: 53] [Article Influence: 5.5] [Reference Citation Analysis]
214 Jannot G, Simard MJ. Tumour-related microRNAs functions in Caenorhabditis elegans. Oncogene 2006;25:6197-201. [PMID: 17028599 DOI: 10.1038/sj.onc.1209921] [Cited by in Crossref: 28] [Cited by in F6Publishing: 24] [Article Influence: 1.8] [Reference Citation Analysis]
215 Loop T, Leemans R, Stiefel U, Hermida L, Egger B, Xie F, Primig M, Certa U, Fischbach KF, Reichert H, Hirth F. Transcriptional signature of an adult brain tumor in Drosophila. BMC Genomics 2004;5:24. [PMID: 15090076 DOI: 10.1186/1471-2164-5-24] [Cited by in Crossref: 28] [Cited by in F6Publishing: 24] [Article Influence: 1.6] [Reference Citation Analysis]
216 Nicholson SC, Nicolay BN, Frolov MV, Moberg KH. Notch-dependent expression of the archipelago ubiquitin ligase subunit in the Drosophila eye. Development 2011;138:251-60. [PMID: 21148181 DOI: 10.1242/dev.054429] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 1.1] [Reference Citation Analysis]
217 Yedukondalu N, Gupta G, R.nadkarni J, Gupta VK, Syed SH, Ali A. Divergent synthesis of prenylated carbazole alkaloid (+)-S-mahanimbine led to the discovery of a notch activator. RSC Adv 2016;6:83069-77. [DOI: 10.1039/c6ra16531a] [Cited by in Crossref: 5] [Article Influence: 0.8] [Reference Citation Analysis]
218 Skarmoutsou E, Bevelacqua V, D' Amico F, Russo A, Spandidos DA, Scalisi A, Malaponte G, Guarneri C. FOXP3 expression is modulated by TGF‑β1/NOTCH1 pathway in human melanoma. Int J Mol Med 2018;42:392-404. [PMID: 29620159 DOI: 10.3892/ijmm.2018.3618] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
219 Ercan C, van Diest PJ, Vooijs M. Mammary development and breast cancer: the role of stem cells. Curr Mol Med. 2011;11:270-285. [PMID: 21506923 DOI: 10.2174/156652411795678007] [Cited by in Crossref: 24] [Cited by in F6Publishing: 22] [Article Influence: 2.2] [Reference Citation Analysis]
220 Massard C, Azaro A, Soria JC, Lassen U, Le Tourneau C, Sarker D, Smith C, Ohnmacht U, Oakley G, Patel BKR, Yuen ESM, Benhadji KA, Rodon J. First-in-human study of LY3039478, an oral Notch signaling inhibitor in advanced or metastatic cancer. Ann Oncol. 2018;29:1911-1917. [PMID: 30060061 DOI: 10.1093/annonc/mdy244] [Cited by in Crossref: 50] [Cited by in F6Publishing: 50] [Article Influence: 16.7] [Reference Citation Analysis]
221 Xu P, Zhang A, Jiang R, Qiu M, Kang C, Jia Z, Wang G, Han L, Fan X, Pu P. The different role of Notch1 and Notch2 in astrocytic gliomas. PLoS One 2013;8:e53654. [PMID: 23349727 DOI: 10.1371/journal.pone.0053654] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 2.1] [Reference Citation Analysis]
222 Nwabo Kamdje AH, Seke Etet PF, Vecchio L, Muller JM, Krampera M, Lukong KE. Signaling pathways in breast cancer: therapeutic targeting of the microenvironment. Cell Signal. 2014;26:2843-2856. [PMID: 25093804 DOI: 10.1016/j.cellsig.2014.07.034] [Cited by in Crossref: 45] [Cited by in F6Publishing: 45] [Article Influence: 5.6] [Reference Citation Analysis]
223 Wang F, Zhou H, Xia X, Sun Q, Wang Y, Cheng B. Activated Notch signaling is required for hepatitis B virus X protein to promote proliferation and survival of human hepatic cells. Cancer Lett. 2010;298:64-73. [PMID: 20638778 DOI: 10.1016/j.canlet.2010.06.003] [Cited by in Crossref: 29] [Cited by in F6Publishing: 26] [Article Influence: 2.4] [Reference Citation Analysis]
224 Karsan A. The role of notch in modeling and maintaining the vasculature. Can J Physiol Pharmacol 2005;83:14-23. [DOI: 10.1139/y04-125] [Cited by in Crossref: 40] [Cited by in F6Publishing: 35] [Article Influence: 2.4] [Reference Citation Analysis]
225 Mihaljevic AL, Michalski CW, Friess H, Kleeff J. Molecular mechanism of pancreatic cancer--understanding proliferation, invasion, and metastasis. Langenbecks Arch Surg. 2010;395:295-308. [PMID: 20237938 DOI: 10.1007/s00423-010-0622-5] [Cited by in Crossref: 48] [Cited by in F6Publishing: 42] [Article Influence: 4.0] [Reference Citation Analysis]
226 Sharghi-Namini S, Tan E, Ong LL, Ge R, Asada HH. Dll4-containing exosomes induce capillary sprout retraction in a 3D microenvironment. Sci Rep 2014;4:4031. [PMID: 24504253 DOI: 10.1038/srep04031] [Cited by in Crossref: 59] [Cited by in F6Publishing: 58] [Article Influence: 7.4] [Reference Citation Analysis]
227 Singh AK, Sharma N, Ghosh M, Park YH, Jeong DK. Emerging importance of dietary phytochemicals in fight against cancer: Role in targeting cancer stem cells. Critical Reviews in Food Science and Nutrition 2017;57:3449-63. [DOI: 10.1080/10408398.2015.1129310] [Cited by in Crossref: 43] [Cited by in F6Publishing: 39] [Article Influence: 8.6] [Reference Citation Analysis]
228 Rustighi A, Tiberi L, Soldano A, Napoli M, Nuciforo P, Rosato A, Kaplan F, Capobianco A, Pece S, Di Fiore PP, Del Sal G. The prolyl-isomerase Pin1 is a Notch1 target that enhances Notch1 activation in cancer. Nat Cell Biol 2009;11:133-42. [PMID: 19151708 DOI: 10.1038/ncb1822] [Cited by in Crossref: 130] [Cited by in F6Publishing: 122] [Article Influence: 10.0] [Reference Citation Analysis]
229 Coccaro N, Zagaria A, Tota G, Anelli L, Orsini P, Casieri P, Cellamare A, Minervini A, Impera L, Minervini CF, Brunetti C, Mestice A, Carluccio P, Cumbo C, Specchia G, Albano F. Overexpression of the LSAMP and TUSC7 genes in acute myeloid leukemia following microdeletion/duplication of chromosome 3. Cancer Genet 2015;208:517-22. [PMID: 26345353 DOI: 10.1016/j.cancergen.2015.07.006] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
230 Takeuchi T, Adachi Y, Sonobe H, Furihata M, Ohtsuki Y. A ubiquitin ligase, skeletrophin, is a negative regulator of melanoma invasion. Oncogene 2006;25:7059-69. [PMID: 16715130 DOI: 10.1038/sj.onc.1209688] [Cited by in Crossref: 32] [Cited by in F6Publishing: 27] [Article Influence: 2.0] [Reference Citation Analysis]
231 Lian W, Zhang L, Yang L, Chen W. AP-2α reverses vincristine-induced multidrug resistance of SGC7901 gastric cancer cells by inhibiting the Notch pathway. Apoptosis 2017;22:933-41. [PMID: 28439677 DOI: 10.1007/s10495-017-1379-x] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 3.8] [Reference Citation Analysis]
232 Allen JG, Galloway DB, Ehsanullah RS, Ruane RJ, Bird HA. The effect of bromazepam (Lexotan) administration on antipyrine pharmacokinetics in humans. Xenobiotica. 1984;14:321-326. [PMID: 6147049 DOI: 10.1016/j.gendis.2018.05.001] [Cited by in Crossref: 166] [Cited by in F6Publishing: 143] [Article Influence: 4.4] [Reference Citation Analysis]
233 van Tetering G, Vooijs M. Proteolytic cleavage of Notch: "HIT and RUN". Curr Mol Med 2011;11:255-69. [PMID: 21506924 DOI: 10.2174/156652411795677972] [Cited by in Crossref: 42] [Cited by in F6Publishing: 43] [Article Influence: 3.8] [Reference Citation Analysis]
234 Fu H, Xing F, Lv Y, Zeng B, You P, Liu J. ICBP90 mediates Notch signaling to facilitate human hepatocellular carcinoma growth. Tissue Cell 2018;54:65-71. [PMID: 30309512 DOI: 10.1016/j.tice.2018.08.004] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
235 Skalska L, Stojnic R, Li J, Fischer B, Cerda-Moya G, Sakai H, Tajbakhsh S, Russell S, Adryan B, Bray SJ. Chromatin signatures at Notch-regulated enhancers reveal large-scale changes in H3K56ac upon activation. EMBO J 2015;34:1889-904. [PMID: 26069324 DOI: 10.15252/embj.201489923] [Cited by in Crossref: 57] [Cited by in F6Publishing: 47] [Article Influence: 8.1] [Reference Citation Analysis]
236 Kelleher FC, Fennelly D, Rafferty M. Common critical pathways in embryogenesis and cancer. Acta Oncol 2006;45:375-88. [PMID: 16760173 DOI: 10.1080/02841860600602946] [Cited by in Crossref: 82] [Cited by in F6Publishing: 75] [Article Influence: 5.1] [Reference Citation Analysis]
237 Kimura K, Satoh K, Kanno A, Hamada S, Hirota M, Endoh M, Masamune A, Shimosegawa T. Activation of Notch signaling in tumorigenesis of experimental pancreatic cancer induced by dimethylbenzanthracene in mice. Cancer Science 2007;98:155-62. [DOI: 10.1111/j.1349-7006.2006.00369.x] [Cited by in Crossref: 46] [Cited by in F6Publishing: 49] [Article Influence: 3.1] [Reference Citation Analysis]
238 Miao K, Lei JH, Valecha MV, Zhang A, Xu J, Wang L, Lyu X, Chen S, Miao Z, Zhang X, Su SM, Shao F, Rajendran BK, Bao J, Zeng J, Sun H, Chen P, Tan K, Chen Q, Wong KH, Xu X, Deng CX. NOTCH1 activation compensates BRCA1 deficiency and promotes triple-negative breast cancer formation. Nat Commun 2020;11:3256. [PMID: 32591500 DOI: 10.1038/s41467-020-16936-9] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 4.0] [Reference Citation Analysis]
239 Carter Y, Jaskula-Sztul R, Chen H, Mazeh H. Signaling pathways as specific pharmacologic targets for neuroendocrine tumor therapy: RET, PI3K, MEK, growth factors, and Notch. Neuroendocrinology. 2013;97:57-66. [PMID: 22343668 DOI: 10.1159/000335136] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 1.4] [Reference Citation Analysis]
240 Nagata Y, Kontani K, Enami T, Kataoka K, Ishii R, Totoki Y, Kataoka TR, Hirata M, Aoki K, Nakano K, Kitanaka A, Sakata-yanagimoto M, Egami S, Shiraishi Y, Chiba K, Tanaka H, Shiozawa Y, Yoshizato T, Suzuki H, Kon A, Yoshida K, Sato Y, Sato-otsubo A, Sanada M, Munakata W, Nakamura H, Hama N, Miyano S, Nureki O, Shibata T, Haga H, Shimoda K, Katada T, Chiba S, Watanabe T, Ogawa S. Variegated RHOA mutations in adult T-cell leukemia/lymphoma. Blood 2016;127:596-604. [DOI: 10.1182/blood-2015-06-644948] [Reference Citation Analysis]
241 Jha HC, Banerjee S, Robertson ES. The Role of Gammaherpesviruses in Cancer Pathogenesis. Pathogens 2016;5:E18. [PMID: 26861404 DOI: 10.3390/pathogens5010018] [Cited by in Crossref: 59] [Cited by in F6Publishing: 63] [Article Influence: 9.8] [Reference Citation Analysis]
242 Herrick DB, Guo Z, Jang W, Schnittke N, Schwob JE. Canonical Notch Signaling Directs the Fate of Differentiating Neurocompetent Progenitors in the Mammalian Olfactory Epithelium. J Neurosci 2018;38:5022-37. [PMID: 29739871 DOI: 10.1523/JNEUROSCI.0484-17.2018] [Cited by in Crossref: 12] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
243 Mitsuhashi Y, Horiuchi A, Miyamoto T, Kashima H, Suzuki A, Shiozawa T. Prognostic significance of Notch signalling molecules and their involvement in the invasiveness of endometrial carcinoma cells. Histopathology. 2012;60:826-837. [PMID: 22348356 DOI: 10.1111/j.1365-2559.2011.04158.x] [Cited by in Crossref: 48] [Cited by in F6Publishing: 50] [Article Influence: 4.8] [Reference Citation Analysis]
244 Newman G, Gonzalez-Perez RR. Leptin-cytokine crosstalk in breast cancer. Mol Cell Endocrinol 2014;382:570-82. [PMID: 23562747 DOI: 10.1016/j.mce.2013.03.025] [Cited by in Crossref: 66] [Cited by in F6Publishing: 69] [Article Influence: 7.3] [Reference Citation Analysis]
245 Mullendore ME, Koorstra JB, Li YM, Offerhaus GJ, Fan X, Henderson CM, Matsui W, Eberhart CG, Maitra A, Feldmann G. Ligand-dependent Notch signaling is involved in tumor initiation and tumor maintenance in pancreatic cancer. Clin Cancer Res. 2009;15:2291-2301. [PMID: 19258443 DOI: 10.1158/1078-0432.ccr-08-2004] [Cited by in Crossref: 126] [Cited by in F6Publishing: 85] [Article Influence: 9.7] [Reference Citation Analysis]
246 Kim M, Ju J, Jang K, Oh S, Song J, Kim CG, Shin I. Protein kinase Cδ negatively regulates Notch1-dependent transcription via a kinase-independent mechanism in vitro. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research 2012;1823:387-97. [DOI: 10.1016/j.bbamcr.2011.11.005] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
247 Eguchi T, Sogawa C, Okusha Y, Uchibe K, Iinuma R, Ono K, Nakano K, Murakami J, Itoh M, Arai K, Fujiwara T, Namba Y, Murata Y, Ohyama K, Shimomura M, Okamura H, Takigawa M, Nakatsura T, Kozaki KI, Okamoto K, Calderwood SK. Organoids with cancer stem cell-like properties secrete exosomes and HSP90 in a 3D nanoenvironment. PLoS One 2018;13:e0191109. [PMID: 29415026 DOI: 10.1371/journal.pone.0191109] [Cited by in Crossref: 62] [Cited by in F6Publishing: 58] [Article Influence: 15.5] [Reference Citation Analysis]
248 Baia GS, Stifani S, Kimura ET, McDermott MW, Pieper RO, Lal A. Notch activation is associated with tetraploidy and enhanced chromosomal instability in meningiomas. Neoplasia 2008;10:604-12. [PMID: 18516297 DOI: 10.1593/neo.08356] [Cited by in Crossref: 30] [Cited by in F6Publishing: 30] [Article Influence: 2.1] [Reference Citation Analysis]
249 Kondo T. Brain cancer stem-like cells. Eur J Cancer 2006;42:1237-42. [PMID: 16632342 DOI: 10.1016/j.ejca.2006.01.038] [Cited by in Crossref: 36] [Cited by in F6Publishing: 25] [Article Influence: 2.3] [Reference Citation Analysis]
250 Agabiti SS, Li J, Dong W, Poe MM, Wiemer AJ. Regulation of the Notch-ATM-abl axis by geranylgeranyl diphosphate synthase inhibition. Cell Death Dis 2019;10:733. [PMID: 31570763 DOI: 10.1038/s41419-019-1973-7] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
251 Fang Q, Fu W, Yang J, Li X, Zhou Z, Chen Z, Pan J. Knockdown of ZFX suppresses renal carcinoma cell growth and induces apoptosis. Cancer Genetics 2014;207:461-6. [DOI: 10.1016/j.cancergen.2014.08.007] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 1.6] [Reference Citation Analysis]
252 Ho M, Goh CY, Patel A, Staunton S, O'Connor R, Godeau M, Bianchi G. Role of the Bone Marrow Milieu in Multiple Myeloma Progression and Therapeutic Resistance. Clin Lymphoma Myeloma Leuk 2020;20:e752-68. [PMID: 32651110 DOI: 10.1016/j.clml.2020.05.026] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
253 Brzozowa-Zasada M, Piecuch A, Michalski M, Segiet O, Kurek J, Harabin-Słowińska M, Wojnicz R. Notch and its oncogenic activity in human malignancies. Eur Surg 2017;49:199-209. [PMID: 29104587 DOI: 10.1007/s10353-017-0491-z] [Cited by in Crossref: 30] [Cited by in F6Publishing: 31] [Article Influence: 6.0] [Reference Citation Analysis]
254 Barat S, Chen X, Cuong Bui K, Bozko P, Götze J, Christgen M, Krech T, Malek NP, Plentz RR. Gamma-Secretase Inhibitor IX (GSI) Impairs Concomitant Activation of Notch and Wnt-Beta-Catenin Pathways in CD44+ Gastric Cancer Stem Cells. Stem Cells Transl Med 2017;6:819-29. [PMID: 28186678 DOI: 10.1002/sctm.16-0335] [Cited by in Crossref: 22] [Cited by in F6Publishing: 19] [Article Influence: 4.4] [Reference Citation Analysis]
255 Feng J, Wang J, Liu Q, Li J, Zhang Q, Zhuang Z, Yao X, Liu C, Li Y, Cao L, Li C, Gong L, Li D, Zhang Y, Gao H. DAPT, a γ-Secretase Inhibitor, Suppresses Tumorigenesis, and Progression of Growth Hormone-Producing Adenomas by Targeting Notch Signaling. Front Oncol 2019;9:809. [PMID: 31508369 DOI: 10.3389/fonc.2019.00809] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]
256 Schwanbeck R, Martini S, Bernoth K, Just U. The Notch signaling pathway: molecular basis of cell context dependency. Eur J Cell Biol 2011;90:572-81. [PMID: 21126799 DOI: 10.1016/j.ejcb.2010.10.004] [Cited by in Crossref: 62] [Cited by in F6Publishing: 60] [Article Influence: 5.2] [Reference Citation Analysis]
257 Mamaeva V, Rosenholm JM, Bate-Eya LT, Bergman L, Peuhu E, Duchanoy A, Fortelius LE, Landor S, Toivola DM, Lindén M, Sahlgren C. Mesoporous silica nanoparticles as drug delivery systems for targeted inhibition of Notch signaling in cancer. Mol Ther 2011;19:1538-46. [PMID: 21629222 DOI: 10.1038/mt.2011.105] [Cited by in Crossref: 155] [Cited by in F6Publishing: 136] [Article Influence: 14.1] [Reference Citation Analysis]
258 Garcia A, Kandel JJ. Notch: a key regulator of tumor angiogenesis and metastasis. Histol Histopathol 2012;27:151-6. [PMID: 22207549 DOI: 10.14670/HH-27.151] [Cited by in F6Publishing: 27] [Reference Citation Analysis]
259 Mohammed TA, Holen KD, Jaskula-Sztul R, Mulkerin D, Lubner SJ, Schelman WR, Eickhoff J, Chen H, Loconte NK. A pilot phase II study of valproic acid for treatment of low-grade neuroendocrine carcinoma. Oncologist 2011;16:835-43. [PMID: 21632454 DOI: 10.1634/theoncologist.2011-0031] [Cited by in Crossref: 49] [Cited by in F6Publishing: 49] [Article Influence: 4.5] [Reference Citation Analysis]
260 Stupnikov MR, Yang Y, Mori M, Lu J, Cardoso WV. Jagged and Delta-like ligands control distinct events during airway progenitor cell differentiation. Elife 2019;8:e50487. [PMID: 31631837 DOI: 10.7554/eLife.50487] [Cited by in Crossref: 15] [Cited by in F6Publishing: 8] [Article Influence: 5.0] [Reference Citation Analysis]
261 Akbar Samadani A, Keymoradzdeh A, Shams S, Soleymanpour A, Elham Norollahi S, Vahidi S, Rashidy-Pour A, Ashraf A, Mirzajani E, Khanaki K, Rahbar Taramsari M, Samimian S, Najafzadeh A. Mechanisms of cancer stem cell therapy. Clin Chim Acta. 2020;510:581-592. [PMID: 32791136 DOI: 10.1016/j.cca.2020.08.016] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
262 Mazza T, Copetti M, Capocefalo D, Fusilli C, Biagini T, Carella M, De Bonis A, Mastrodonato N, Piepoli A, Pazienza V, Maiello E, di Mola FF, di Sebastiano P, Andriulli A, Tavano F. MicroRNA co-expression networks exhibit increased complexity in pancreatic ductal compared to Vater's papilla adenocarcinoma. Oncotarget 2017;8:105320-39. [PMID: 29285254 DOI: 10.18632/oncotarget.22184] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
263 Hanlon L, Avila JL, Demarest RM, Troutman S, Allen M, Ratti F, Rustgi AK, Stanger BZ, Radtke F, Adsay V. Notch1 functions as a tumor suppressor in a model of K-ras-induced pancreatic ductal adenocarcinoma. Cancer Res. 2010;70:4280-4286. [PMID: 20484026 DOI: 10.1158/0008-5472.can-09-4645] [Cited by in Crossref: 107] [Cited by in F6Publishing: 64] [Article Influence: 8.9] [Reference Citation Analysis]
264 Mu X, Isaac C, Greco N, Huard J, Weiss K. Notch Signaling is Associated with ALDH Activity and an Aggressive Metastatic Phenotype in Murine Osteosarcoma Cells. Front Oncol 2013;3:143. [PMID: 23805413 DOI: 10.3389/fonc.2013.00143] [Cited by in Crossref: 46] [Cited by in F6Publishing: 48] [Article Influence: 5.1] [Reference Citation Analysis]
265 Yamashita AS, Geraldo MV, Fuziwara CS, Kulcsar MA, Friguglietti CU, da Costa RB, Baia GS, Kimura ET. Notch pathway is activated by MAPK signaling and influences papillary thyroid cancer proliferation. Transl Oncol 2013;6:197-205. [PMID: 23544172 DOI: 10.1593/tlo.12442] [Cited by in Crossref: 50] [Cited by in F6Publishing: 51] [Article Influence: 5.6] [Reference Citation Analysis]
266 Pouponnot C, Sii-Felice K, Hmitou I, Rocques N, Lecoin L, Druillennec S, Felder-Schmittbuhl MP, Eychène A. Cell context reveals a dual role for Maf in oncogenesis. Oncogene 2006;25:1299-310. [PMID: 16247450 DOI: 10.1038/sj.onc.1209171] [Cited by in Crossref: 32] [Cited by in F6Publishing: 31] [Article Influence: 2.0] [Reference Citation Analysis]
267 Ferreira AC, Suriano G, Mendes N, Gomes B, Wen X, Carneiro F, Seruca R, Machado JC. E-cadherin impairment increases cell survival through Notch-dependent upregulation of Bcl-2. Human Molecular Genetics 2012;21:334-43. [DOI: 10.1093/hmg/ddr469] [Cited by in Crossref: 31] [Cited by in F6Publishing: 27] [Article Influence: 2.8] [Reference Citation Analysis]
268 Bettinsoli P, Ferrari-Toninelli G, Bonini SA, Prandelli C, Memo M. Notch ligand Delta-like 1 as a novel molecular target in childhood neuroblastoma. BMC Cancer 2017;17:352. [PMID: 28525978 DOI: 10.1186/s12885-017-3340-3] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 2.8] [Reference Citation Analysis]
269 Matsuo K, Taniguchi K, Hamamoto H, Ito Y, Futaki S, Inomata Y, Shima T, Asakuma M, Lee SW, Tanaka K, Okuda J, Kondo Y, Uchiyama K. Delta-like 3 localizes to neuroendocrine cells and plays a pivotal role in gastrointestinal neuroendocrine malignancy. Cancer Sci 2019;110:3122-31. [PMID: 31369178 DOI: 10.1111/cas.14157] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 3.3] [Reference Citation Analysis]
270 Zhu YY, Yuan Z. Pancreatic cancer stem cells: Advances and perspectives. Shijie Huaren Xiaohua Zazhi 2015; 23(11): 1703-1711 [DOI: 10.11569/wcjd.v23.i11.1703] [Reference Citation Analysis]
271 Singh A, Singh AK, Giri R, Kumar D, Sharma R, Valis M, Kuca K, Garg N. The role of microRNA-21 in the onset and progression of cancer. Future Med Chem 2021;13:1885-906. [PMID: 34590501 DOI: 10.4155/fmc-2021-0096] [Reference Citation Analysis]
272 Lodh S, O'Hare EA, Zaghloul NA. Primary cilia in pancreatic development and disease. Birth Defects Res C Embryo Today 2014;102:139-58. [PMID: 24864023 DOI: 10.1002/bdrc.21063] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 2.9] [Reference Citation Analysis]
273 Yamaguchi M, Tonou-Fujimori N, Komori A, Maeda R, Nojima Y, Li H, Okamoto H, Masai I. Histone deacetylase 1 regulates retinal neurogenesis in zebrafish by suppressing Wnt and Notch signaling pathways. Development 2005;132:3027-43. [PMID: 15944187 DOI: 10.1242/dev.01881] [Cited by in Crossref: 164] [Cited by in F6Publishing: 156] [Article Influence: 9.6] [Reference Citation Analysis]
274 Masai I, Yamaguchi M, Tonou-fujimori N, Komori A, Okamoto H. The hedgehog-PKA pathway regulates two distinct steps of the differentiation of retinal ganglion cells: the cell-cycle exit of retinoblasts and their neuronal maturation. Development 2005;132:1539-53. [DOI: 10.1242/dev.01714] [Cited by in Crossref: 82] [Cited by in F6Publishing: 76] [Article Influence: 4.8] [Reference Citation Analysis]
275 Duan L, Yao J, Wu X, Fan M. Growth suppression induced by Notch1 activation involves Wnt-beta-catenin down-regulation in human tongue carcinoma cells. Biol Cell 2006;98:479-90. [PMID: 16608439 DOI: 10.1042/BC20060020] [Cited by in Crossref: 58] [Cited by in F6Publishing: 30] [Article Influence: 3.6] [Reference Citation Analysis]
276 Scorey N, Fraser SP, Patel P, Pridgeon C, Dallman MJ, Djamgoz MB. Notch signalling and voltage-gated Na+ channel activity in human prostate cancer cells: independent modulation of in vitro motility. Prostate Cancer Prostatic Dis 2006;9:399-406. [PMID: 16832382 DOI: 10.1038/sj.pcan.4500894] [Cited by in Crossref: 27] [Cited by in F6Publishing: 28] [Article Influence: 1.7] [Reference Citation Analysis]
277 Lewis HD, Leveridge M, Strack PR, Haldon CD, O'neil J, Kim H, Madin A, Hannam JC, Look AT, Kohl N, Draetta G, Harrison T, Kerby JA, Shearman MS, Beher D. Apoptosis in T cell acute lymphoblastic leukemia cells after cell cycle arrest induced by pharmacological inhibition of notch signaling. Chem Biol. 2007;14:209-219. [PMID: 17317574 DOI: 10.1016/j.chembiol.2006.12.010] [Cited by in Crossref: 108] [Cited by in F6Publishing: 95] [Article Influence: 7.2] [Reference Citation Analysis]
278 Giovannini C, Bolondi L, Gramantieri L. Targeting Notch3 in Hepatocellular Carcinoma: Molecular Mechanisms and Therapeutic Perspectives. Int J Mol Sci. 2016;18. [PMID: 28036048 DOI: 10.3390/ijms18010056] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 3.8] [Reference Citation Analysis]
279 Kim SB, Chae GW, Lee J, Park J, Tak H, Chung JH, Park TG, Ahn JK, Joe CO. Activated Notch1 interacts with p53 to inhibit its phosphorylation and transactivation. Cell Death Differ 2007;14:982-91. [PMID: 17186020 DOI: 10.1038/sj.cdd.4402083] [Cited by in Crossref: 44] [Cited by in F6Publishing: 41] [Article Influence: 2.8] [Reference Citation Analysis]
280 Ramos EK, Hoffmann AD, Gerson SL, Liu H. New Opportunities and Challenges to Defeat Cancer Stem Cells. Trends Cancer 2017;3:780-96. [PMID: 29120754 DOI: 10.1016/j.trecan.2017.08.007] [Cited by in Crossref: 38] [Cited by in F6Publishing: 42] [Article Influence: 7.6] [Reference Citation Analysis]
281 Fassl A, Tagscherer KE, Richter J, De-Castro Arce J, Savini C, Rösl F, Roth W. Inhibition of Notch1 signaling overcomes resistance to the death ligand Trail by specificity protein 1-dependent upregulation of death receptor 5. Cell Death Dis 2015;6:e1921. [PMID: 26469969 DOI: 10.1038/cddis.2015.261] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.1] [Reference Citation Analysis]
282 Dell'albani P, Rodolico M, Pellitteri R, Tricarichi E, Torrisi SA, D'Antoni S, Zappia M, Albanese V, Caltabiano R, Platania N, Aronica E, Catania MV. Differential patterns of NOTCH1-4 receptor expression are markers of glioma cell differentiation. Neuro Oncol 2014;16:204-16. [PMID: 24305720 DOI: 10.1093/neuonc/not168] [Cited by in Crossref: 24] [Cited by in F6Publishing: 19] [Article Influence: 2.7] [Reference Citation Analysis]
283 Simon F, Fichelson P, Gho M, Audibert A. Notch and Prospero repress proliferation following cyclin E overexpression in the Drosophila bristle lineage. PLoS Genet 2009;5:e1000594. [PMID: 19662164 DOI: 10.1371/journal.pgen.1000594] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 1.1] [Reference Citation Analysis]
284 Baonza A, Freeman M. Control of Cell Proliferation in the Drosophila Eye by Notch Signaling. Developmental Cell 2005;8:529-39. [DOI: 10.1016/j.devcel.2005.01.019] [Cited by in Crossref: 102] [Cited by in F6Publishing: 101] [Article Influence: 6.0] [Reference Citation Analysis]
285 Helle E, Córdova-Palomera A, Ojala T, Saha P, Potiny P, Gustafsson S, Ingelsson E, Bamshad M, Nickerson D, Chong JX, Ashley E, Priest JR; University of Washington Center for Mendelian Genomics. Loss of function, missense, and intronic variants in NOTCH1 confer different risks for left ventricular outflow tract obstructive heart defects in two European cohorts. Genet Epidemiol 2019;43:215-26. [PMID: 30511478 DOI: 10.1002/gepi.22176] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 3.3] [Reference Citation Analysis]
286 Ban J, Bennani-Baiti IM, Kauer M, Schaefer KL, Poremba C, Jug G, Schwentner R, Smrzka O, Muehlbacher K, Aryee DN, Kovar H. EWS-FLI1 suppresses NOTCH-activated p53 in Ewing's sarcoma. Cancer Res 2008;68:7100-9. [PMID: 18757425 DOI: 10.1158/0008-5472.CAN-07-6145] [Cited by in Crossref: 72] [Cited by in F6Publishing: 50] [Article Influence: 5.1] [Reference Citation Analysis]
287 Lan K, Choudhuri T, Murakami M, Kuppers DA, Robertson ES. Intracellular activated Notch1 is critical for proliferation of Kaposi's sarcoma-associated herpesvirus-associated B-lymphoma cell lines in vitro. J Virol 2006;80:6411-9. [PMID: 16775329 DOI: 10.1128/JVI.00239-06] [Cited by in Crossref: 24] [Cited by in F6Publishing: 22] [Article Influence: 1.5] [Reference Citation Analysis]
288 Voulgari A, Pintzas A. Epithelial–mesenchymal transition in cancer metastasis: Mechanisms, markers and strategies to overcome drug resistance in the clinic. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 2009;1796:75-90. [DOI: 10.1016/j.bbcan.2009.03.002] [Cited by in Crossref: 121] [Cited by in F6Publishing: 314] [Article Influence: 9.3] [Reference Citation Analysis]
289 Maksimović-Ivanić D, Bulatović M, Edeler D, Bensing C, Golić I, Korać A, Kaluđerović GN, Mijatović S. The interaction between SBA-15 derivative loaded with Ph3Sn(CH2)6OH and human melanoma A375 cell line: uptake and stem phenotype loss. J Biol Inorg Chem 2019;24:223-34. [PMID: 30759278 DOI: 10.1007/s00775-019-01640-x] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
290 Das PK, Rakib MA, Khanam JA, Pillai S, Islam F. Novel Therapeutics Against Breast Cancer Stem Cells by Targeting Surface Markers and Signaling Pathways. CSCR 2019;14:669-82. [DOI: 10.2174/1574888x14666190628104721] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
291 Cai H, Kumar N, Ai N, Gupta S, Rath P, Baudis M. Progenetix: 12 years of oncogenomic data curation. Nucleic Acids Res 2014;42:D1055-62. [PMID: 24225322 DOI: 10.1093/nar/gkt1108] [Cited by in Crossref: 29] [Cited by in F6Publishing: 21] [Article Influence: 3.2] [Reference Citation Analysis]
292 Dasari V, Gallup M, Lemjabbar H, Maltseva I, Mcnamara N. Epithelial–Mesenchymal Transition in Lung Cancer: Is Tobacco the “Smoking Gun”? Am J Respir Cell Mol Biol 2006;35:3-9. [DOI: 10.1165/rcmb.2006-0051sf] [Cited by in Crossref: 43] [Cited by in F6Publishing: 21] [Article Influence: 2.7] [Reference Citation Analysis]
293 Zhong Y, Lin Y, Shen S, Zhou Y, Mao F, Guan J, Sun Q. Expression of ALDH1 in breast invasive ductal carcinoma: an independent predictor of early tumor relapse. Cancer Cell Int 2013;13:60. [PMID: 23767668 DOI: 10.1186/1475-2867-13-60] [Cited by in Crossref: 26] [Cited by in F6Publishing: 24] [Article Influence: 2.9] [Reference Citation Analysis]
294 Totaro A, Castellan M, Battilana G, Zanconato F, Azzolin L, Giulitti S, Cordenonsi M, Piccolo S. YAP/TAZ link cell mechanics to Notch signalling to control epidermal stem cell fate. Nat Commun 2017;8:15206. [PMID: 28513598 DOI: 10.1038/ncomms15206] [Cited by in Crossref: 121] [Cited by in F6Publishing: 115] [Article Influence: 24.2] [Reference Citation Analysis]
295 Tanaka N, Kyuuma M, Sugamura K. Endosomal sorting complex required for transport proteins in cancer pathogenesis, vesicular transport, and non-endosomal functions. Cancer Science 2008;99:1293-303. [DOI: 10.1111/j.1349-7006.2008.00825.x] [Cited by in Crossref: 44] [Cited by in F6Publishing: 41] [Article Influence: 3.1] [Reference Citation Analysis]
296 Wu YJ, Hu ZL, Hu SD, Li YX, Xing XW, Yang Y, Du XH. Glutamate dehydrogenase inhibits tumor growth in gastric cancer through the Notch signaling pathway. Cancer Biomark 2019;26:303-12. [PMID: 31322543 DOI: 10.3233/CBM-190022] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
297 Qiu W, Tang SM, Lee S, Turk AT, Sireci AN, Qiu A, Rose C, Xie C, Kitajewski J, Wen HJ, Crawford HC, Sims PA, Hruban RH, Remotti HE, Su GH. Loss of Activin Receptor Type 1B Accelerates Development of Intraductal Papillary Mucinous Neoplasms in Mice With Activated KRAS. Gastroenterology 2016;150:218-228.e12. [PMID: 26408346 DOI: 10.1053/j.gastro.2015.09.013] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 2.9] [Reference Citation Analysis]
298 Xu Y, Shu B, Tian Y, Wang G, Wang Y, Wang J, Dong Y. Oleanolic acid induces osteosarcoma cell apoptosis by inhibition of Notch signaling. Molecular Carcinogenesis 2018;57:896-902. [DOI: 10.1002/mc.22810] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 2.5] [Reference Citation Analysis]
299 Alam MS, Maekawa Y, Kitamura A, Tanigaki K, Yoshimoto T, Kishihara K, Yasutomo K. Notch signaling drives IL-22 secretion in CD4+ T cells by stimulating the aryl hydrocarbon receptor. Proc Natl Acad Sci USA. 2010;107:5943-5948. [PMID: 20231432 DOI: 10.1073/pnas.0911755107] [Cited by in Crossref: 115] [Cited by in F6Publishing: 111] [Article Influence: 9.6] [Reference Citation Analysis]
300 Pirot P, Grunsven LAV, Marine J, Huylebroeck D, Bellefroid EJ. Direct regulation of the Nrarp gene promoter by the Notch signaling pathway. Biochemical and Biophysical Research Communications 2004;322:526-34. [DOI: 10.1016/j.bbrc.2004.07.157] [Cited by in Crossref: 39] [Cited by in F6Publishing: 37] [Article Influence: 2.2] [Reference Citation Analysis]
301 Xuan S, Shin DH, Kim J. Angiopep-2-conjugated liposomes encapsulating γ-secretase inhibitor for targeting glioblastoma stem cells. Journal of Pharmaceutical Investigation 2014;44:473-83. [DOI: 10.1007/s40005-014-0151-2] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
302 Yao Y, Wang L, Zhang H, Wang H, Zhao X, Zhang Y, Zhang L, Fan X, Qian G, Hu JF, Ge S. A novel anticancer therapy that simultaneously targets aberrant p53 and Notch activities in tumors. PLoS One 2012;7:e46627. [PMID: 23071601 DOI: 10.1371/journal.pone.0046627] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
303 Föll MC, Fahrner M, Gretzmeier C, Thoma K, Biniossek ML, Kiritsi D, Meiss F, Schilling O, Nyström A, Kern JS. Identification of tissue damage, extracellular matrix remodeling and bacterial challenge as common mechanisms associated with high-risk cutaneous squamous cell carcinomas. Matrix Biol 2018;66:1-21. [PMID: 29158163 DOI: 10.1016/j.matbio.2017.11.004] [Cited by in Crossref: 25] [Cited by in F6Publishing: 23] [Article Influence: 5.0] [Reference Citation Analysis]
304 Hardy KM, Kirschmann DA, Seftor EA, Margaryan NV, Postovit LM, Strizzi L, Hendrix MJ. Regulation of the embryonic morphogen Nodal by Notch4 facilitates manifestation of the aggressive melanoma phenotype. Cancer Res 2010;70:10340-50. [PMID: 21159651 DOI: 10.1158/0008-5472.CAN-10-0705] [Cited by in Crossref: 92] [Cited by in F6Publishing: 56] [Article Influence: 8.4] [Reference Citation Analysis]
305 Zong ZH, Liu Y, Chen S, Zhao Y. Circ_PUM1 promotes the development of endometrial cancer by targeting the miR-136/NOTCH3 pathway. J Cell Mol Med 2020;24:4127-35. [PMID: 32073729 DOI: 10.1111/jcmm.15069] [Cited by in Crossref: 24] [Cited by in F6Publishing: 26] [Article Influence: 12.0] [Reference Citation Analysis]
306 Chadwick N, Fennessy C, Nostro MC, Baron M, Brady G, Buckle AM. Notch induces cell cycle arrest and apoptosis in human erythroleukaemic TF-1 cells. Blood Cells Mol Dis 2008;41:270-7. [PMID: 18693120 DOI: 10.1016/j.bcmd.2008.06.003] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 0.7] [Reference Citation Analysis]
307 Majumder S, Crabtree JS, Golde TE, Minter LM, Osborne BA, Miele L. Targeting Notch in oncology: the path forward. Nat Rev Drug Discov 2021;20:125-44. [PMID: 33293690 DOI: 10.1038/s41573-020-00091-3] [Cited by in Crossref: 13] [Cited by in F6Publishing: 20] [Article Influence: 6.5] [Reference Citation Analysis]
308 Hübscher SG, Strain AJ. Another Notch to be added to the list of hepatocellular growth regulatory factors? Hepatology 2005;41:439-42. [DOI: 10.1002/hep.20640] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
309 Hussain M, Xu C, Ahmad M, Yang Y, Lu M, Wu X, Tang L, Wu X. Notch Signaling: Linking Embryonic Lung Development and Asthmatic Airway Remodeling. Mol Pharmacol 2017;92:676-93. [PMID: 29025966 DOI: 10.1124/mol.117.110254] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 3.8] [Reference Citation Analysis]
310 Sinicropi-Yao SL, Amann JM, Lopez DLY, Cerciello F, Coombes KR, Carbone DP. Co-Expression Analysis Reveals Mechanisms Underlying the Varied Roles of NOTCH1 in NSCLC. J Thorac Oncol 2019;14:223-36. [PMID: 30408569 DOI: 10.1016/j.jtho.2018.10.162] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.8] [Reference Citation Analysis]
311 Bridges E, Oon CE, Harris A. Notch regulation of tumor angiogenesis. Future Oncol 2011;7:569-88. [PMID: 21463145 DOI: 10.2217/fon.11.20] [Cited by in Crossref: 40] [Cited by in F6Publishing: 40] [Article Influence: 3.6] [Reference Citation Analysis]
312 Ahmad R, Dhawan P, Singh AB. Cancer Stem Cell and Gastrointestinal Cancer: Current Status, Targeted Therapy and Future Implications. Biochem Pharmacol (Los Angel) 2016;5:202. [PMID: 31656694 DOI: 10.4172/2167-0501.1000202] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
313 Zhou N, Bao J. FerrDb: a manually curated resource for regulators and markers of ferroptosis and ferroptosis-disease associations. Database (Oxford) 2020;2020:baaa021. [PMID: 32219413 DOI: 10.1093/database/baaa021] [Cited by in Crossref: 34] [Cited by in F6Publishing: 50] [Article Influence: 34.0] [Reference Citation Analysis]
314 Shao H, Moller M, Cai L, Prokupets R, Yang C, Costa C, Yu K, Le N, Liu ZJ. Converting melanoma-associated fibroblasts into a tumor-suppressive phenotype by increasing intracellular Notch1 pathway activity. PLoS One 2021;16:e0248260. [PMID: 33705467 DOI: 10.1371/journal.pone.0248260] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
315 Nickoloff BJ, Ben-neriah Y, Pikarsky E. Inflammation and Cancer: Is the Link as Simple as We Think? Journal of Investigative Dermatology 2005;124:x-xiv. [DOI: 10.1111/j.0022-202x.2005.23724.x] [Cited by in Crossref: 65] [Cited by in F6Publishing: 30] [Article Influence: 3.8] [Reference Citation Analysis]
316 Gómez-Galeno JE, Hurtado C, Cheng J, Yardimci C, Mercola M, Cashman JR. b-Annulated 1,4-dihydropyridines as Notch inhibitors. Bioorg Med Chem Lett 2018;28:3363-7. [PMID: 30201292 DOI: 10.1016/j.bmcl.2018.09.002] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
317 Saeki N, Gu J, Yoshida T, Wu X. Prostate stem cell antigen: a Jekyll and Hyde molecule? Clin Cancer Res 2010;16:3533-8. [PMID: 20501618 DOI: 10.1158/1078-0432.CCR-09-3169] [Cited by in Crossref: 100] [Cited by in F6Publishing: 67] [Article Influence: 8.3] [Reference Citation Analysis]
318 Kang HG, Kim DH, Kim SJ, Cho Y, Jung J, Jang W, Chun KH. Galectin-3 supports stemness in ovarian cancer stem cells by activation of the Notch1 intracellular domain. Oncotarget. 2016;7:68229-68241. [PMID: 27626163 DOI: 10.18632/oncotarget.11920] [Cited by in Crossref: 39] [Cited by in F6Publishing: 36] [Article Influence: 9.8] [Reference Citation Analysis]
319 Andersen P, Uosaki H, Shenje LT, Kwon C. Non-canonical Notch signaling: emerging role and mechanism. Trends Cell Biol. 2012;22:257-265. [PMID: 22397947 DOI: 10.1016/j.tcb.2012.02.003] [Cited by in Crossref: 145] [Cited by in F6Publishing: 134] [Article Influence: 14.5] [Reference Citation Analysis]
320 Cong Z, Wu H, Guo Z, Qin T, Xu Y, Jing H, Wang Y, Shen Y. High expression of C-X-C chemokine receptor 4 and Notch1 is predictive of lymphovascular invasion and poor prognosis in lung adenocarcinoma. Tumour Biol 2017;39:101042831770869. [DOI: 10.1177/1010428317708698] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
321 Yuan R, Ke J, Sun L, He Z, Zou Y, He X, Chen Y, Wu X, Cai Z, Wang L, Wang J, Fan X, Wu X, Lan P. HES1 promotes metastasis and predicts poor survival in patients with colorectal cancer. Clin Exp Metastasis 2015;32:169-79. [PMID: 25636905 DOI: 10.1007/s10585-015-9700-y] [Cited by in Crossref: 24] [Cited by in F6Publishing: 22] [Article Influence: 3.4] [Reference Citation Analysis]
322 Souilhol C, Cormier S, Monet M, Vandormael-Pournin S, Joutel A, Babinet C, Cohen-Tannoudji M. Nas transgenic mouse line allows visualization of Notch pathway activity in vivo. Genesis 2006;44:277-86. [PMID: 16708386 DOI: 10.1002/dvg.20208] [Cited by in Crossref: 27] [Cited by in F6Publishing: 29] [Article Influence: 1.7] [Reference Citation Analysis]
323 Du Y, Shao H, Moller M, Prokupets R, Tse YT, Liu ZJ. Intracellular Notch1 Signaling in Cancer-Associated Fibroblasts Dictates the Plasticity and Stemness of Melanoma Stem/Initiating Cells. Stem Cells. 2019;37:865-875. [PMID: 30941836 DOI: 10.1002/stem.3013] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 3.3] [Reference Citation Analysis]
324 Wakabayashi N, Skoko JJ, Chartoumpekis DV, Kimura S, Slocum SL, Noda K, Palliyaguru DL, Fujimuro M, Boley PA, Tanaka Y, Shigemura N, Biswal S, Yamamoto M, Kensler TW. Notch-Nrf2 axis: regulation of Nrf2 gene expression and cytoprotection by notch signaling. Mol Cell Biol 2014;34:653-63. [PMID: 24298019 DOI: 10.1128/MCB.01408-13] [Cited by in F6Publishing: 50] [Reference Citation Analysis]
325 Bissell MJ, Kenny PA, Radisky DC. Microenvironmental regulators of tissue structure and function also regulate tumor induction and progression: the role of extracellular matrix and its degrading enzymes. Cold Spring Harb Symp Quant Biol 2005;70:343-56. [PMID: 16869771 DOI: 10.1101/sqb.2005.70.013] [Cited by in Crossref: 188] [Cited by in F6Publishing: 184] [Article Influence: 11.8] [Reference Citation Analysis]
326 Wang X, Leow CC, Zha J, Tang Z, Modrusan Z, Radtke F, Aguet M, de Sauvage FJ, Gao W. Notch signaling is required for normal prostatic epithelial cell proliferation and differentiation. Developmental Biology 2006;290:66-80. [DOI: 10.1016/j.ydbio.2005.11.009] [Cited by in Crossref: 104] [Cited by in F6Publishing: 103] [Article Influence: 6.5] [Reference Citation Analysis]
327 Sainson RCA, Harris AL. Regulation of angiogenesis by homotypic and heterotypic notch signalling in endothelial cells and pericytes: from basic research to potential therapies. Angiogenesis 2008;11:41-51. [DOI: 10.1007/s10456-008-9098-0] [Cited by in Crossref: 68] [Cited by in F6Publishing: 63] [Article Influence: 4.9] [Reference Citation Analysis]
328 Ong DC, Ho YM, Rudduck C, Chin K, Kuo WL, Lie DK, Chua CL, Tan PH, Eu KW, Seow-Choen F, Wong CY, Hong GS, Gray JW, Lee AS. LARG at chromosome 11q23 has functional characteristics of a tumor suppressor in human breast and colorectal cancer. Oncogene 2009;28:4189-200. [PMID: 19734946 DOI: 10.1038/onc.2009.266] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 1.5] [Reference Citation Analysis]
329 Chiba S. Notch signaling in stem cell systems. Stem Cells. 2006;24:2437-2447. [PMID: 16888285 DOI: 10.1634/stemcells.2005-0661] [Cited by in Crossref: 281] [Cited by in F6Publishing: 267] [Article Influence: 17.6] [Reference Citation Analysis]
330 Su C, Chen Z, Luo H, Su Y, Liu W, Cai L, Wang T, Lei Y, Zhong B. Different patterns of NF-κB and Notch1 signaling contribute to tumor-induced lymphangiogenesis of esophageal squamous cell carcinoma. J Exp Clin Cancer Res. 2011;30:85. [PMID: 21939555 DOI: 10.1186/1756-9966-30-85] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 1.3] [Reference Citation Analysis]
331 Gridley T. Kick it up a Notch. Cancer Cell 2004;6:431-2. [DOI: 10.1016/j.ccr.2004.10.019] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 0.5] [Reference Citation Analysis]
332 Tyagi A, Sharma AK, Damodaran C. A Review on Notch Signaling and Colorectal Cancer. Cells 2020;9:E1549. [PMID: 32630477 DOI: 10.3390/cells9061549] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
333 Xu P, Yu S, Jiang R, Kang C, Wang G, Jiang H, Pu P. Differential expression of Notch family members in astrocytomas and medulloblastomas. Pathol Oncol Res 2009;15:703-10. [PMID: 19424825 DOI: 10.1007/s12253-009-9173-x] [Cited by in Crossref: 30] [Cited by in F6Publishing: 30] [Article Influence: 2.3] [Reference Citation Analysis]
334 Ayannuga OA, Naicker T. Cortical Oligodendrocytes in Kaolin-Induced Hydrocephalus in Wistar Rat: Impact of Degree and Duration of Ventriculomegaly. Ann Neurosci 2017;24:164-72. [PMID: 28867898 DOI: 10.1159/000477154] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
335 Afaloniati H, Karagiannis GS, Karavanis E, Psarra TA, Karampatzakis-Kouritas A, Poutahidis T, Angelopoulou K. Inflammation-induced colon cancer in uPA-deficient mice is associated with a deregulated expression of Notch signaling pathway components. Mol Cell Biochem 2020;464:181-91. [PMID: 31758376 DOI: 10.1007/s11010-019-03659-9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
336 Zhang P, Yang Y, Nolo R, Zweidler-McKay PA, Hughes DP. Regulation of NOTCH signaling by reciprocal inhibition of HES1 and Deltex 1 and its role in osteosarcoma invasiveness. Oncogene 2010;29:2916-26. [PMID: 20208568 DOI: 10.1038/onc.2010.62] [Cited by in Crossref: 64] [Cited by in F6Publishing: 63] [Article Influence: 5.3] [Reference Citation Analysis]
337 Shao H, Cai L, Moller M, Issac B, Zhang L, Owyong M, Moscowitz AE, Vazquez-Padron R, Radtke F, Liu ZJ. Notch1-WISP-1 axis determines the regulatory role of mesenchymal stem cell-derived stromal fibroblasts in melanoma metastasis. Oncotarget 2016;7:79262-73. [PMID: 27813493 DOI: 10.18632/oncotarget.13021] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 2.8] [Reference Citation Analysis]
338 Sun P, Zhang N, Tang Y, Yang Y, Chu X, Zhao Y. SL2B aptamer and folic acid dual-targeting DNA nanostructures for synergic biological effect with chemotherapy to combat colorectal cancer. Int J Nanomedicine 2017;12:2657-72. [PMID: 28435250 DOI: 10.2147/IJN.S132929] [Cited by in Crossref: 26] [Cited by in F6Publishing: 9] [Article Influence: 5.2] [Reference Citation Analysis]
339 Boulay JL, Miserez AR, Zweifel C, Sivasankaran B, Kana V, Ghaffari A, Luyken C, Sabel M, Zerrouqi A, Wasner M, Van Meir E, Tolnay M, Reifenberger G, Merlo A. Loss of NOTCH2 positively predicts survival in subgroups of human glial brain tumors. PLoS One 2007;2:e576. [PMID: 17593975 DOI: 10.1371/journal.pone.0000576] [Cited by in Crossref: 46] [Cited by in F6Publishing: 43] [Article Influence: 3.1] [Reference Citation Analysis]
340 de la Pompa JL. Notch signaling in cardiac development and disease. Pediatr Cardiol 2009;30:643-50. [PMID: 19184573 DOI: 10.1007/s00246-008-9368-z] [Cited by in Crossref: 32] [Cited by in F6Publishing: 32] [Article Influence: 2.5] [Reference Citation Analysis]
341 Castro NP, Fedorova-Abrams ND, Merchant AS, Rangel MC, Nagaoka T, Karasawa H, Klauzinska M, Hewitt SM, Biswas K, Sharan SK, Salomon DS. Cripto-1 as a novel therapeutic target for triple negative breast cancer. Oncotarget 2015;6:11910-29. [PMID: 26059540 DOI: 10.18632/oncotarget.4182] [Cited by in Crossref: 42] [Cited by in F6Publishing: 42] [Article Influence: 7.0] [Reference Citation Analysis]
342 Doroquez DB, Rebay I. Signal integration during development: mechanisms of EGFR and Notch pathway function and cross-talk. Crit Rev Biochem Mol Biol 2006;41:339-85. [PMID: 17092823 DOI: 10.1080/10409230600914344] [Cited by in Crossref: 101] [Cited by in F6Publishing: 100] [Article Influence: 6.7] [Reference Citation Analysis]
343 Kang S, Yang C, Luo R. Induction of CCL2 by siMAML1 through upregulation of TweakR in melanoma cells. Biochem Biophys Res Commun 2008;372:629-33. [PMID: 18503747 DOI: 10.1016/j.bbrc.2008.05.079] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.5] [Reference Citation Analysis]
344 Matsuo K, Taniguchi K, Hamamoto H, Inomata Y, Komura K, Tanaka T, Lee SW, Uchiyama K. Delta-like canonical Notch ligand 3 as a potential therapeutic target in malignancies: A brief overview. Cancer Sci 2021;112:2984-92. [PMID: 34107132 DOI: 10.1111/cas.15017] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
345 Morrison BJ, Morris JC, Steel JC. Lung cancer-initiating cells: a novel target for cancer therapy. Target Oncol. 2013;8:159-172. [PMID: 23314952 DOI: 10.1007/s11523-012-0247-4] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 2.2] [Reference Citation Analysis]
346 Rafel N, Milán M. Notch signalling coordinates tissue growth and wing fate specification in Drosophila. Development 2008;135:3995-4001. [PMID: 18987026 DOI: 10.1242/dev.027789] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 1.1] [Reference Citation Analysis]
347 Falk R, Falk A, Dyson MR, Melidoni AN, Parthiban K, Young JL, Roake W, McCafferty J. Generation of anti-Notch antibodies and their application in blocking Notch signalling in neural stem cells. Methods 2012;58:69-78. [PMID: 22842086 DOI: 10.1016/j.ymeth.2012.07.008] [Cited by in Crossref: 43] [Cited by in F6Publishing: 41] [Article Influence: 4.3] [Reference Citation Analysis]
348 Peltonen HM, Haapasalo A, Hiltunen M, Kataja V, Kosma VM, Mannermaa A. Γ-secretase components as predictors of breast cancer outcome. PLoS One 2013;8:e79249. [PMID: 24223915 DOI: 10.1371/journal.pone.0079249] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
349 Luo M, Clouthier SG, Deol Y, Liu S, Nagrath S, Azizi E, Wicha MS. Breast cancer stem cells: current advances and clinical implications. Methods Mol Biol. 2015;1293:1-49. [PMID: 26040679 DOI: 10.1007/978-1-4939-2519-3_1] [Cited by in Crossref: 52] [Cited by in F6Publishing: 55] [Article Influence: 8.7] [Reference Citation Analysis]
350 Saito S, Ishiguro H, Kimura M, Ogawa R, Miyai H, Tanaka T, Mizoguchi K, Takeyama H. Clinical significance of NOTCH1 intracellular cytoplasmic domain translocation into the nucleus in gastric cancer. Biomed Rep 2016;5:344-8. [PMID: 27602214 DOI: 10.3892/br.2016.723] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
351 Zhao Y, Katzman RB, Delmolino LM, Bhat I, Zhang Y, Gurumurthy CB, Germaniuk-Kurowska A, Reddi HV, Solomon A, Zeng MS, Kung A, Ma H, Gao Q, Dimri G, Stanculescu A, Miele L, Wu L, Griffin JD, Wazer DE, Band H, Band V. The notch regulator MAML1 interacts with p53 and functions as a coactivator. J Biol Chem 2007;282:11969-81. [PMID: 17317671 DOI: 10.1074/jbc.M608974200] [Cited by in Crossref: 58] [Cited by in F6Publishing: 34] [Article Influence: 3.9] [Reference Citation Analysis]
352 Mikhail S, Zeidan A. Stem cells in gastrointestinal cancers: The road less travelled. World J Stem Cells 2014; 6(5): 606-613 [PMID: 25426257 DOI: 10.4252/wjsc.v6.i5.606] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 1.3] [Reference Citation Analysis]
353 Podar K, Chauhan D, Anderson KC. Bone marrow microenvironment and the identification of new targets for myeloma therapy. Leukemia. 2009;23:10-24. [PMID: 18843284 DOI: 10.1038/leu.2008.259] [Cited by in Crossref: 250] [Cited by in F6Publishing: 220] [Article Influence: 17.9] [Reference Citation Analysis]
354 Bhuyan ZA, Asanoma M, Iwata A, Ishifune C, Maekawa Y, Shimada M, Yasutomo K. Abrogation of Rbpj attenuates experimental autoimmune uveoretinitis by inhibiting IL-22-producing CD4+ T cells. PLoS One 2014;9:e89266. [PMID: 24586644 DOI: 10.1371/journal.pone.0089266] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.5] [Reference Citation Analysis]
355 Sparaneo A, Fabrizio FP, Muscarella LA. Nrf2 and Notch Signaling in Lung Cancer: Near the Crossroad. Oxid Med Cell Longev 2016;2016:7316492. [PMID: 27847554 DOI: 10.1155/2016/7316492] [Cited by in Crossref: 17] [Cited by in F6Publishing: 19] [Article Influence: 2.8] [Reference Citation Analysis]
356 Duke CM, Taylor HS. Stem cells and the reproductive system: historical perspective and future directions. Maturitas. 2013;76:284-289. [PMID: 24144960 DOI: 10.1016/j.maturitas.2013.08.012] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 1.6] [Reference Citation Analysis]
357 Hummel TR, Chow LM, Fouladi M, Franz D. Pharmacotherapeutic management of pediatric gliomas : current and upcoming strategies. Paediatr Drugs 2013;15:29-42. [PMID: 23329387 DOI: 10.1007/s40272-012-0002-4] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 0.9] [Reference Citation Analysis]
358 Hayward P, Brennan K, Sanders P, Balayo T, DasGupta R, Perrimon N, Martinez Arias A. Notch modulates Wnt signalling by associating with Armadillo/beta-catenin and regulating its transcriptional activity. Development. 2005;132:1819-1830. [PMID: 15772135 DOI: 10.1242/dev.01724] [Cited by in Crossref: 143] [Cited by in F6Publishing: 139] [Article Influence: 8.4] [Reference Citation Analysis]
359 Margareto J, Leis O, Larrarte E, Idoate MA, Carrasco A, Lafuente JV. Gene expression profiling of human gliomas reveals differences between GBM and LGA related to energy metabolism and notch signaling pathways. J Mol Neurosci 2007;32:53-63. [PMID: 17873288 DOI: 10.1007/s12031-007-0008-5] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 1.3] [Reference Citation Analysis]
360 Telerman A, Amson R. The molecular programme of tumour reversion: the steps beyond malignant transformation. Nat Rev Cancer. 2009;9:206-216. [PMID: 19180095 DOI: 10.1038/nrc2589] [Cited by in Crossref: 110] [Cited by in F6Publishing: 102] [Article Influence: 8.5] [Reference Citation Analysis]
361 Hodkinson PS, Elliott PA, Lad Y, Mchugh BJ, Mackinnon AC, Haslett C, Sethi T. Mammalian NOTCH-1 Activates β1 Integrins via the Small GTPase R-Ras. Journal of Biological Chemistry 2007;282:28991-9001. [DOI: 10.1074/jbc.m703601200] [Cited by in Crossref: 62] [Cited by in F6Publishing: 34] [Article Influence: 4.1] [Reference Citation Analysis]
362 Ryan BM, O'Donovan N, Duffy MJ. Survivin: a new target for anti-cancer therapy. Cancer Treat Rev 2009;35:553-62. [PMID: 19559538 DOI: 10.1016/j.ctrv.2009.05.003] [Cited by in Crossref: 273] [Cited by in F6Publishing: 255] [Article Influence: 21.0] [Reference Citation Analysis]
363 Mikesch JH, Steffen B, Berdel WE, Serve H, Müller-Tidow C. The emerging role of Wnt signaling in the pathogenesis of acute myeloid leukemia. Leukemia 2007;21:1638-47. [PMID: 17554387 DOI: 10.1038/sj.leu.2404732] [Cited by in Crossref: 75] [Cited by in F6Publishing: 67] [Article Influence: 5.0] [Reference Citation Analysis]
364 Azaro A, Massard C, Tap WD, Cassier PA, Merchan J, Italiano A, Anderson B, Yuen E, Yu D, Oakley G 3rd, Benhadji KA, Pant S. A phase 1b study of the Notch inhibitor crenigacestat (LY3039478) in combination with other anticancer target agents (taladegib, LY3023414, or abemaciclib) in patients with advanced or metastatic solid tumors. Invest New Drugs 2021;39:1089-98. [PMID: 33686452 DOI: 10.1007/s10637-021-01094-6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
365 Lan K, Murakami M, Bajaj B, Kaul R, He Z, Gan R, Feldman M, Robertson ES. Inhibition of KSHV-infected primary effusion lymphomas in NOD/SCID mice by gamma-secretase inhibitor. Cancer Biol Ther 2009;8:2136-43. [PMID: 19783901 DOI: 10.4161/cbt.8.22.9743] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 1.2] [Reference Citation Analysis]
366 Even C, Lassen U, Merchan J, Le Tourneau C, Soria JC, Ferte C, Ricci F, Diener JT, Yuen E, Smith C, Oakley GJ 3rd, Benhadji KA, Massard C. Safety and clinical activity of the Notch inhibitor, crenigacestat (LY3039478), in an open-label phase I trial expansion cohort of advanced or metastatic adenoid cystic carcinoma. Invest New Drugs 2020;38:402-9. [PMID: 30953269 DOI: 10.1007/s10637-019-00739-x] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 5.3] [Reference Citation Analysis]
367 Lee C, Dunn SE, Yip S. Stem cells in brain tumour development and therapy- two-sides of the same coin. Can J Neurol Sci 2012;39:145-56. [PMID: 22343146 DOI: 10.1017/s0317167100013159] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
368 Ahmad A. Pathways to breast cancer recurrence. ISRN Oncol 2013;2013:290568. [PMID: 23533807 DOI: 10.1155/2013/290568] [Cited by in Crossref: 33] [Cited by in F6Publishing: 44] [Article Influence: 3.7] [Reference Citation Analysis]
369 Lai PY, Tsai CB, Tseng MJ. Active form Notch4 promotes the proliferation and differentiation of 3T3-L1 preadipocytes. Biochem Biophys Res Commun 2013;430:1132-9. [PMID: 23237809 DOI: 10.1016/j.bbrc.2012.12.024] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 2.0] [Reference Citation Analysis]
370 Aristizabal Prada ET, Auernhammer CJ. Targeted therapy of gastroenteropancreatic neuroendocrine tumours: preclinical strategies and future targets. Endocr Connect 2018;7:R1-R25. [PMID: 29146887 DOI: 10.1530/EC-17-0286] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 2.8] [Reference Citation Analysis]
371 Yamamoto S, Tateishi K, Kudo Y, Yamamoto K, Isagawa T, Nagae G, Nakatsuka T, Asaoka Y, Ijichi H, Hirata Y, Otsuka M, Ikenoue T, Aburatani H, Omata M, Koike K. Histone demethylase KDM4C regulates sphere formation by mediating the cross talk between Wnt and Notch pathways in colonic cancer cells. Carcinogenesis 2013;34:2380-8. [PMID: 23698634 DOI: 10.1093/carcin/bgt174] [Cited by in Crossref: 27] [Cited by in F6Publishing: 28] [Article Influence: 3.0] [Reference Citation Analysis]
372 Kuncharin Y, Sangphech N, Kueanjinda P, Bhattarakosol P, Palaga T. MAML1 regulates cell viability via the NF-κB pathway in cervical cancer cell lines. Experimental Cell Research 2011;317:1830-40. [DOI: 10.1016/j.yexcr.2011.05.005] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.0] [Reference Citation Analysis]
373 Kolev V, Kacer D, Trifonova R, Small D, Duarte M, Soldi R, Graziani I, Sideleva O, Larman B, Maciag T, Prudovsky I. The intracellular domain of Notch ligand Delta1 induces cell growth arrest. FEBS Lett 2005;579:5798-802. [PMID: 16225865 DOI: 10.1016/j.febslet.2005.09.042] [Cited by in Crossref: 32] [Cited by in F6Publishing: 28] [Article Influence: 1.9] [Reference Citation Analysis]
374 Mir O, Azaro A, Merchan J, Chugh R, Trent J, Rodon J, Ohnmacht U, Diener JT, Smith C, Yuen E, Oakley GJ, Le Cesne A, Soria JC, Benhadji KA, Massard C. Notch pathway inhibition with LY3039478 in soft tissue sarcoma and gastrointestinal stromal tumours. Eur J Cancer. 2018;103:88-97. [PMID: 30218977 DOI: 10.1016/j.ejca.2018.08.012] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 3.0] [Reference Citation Analysis]
375 Rahman R, Heath R, Grundy R. Cellular immortality in brain tumours: an integration of the cancer stem cell paradigm. Biochim Biophys Acta 2009;1792:280-8. [PMID: 19419702 DOI: 10.1016/j.bbadis.2009.01.011] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 0.7] [Reference Citation Analysis]
376 Taal HR, Pourcain BS, Thiering E, Das S, Mook-Kanamori DO, Warrington NM, Kaakinen M, Kreiner-Møller E, Bradfield JP, Freathy RM, Geller F, Guxens M, Cousminer DL, Kerkhof M, Timpson NJ, Ikram MA, Beilin LJ, Bønnelykke K, Buxton JL, Charoen P, Chawes BLK, Eriksson J, Evans DM, Hofman A, Kemp JP, Kim CE, Klopp N, Lahti J, Lye SJ, McMahon G, Mentch FD, Müller M, O'Reilly PF, Prokopenko I, Rivadeneira F, Steegers EAP, Sunyer J, Tiesler C, Yaghootkar H, Breteler MMB, Debette S, Fornage M, Gudnason V, Launer LJ, van der Lugt A, Mosley TH, Seshadri S, Smith AV, Vernooij MW, Blakemore AI, Chiavacci RM, Feenstra B, Fernandez-Benet J, Grant SFA, Hartikainen AL, van der Heijden AJ, Iñiguez C, Lathrop M, McArdle WL, Mølgaard A, Newnham JP, Palmer LJ, Palotie A, Pouta A, Ring SM, Sovio U, Standl M, Uitterlinden AG, Wichmann HE, Vissing NH, DeCarli C, van Duijn CM, McCarthy MI, Koppelman GH, Estivill X, Hattersley AT, Melbye M, Bisgaard H, Pennell CE, Widen E, Hakonarson H, Smith GD, Heinrich J, Jarvelin MR, Jaddoe VWV; Cohorts for Heart and Aging Research in Genetic Epidemiology (CHARGE) Consortium., Early Genetics & Lifecourse Epidemiology (EAGLE) consortium., Early Growth Genetics (EGG) Consortium. Common variants at 12q15 and 12q24 are associated with infant head circumference. Nat Genet 2012;44:532-8. [PMID: 22504419 DOI: 10.1038/ng.2238] [Cited by in Crossref: 96] [Cited by in F6Publishing: 83] [Article Influence: 9.6] [Reference Citation Analysis]
377 Troy JD, Weissfeld JL, Youk AO, Thomas S, Wang L, Grandis JR. Expression of EGFR, VEGF, and NOTCH1 suggest differences in tumor angiogenesis in HPV-positive and HPV-negative head and neck squamous cell carcinoma. Head Neck Pathol 2013;7:344-55. [PMID: 23645351 DOI: 10.1007/s12105-013-0447-y] [Cited by in Crossref: 29] [Cited by in F6Publishing: 26] [Article Influence: 3.2] [Reference Citation Analysis]
378 Raimondi L, Ciarapica R, De Salvo M, Verginelli F, Gueguen M, Martini C, De Sio L, Cortese G, Locatelli M, Dang TP, Carlesso N, Miele L, Stifani S, Limon I, Locatelli F, Rota R. Inhibition of Notch3 signalling induces rhabdomyosarcoma cell differentiation promoting p38 phosphorylation and p21(Cip1) expression and hampers tumour cell growth in vitro and in vivo. Cell Death Differ 2012;19:871-81. [PMID: 22117196 DOI: 10.1038/cdd.2011.171] [Cited by in Crossref: 41] [Cited by in F6Publishing: 40] [Article Influence: 3.7] [Reference Citation Analysis]
379 Fukaya R, Ohta S, Yamaguchi M, Fujii H, Kawakami Y, Kawase T, Toda M. Isolation of cancer stem-like cells from a side population of a human glioblastoma cell line, SK-MG-1. Cancer Lett. 2010;291:150-157. [PMID: 19913993 DOI: 10.1016/j.canlet.2009.10.010] [Cited by in Crossref: 38] [Cited by in F6Publishing: 37] [Article Influence: 2.9] [Reference Citation Analysis]
380 Chang L, Wong F, Niessen K, Karsan A. Notch activation promotes endothelial survival through a PI3K-Slug axis. Microvasc Res 2013;89:80-5. [PMID: 23743248 DOI: 10.1016/j.mvr.2013.05.007] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 0.3] [Reference Citation Analysis]
381 Bergler-Czop B, Miziołek B, Sierant K, Sazanów-Lubelski J, Brzezińska-Wcisło L. Evaluation of PSEN1 subunit of the γ-secretase gene in patients with psoriasis vulgaris: a pilot study. Postepy Dermatol Alergol 2020;37:915-20. [PMID: 33603609 DOI: 10.5114/ada.2020.102108] [Reference Citation Analysis]
382 Cho S, Lu M, He X, Ee PL, Bhat U, Schneider E, Miele L, Beck WT. Notch1 regulates the expression of the multidrug resistance gene ABCC1/MRP1 in cultured cancer cells. Proc Natl Acad Sci USA. 2011;108:20778-20783. [PMID: 22143792 DOI: 10.1073/pnas.1019452108] [Cited by in Crossref: 58] [Cited by in F6Publishing: 53] [Article Influence: 5.3] [Reference Citation Analysis]
383 Liang YK, Lin HY, Dou XW, Chen M, Wei XL, Zhang YQ, Wu Y, Chen CF, Bai JW, Xiao YS, Qi YZ, Kruyt FAE, Zhang GJ. MiR-221/222 promote epithelial-mesenchymal transition by targeting Notch3 in breast cancer cell lines. NPJ Breast Cancer 2018;4:20. [PMID: 30109262 DOI: 10.1038/s41523-018-0073-7] [Cited by in Crossref: 25] [Cited by in F6Publishing: 24] [Article Influence: 6.3] [Reference Citation Analysis]
384 Housden BE, Terriente-Felix A, Bray SJ. Context-dependent enhancer selection confers alternate modes of notch regulation on argos. Mol Cell Biol 2014;34:664-72. [PMID: 24324007 DOI: 10.1128/MCB.01045-13] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
385 Dirks PB. Brain tumor stem cells: bringing order to the chaos of brain cancer. J Clin Oncol. 2008;26:2916-2924. [PMID: 18539973 DOI: 10.1200/jco.2008.17.6792] [Cited by in Crossref: 129] [Cited by in F6Publishing: 62] [Article Influence: 9.2] [Reference Citation Analysis]
386 Lee SF, Srinivasan B, Sephton CF, Dries DR, Wang B, Yu C, Wang Y, Dewey CM, Shah S, Jiang J, Yu G. Gamma-secretase-regulated proteolysis of the Notch receptor by mitochondrial intermediate peptidase. J Biol Chem 2011;286:27447-53. [PMID: 21685396 DOI: 10.1074/jbc.M111.243154] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
387 Keller PC 2nd, Tomita T, Hayashi I, Chandu D, Weber JD, Cistola DP, Kopan R. A faster migrating variant masquerades as NICD when performing in vitro gamma-secretase assays with bacterially expressed Notch substrates. Biochemistry 2006;45:5351-8. [PMID: 16618124 DOI: 10.1021/bi052228a] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
388 Nandi A, Chakrabarti R. The many facets of Notch signaling in breast cancer: toward overcoming therapeutic resistance. Genes Dev 2020;34:1422-38. [PMID: 33872192 DOI: 10.1101/gad.342287.120] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
389 Dinicola S, Pasqualato A, Proietti S, Masiello MG, Palombo A, Coluccia P, Canipari R, Catizone A, Ricci G, Harrath AH, Alwasel SH, Cucina A, Bizzarri M. Paradoxical E-cadherin increase in 5FU-resistant colon cancer is unaffected during mesenchymal-epithelial reversion induced by γ-secretase inhibition. Life Sci 2016;145:174-83. [PMID: 26746659 DOI: 10.1016/j.lfs.2015.12.048] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 1.6] [Reference Citation Analysis]
390 Bushell M, Stoneley M, Kong YW, Hamilton TL, Spriggs KA, Dobbyn HC, Qin X, Sarnow P, Willis AE. Polypyrimidine tract binding protein regulates IRES-mediated gene expression during apoptosis. Mol Cell 2006;23:401-12. [PMID: 16885029 DOI: 10.1016/j.molcel.2006.06.012] [Cited by in Crossref: 111] [Cited by in F6Publishing: 114] [Article Influence: 6.9] [Reference Citation Analysis]
391 Wilting SM, de Wilde J, Meijer CJ, Berkhof J, Yi Y, van Wieringen WN, Braakhuis BJ, Meijer GA, Ylstra B, Snijders PJ. Integrated genomic and transcriptional profiling identifies chromosomal loci with altered gene expression in cervical cancer. Genes Chromosomes Cancer. 2008;47:890-905. [PMID: 18618715 DOI: 10.1002/gcc.20590] [Cited by in Crossref: 43] [Cited by in F6Publishing: 46] [Article Influence: 3.1] [Reference Citation Analysis]
392 Del Monte G, Grego-Bessa J, González-Rajal A, Bolós V, De La Pompa JL. Monitoring Notch1 activity in development: evidence for a feedback regulatory loop. Dev Dyn 2007;236:2594-614. [PMID: 17685488 DOI: 10.1002/dvdy.21246] [Cited by in Crossref: 99] [Cited by in F6Publishing: 94] [Article Influence: 6.6] [Reference Citation Analysis]
393 Fouladi M, Stewart CF, Olson J, Wagner LM, Onar-Thomas A, Kocak M, Packer RJ, Goldman S, Gururangan S, Gajjar A, Demuth T, Kun LE, Boyett JM, Gilbertson RJ. Phase I trial of MK-0752 in children with refractory CNS malignancies: a pediatric brain tumor consortium study. J Clin Oncol. 2011;29:3529-3534. [PMID: 21825264 DOI: 10.1200/jco.2011.35.7806] [Cited by in Crossref: 117] [Cited by in F6Publishing: 61] [Article Influence: 10.6] [Reference Citation Analysis]
394 Carrieri FA, Dale JK. Turn It Down a Notch. Front Cell Dev Biol 2016;4:151. [PMID: 28149836 DOI: 10.3389/fcell.2016.00151] [Cited by in Crossref: 9] [Cited by in F6Publishing: 17] [Article Influence: 1.8] [Reference Citation Analysis]
395 Hengeveld PJ, Kersten MJ. B-cell activating factor in the pathophysiology of multiple myeloma: a target for therapy? Blood Cancer J 2015;5:e282. [PMID: 25723853 DOI: 10.1038/bcj.2015.3] [Cited by in Crossref: 53] [Cited by in F6Publishing: 51] [Article Influence: 7.6] [Reference Citation Analysis]
396 Guo S, Liu M, Wang G, Torroella-Kouri M, Gonzalez-Perez RR. Oncogenic role and therapeutic target of leptin signaling in breast cancer and cancer stem cells. Biochim Biophys Acta 2012;1825:207-22. [PMID: 22289780 DOI: 10.1016/j.bbcan.2012.01.002] [Cited by in Crossref: 39] [Cited by in F6Publishing: 70] [Article Influence: 3.9] [Reference Citation Analysis]
397 Yang Z, Guo L, Liu D, Sun L, Chen H, Deng Q, Liu Y, Yu M, Ma Y, Guo N, Shi M. Acquisition of resistance to trastuzumab in gastric cancer cells is associated with activation of IL-6/STAT3/Jagged-1/Notch positive feedback loop. Oncotarget. 2015;6:5072-5087. [PMID: 25669984 DOI: 10.18632/oncotarget.3241] [Cited by in Crossref: 58] [Cited by in F6Publishing: 59] [Article Influence: 9.7] [Reference Citation Analysis]
398 Li NN, Guo Y, Jiang CJ, Zhou YY, Li CH, Li ZG, Wang DL. Allyl isothiocyanate upregulates MRP1 expression through Notch1 signaling in human bronchial epithelial cells. Can J Physiol Pharmacol 2020;98:324-31. [PMID: 31747319 DOI: 10.1139/cjpp-2019-0448] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
399 Crea F, Duhagon MA, Farrar WL, Danesi R. Pharmacogenomics and cancer stem cells: a changing landscape? Trends Pharmacol Sci 2011;32:487-94. [PMID: 21529973 DOI: 10.1016/j.tips.2011.03.010] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 1.4] [Reference Citation Analysis]
400 Sun Z, Zhou C, Liu F, Zhang W, Chen J, Pan Y, Ma L, Liu Q, Du Y, Yang J, Wang Q. Inhibition of breast cancer cell survival by Xanthohumol via modulation of the Notch signaling pathway in vivo and in vitro. Oncol Lett 2018;15:908-16. [PMID: 29422966 DOI: 10.3892/ol.2017.7434] [Cited by in Crossref: 12] [Cited by in F6Publishing: 17] [Article Influence: 2.4] [Reference Citation Analysis]
401 Rose SL. Notch Signaling Pathway in Ovarian Cancer: . International Journal of Gynecological Cancer 2009;19:564-6. [DOI: 10.1111/igc.0b013e3181a12ed2] [Cited by in Crossref: 29] [Cited by in F6Publishing: 16] [Article Influence: 2.2] [Reference Citation Analysis]
402 Bernard F, Krejci A, Housden B, Adryan B, Bray SJ. Specificity of Notch pathway activation: twist controls the transcriptional output in adult muscle progenitors. Development 2010;137:2633-42. [PMID: 20610485 DOI: 10.1242/dev.053181] [Cited by in Crossref: 56] [Cited by in F6Publishing: 52] [Article Influence: 4.7] [Reference Citation Analysis]
403 Taylor MD, Poppleton H, Fuller C, Su X, Liu Y, Jensen P, Magdaleno S, Dalton J, Calabrese C, Board J, Macdonald T, Rutka J, Guha A, Gajjar A, Curran T, Gilbertson RJ. Radial glia cells are candidate stem cells of ependymoma. Cancer Cell. 2005;8:323-335. [PMID: 16226707 DOI: 10.1016/j.ccr.2005.09.001] [Cited by in Crossref: 599] [Cited by in F6Publishing: 503] [Article Influence: 35.2] [Reference Citation Analysis]
404 Basak NP, Roy A, Banerjee S. Alteration of mitochondrial proteome due to activation of Notch1 signaling pathway. J Biol Chem 2014;289:7320-34. [PMID: 24474689 DOI: 10.1074/jbc.M113.519405] [Cited by in Crossref: 35] [Cited by in F6Publishing: 17] [Article Influence: 4.4] [Reference Citation Analysis]
405 Orzechowska M, Anusewicz D, Bednarek AK. Functional Gene Expression Differentiation of the Notch Signaling Pathway in Female Reproductive Tract Tissues-A Comprehensive Review With Analysis. Front Cell Dev Biol 2020;8:592616. [PMID: 33384996 DOI: 10.3389/fcell.2020.592616] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
406 Yoon HA, Noh MH, Kim BG, Han JS, Jang JS, Choi SR, Jeong JS, Chun JH. Clinicopathological significance of altered Notch signaling in extrahepatic cholangiocarcinoma and gallbladder carcinoma. World J Gastroenterol 2011; 17(35): 4023-4030 [PMID: 22046092 DOI: 10.3748/wjg.v17.i35.4023] [Cited by in CrossRef: 30] [Cited by in F6Publishing: 28] [Article Influence: 2.7] [Reference Citation Analysis]
407 Klinakis A, Szabolcs M, Politi K, Kiaris H, Artavanis-Tsakonas S, Efstratiadis A. Myc is a Notch1 transcriptional target and a requisite for Notch1-induced mammary tumorigenesis in mice. Proc Natl Acad Sci USA. 2006;103:9262-9267. [PMID: 16751266 DOI: 10.1073/pnas.0603371103] [Cited by in Crossref: 151] [Cited by in F6Publishing: 146] [Article Influence: 9.4] [Reference Citation Analysis]
408 Piovan E, Tosello V, Amadori A, Zanovello P. Chemotactic Cues for NOTCH1-Dependent Leukemia. Front Immunol 2018;9:633. [PMID: 29666622 DOI: 10.3389/fimmu.2018.00633] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
409 Xia J, Chen C, Chen Z, Miele L, Sarkar FH, Wang Z. Targeting pancreatic cancer stem cells for cancer therapy. Biochim Biophys Acta. 2012;1826:385-399. [PMID: 22728049 DOI: 10.1016/j.bbcan.2012.06.002] [Cited by in Crossref: 6] [Cited by in F6Publishing: 12] [Article Influence: 0.6] [Reference Citation Analysis]
410 Shibata T, Aburatani H. Exploration of liver cancer genomes. Nat Rev Gastroenterol Hepatol. 2014;11:340-349. [PMID: 24473361 DOI: 10.1038/nrgastro.2014.6] [Cited by in Crossref: 113] [Cited by in F6Publishing: 110] [Article Influence: 14.1] [Reference Citation Analysis]
411 Bolós V, Blanco M, Medina V, Aparicio G, Díaz-Prado S, Grande E. Notch signalling in cancer stem cells. Clin Transl Oncol. 2009;11:11-19. [PMID: 19155199 DOI: 10.1007/s12094-009-0305-2] [Cited by in Crossref: 60] [Cited by in F6Publishing: 62] [Article Influence: 4.6] [Reference Citation Analysis]
412 Nishiya N, Yonezawa H. Domestication of chemicals attacking metazoan embryogenesis: identification of safe natural products modifying developmental signaling pathways in human. J Antibiot (Tokyo) 2021. [PMID: 34381189 DOI: 10.1038/s41429-021-00461-y] [Reference Citation Analysis]
413 Urs S, Roudabush A, O'Neill CF, Pinz I, Prudovsky I, Kacer D, Tang Y, Liaw L, Small D. Soluble forms of the Notch ligands Delta1 and Jagged1 promote in vivo tumorigenicity in NIH3T3 fibroblasts with distinct phenotypes. Am J Pathol 2008;173:865-78. [PMID: 18688026 DOI: 10.2353/ajpath.2008.080006] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 1.4] [Reference Citation Analysis]
414 Mak DW, Li S, Minchom A. Challenging the recalcitrant disease—developing molecularly driven treatments for small cell lung cancer. European Journal of Cancer 2019;119:132-50. [DOI: 10.1016/j.ejca.2019.04.037] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 2.7] [Reference Citation Analysis]
415 Bennani-Baiti IM, Aryee DN, Ban J, Machado I, Kauer M, Mühlbacher K, Amann G, Llombart-Bosch A, Kovar H. Notch signalling is off and is uncoupled from HES1 expression in Ewing's sarcoma. J Pathol 2011;225:353-63. [PMID: 21984123 DOI: 10.1002/path.2966] [Cited by in Crossref: 23] [Cited by in F6Publishing: 21] [Article Influence: 2.1] [Reference Citation Analysis]
416 Gomperts BD, Kramer IM, Tatham PE. Notch. Signal Transduction. Elsevier; 2009. pp. 699-734. [DOI: 10.1016/b978-0-12-369441-6.00022-2] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
417 Maiso P, Mogollón P, Ocio EM, Garayoa M. Bone Marrow Mesenchymal Stromal Cells in Multiple Myeloma: Their Role as Active Contributors to Myeloma Progression. Cancers (Basel) 2021;13:2542. [PMID: 34067236 DOI: 10.3390/cancers13112542] [Reference Citation Analysis]
418 Mallipeddi H, Thyagarajan A, Sahu RP. Implications of Withaferin-A for triple-negative breast cancer chemoprevention. Biomed Pharmacother 2021;134:111124. [PMID: 33434782 DOI: 10.1016/j.biopha.2020.111124] [Reference Citation Analysis]
419 Xu J, Liu S. Noncoding RNAs in Cancer Cell Plasticity. Adv Exp Med Biol 2016;927:173-89. [PMID: 27376735 DOI: 10.1007/978-981-10-1498-7_6] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
420 Aoyama K, Ota Y, Kajiwara K, Hirayama N, Kimura M. Frequent mutations in NOTCH1 ligand-binding regions in Japanese oral squamous cell carcinoma. Biochemical and Biophysical Research Communications 2014;452:980-5. [DOI: 10.1016/j.bbrc.2014.09.021] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.1] [Reference Citation Analysis]
421 Housden BE, Fu AQ, Krejci A, Bernard F, Fischer B, Tavaré S, Russell S, Bray SJ. Transcriptional dynamics elicited by a short pulse of notch activation involves feed-forward regulation by E(spl)/Hes genes. PLoS Genet 2013;9:e1003162. [PMID: 23300480 DOI: 10.1371/journal.pgen.1003162] [Cited by in Crossref: 48] [Cited by in F6Publishing: 36] [Article Influence: 5.3] [Reference Citation Analysis]
422 Yuasa S, Fukuda K. Recent advances in cardiovascular regenerative medicine: the induced pluripotent stem cell era. Expert Rev Cardiovasc Ther. 2008;6:803-810. [PMID: 18570618 DOI: 10.1586/14779072.6.6.803] [Cited by in Crossref: 27] [Cited by in F6Publishing: 19] [Article Influence: 1.9] [Reference Citation Analysis]
423 Shao J, Zhou Y, Xiao Y. The regulatory roles of Notch in osteocyte differentiation via the crosstalk with canonical Wnt pathways during the transition of osteoblasts to osteocytes. Bone 2018;108:165-78. [PMID: 29331299 DOI: 10.1016/j.bone.2018.01.010] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 2.8] [Reference Citation Analysis]
424 Ruffini PA, Vaja V, Allegretti M. Improving cancer therapy by targeting cancer stem cells: Directions, challenges, and clinical results. World J Pharmacol 2015; 4(1): 58-74 [DOI: 10.5497/wjp.v4.i1.58] [Cited by in CrossRef: 1] [Article Influence: 0.1] [Reference Citation Analysis]
425 Astudillo L, Da Silva TG, Wang Z, Han X, Jin K, VanWye J, Zhu X, Weaver K, Oashi T, Lopes PE, Orton D, Neitzel LR, Lee E, Landgraf R, Robbins DJ, MacKerell AD, Capobianco AJ. The Small Molecule IMR-1 Inhibits the Notch Transcriptional Activation Complex to Suppress Tumorigenesis. Cancer Res. 2016;76:3593-3603. [PMID: 27197169 DOI: 10.1158/0008-5472.can-16-0061] [Cited by in Crossref: 32] [Cited by in F6Publishing: 20] [Article Influence: 5.3] [Reference Citation Analysis]
426 Tanaka M, Setoguchi T, Hirotsu M, Gao H, Sasaki H, Matsunoshita Y, Komiya S. Inhibition of Notch pathway prevents osteosarcoma growth by cell cycle regulation. Br J Cancer. 2009;100:1957-1965. [PMID: 19455146 DOI: 10.1038/sj.bjc.6605060] [Cited by in Crossref: 100] [Cited by in F6Publishing: 93] [Article Influence: 7.7] [Reference Citation Analysis]
427 Court H, Amoyel M, Hackman M, Lee KE, Xu R, Miller G, Bar-Sagi D, Bach EA, Bergö MO, Philips MR. Isoprenylcysteine carboxylmethyltransferase deficiency exacerbates KRAS-driven pancreatic neoplasia via Notch suppression. J Clin Invest 2013;123:4681-94. [PMID: 24216479 DOI: 10.1172/JCI65764] [Cited by in Crossref: 39] [Cited by in F6Publishing: 26] [Article Influence: 4.9] [Reference Citation Analysis]
428 Schouwey K, Aydin IT, Radtke F, Beermann F. RBP-Jκ-dependent Notch signaling enhances retinal pigment epithelial cell proliferation in transgenic mice. Oncogene 2011;30:313-22. [DOI: 10.1038/onc.2010.428] [Cited by in Crossref: 26] [Cited by in F6Publishing: 23] [Article Influence: 2.2] [Reference Citation Analysis]
429 Kanamori M, Kawaguchi T, Nigro JM, Feuerstein BG, Berger MS, Miele L, Pieper RO. Contribution of Notch signaling activation to human glioblastoma multiforme. J Neurosurg. 2007;106:417-427. [PMID: 17367064 DOI: 10.3171/jns.2007.106.3.417] [Cited by in Crossref: 138] [Cited by in F6Publishing: 132] [Article Influence: 9.2] [Reference Citation Analysis]
430 Xu J, Yun X, Jiang J, Wei Y, Wu Y, Zhang W, Liu Y, Wang W, Wen Y, Gu J. Hepatitis B virus X protein blunts senescence-like growth arrest of human hepatocellular carcinoma by reducing Notch1 cleavage. Hepatology. 2010;52:142-154. [PMID: 20578140 DOI: 10.1002/hep.23613] [Cited by in Crossref: 64] [Cited by in F6Publishing: 60] [Article Influence: 5.3] [Reference Citation Analysis]
431 Soylu H, Kırca M, Avcı S, Ozpolat B, Ustunel I. Antiandrogen abiraterone and docetaxel treatments affect Notch1, Jagged1 and Hes1 expressions in metastatic prostate cancer cells. Exp Mol Pathol 2021;119:104607. [PMID: 33482170 DOI: 10.1016/j.yexmp.2021.104607] [Reference Citation Analysis]
432 Pancewicz-Wojtkiewicz J, Eljaszewicz A, Kowalczuk O, Niklinska W, Charkiewicz R, Kozłowski M, Miasko A, Moniuszko M. Prognostic significance of Notch ligands in patients with non-small cell lung cancer. Oncol Lett 2017;13:506-10. [PMID: 28123589 DOI: 10.3892/ol.2016.5420] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
433 Dirks PB. Brain tumour stem cells: the undercurrents of human brain cancer and their relationship to neural stem cells. Philos Trans R Soc Lond B Biol Sci 2008;363:139-52. [PMID: 17309866 DOI: 10.1098/rstb.2006.2017] [Cited by in Crossref: 52] [Cited by in F6Publishing: 44] [Article Influence: 3.7] [Reference Citation Analysis]
434 Cobellis L, Caprio F, Trabucco E, Mastrogiacomo A, Coppola G, Manente L, Colacurci N, De Falco M, De Luca A. The pattern of expression of Notch protein members in normal and pathological endometrium. J Anat. 2008;213:464-472. [PMID: 18691378 DOI: 10.1111/j.1469-7580.2008.00963.x] [Cited by in Crossref: 42] [Cited by in F6Publishing: 43] [Article Influence: 3.0] [Reference Citation Analysis]
435 Shao H, Kong R, Ferrari ML, Radtke F, Capobianco AJ, Liu ZJ. Notch1 Pathway Activity Determines the Regulatory Role of Cancer-Associated Fibroblasts in Melanoma Growth and Invasion. PLoS One 2015;10:e0142815. [PMID: 26562315 DOI: 10.1371/journal.pone.0142815] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 1.3] [Reference Citation Analysis]
436 Bray SJ. Notch signalling in context. Nat Rev Mol Cell Biol. 2016;17:722-735. [PMID: 27507209 DOI: 10.1038/nrm.2016.94] [Cited by in Crossref: 451] [Cited by in F6Publishing: 411] [Article Influence: 75.2] [Reference Citation Analysis]
437 Ishikawa Y, Onoyama I, Nakayama KI, Nakayama K. Notch-dependent cell cycle arrest and apoptosis in mouse embryonic fibroblasts lacking Fbxw7. Oncogene 2008;27:6164-74. [PMID: 18641686 DOI: 10.1038/onc.2008.216] [Cited by in Crossref: 44] [Cited by in F6Publishing: 42] [Article Influence: 3.1] [Reference Citation Analysis]
438 Kang S, Xie J, Miao J, Li R, Liao W, Luo R. A knockdown of Maml1 that results in melanoma cell senescence promotes an innate and adaptive immune response. Cancer Immunol Immunother. 2013;62:183-190. [PMID: 22864395 DOI: 10.1007/s00262-012-1318-1] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 0.9] [Reference Citation Analysis]
439 Mazzone M, Selfors LM, Albeck J, Overholtzer M, Sale S, Carroll DL, Pandya D, Lu Y, Mills GB, Aster JC, Artavanis-Tsakonas S, Brugge JS. Dose-dependent induction of distinct phenotypic responses to Notch pathway activation in mammary epithelial cells. Proc Natl Acad Sci U S A 2010;107:5012-7. [PMID: 20194747 DOI: 10.1073/pnas.1000896107] [Cited by in Crossref: 111] [Cited by in F6Publishing: 116] [Article Influence: 9.3] [Reference Citation Analysis]
440 Jin H, Tan X, Liu X, Ding Y. The study of effect of tea polyphenols on microsatellite instability colorectal cancer and its molecular mechanism. Int J Colorectal Dis. 2010;25:1407-1415. [PMID: 20730438 DOI: 10.1007/s00384-010-1047-x] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 1.0] [Reference Citation Analysis]
441 Aiello NM, Stanger BZ. Echoes of the embryo: using the developmental biology toolkit to study cancer. Dis Model Mech 2016;9:105-14. [PMID: 26839398 DOI: 10.1242/dmm.023184] [Cited by in Crossref: 54] [Cited by in F6Publishing: 42] [Article Influence: 9.0] [Reference Citation Analysis]
442 Siekmann AF, Covassin L, Lawson ND. Modulation of VEGF signalling output by the Notch pathway. Bioessays. 2008;30:303-313. [PMID: 18348190 DOI: 10.1002/bies.20736] [Cited by in Crossref: 118] [Cited by in F6Publishing: 105] [Article Influence: 8.4] [Reference Citation Analysis]
443 Oishi H, Sunamura M, Egawa S, Motoi F, Unno M, Furukawa T, Habib NA, Yagita H. Blockade of delta-like ligand 4 signaling inhibits both growth and angiogenesis of pancreatic cancer. Pancreas. 2010;39:897-903. [PMID: 20182391 DOI: 10.1097/mpa.0b013e3181ce7185] [Cited by in Crossref: 24] [Cited by in F6Publishing: 10] [Article Influence: 2.2] [Reference Citation Analysis]
444 Batista CM, Mariano ED, Barbosa BJ, Morgalla M, Marie SK, Teixeira MJ, Lepski G. Adult neurogenesis and glial oncogenesis: when the process fails. Biomed Res Int 2014;2014:438639. [PMID: 24738058 DOI: 10.1155/2014/438639] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
445 Hsu KT, Yu XM, Audhya AW, Jaume JC, Lloyd RV, Miyamoto S, Prolla TA, Chen H. Novel approaches in anaplastic thyroid cancer therapy. Oncologist 2014;19:1148-55. [PMID: 25260367 DOI: 10.1634/theoncologist.2014-0182] [Cited by in Crossref: 36] [Cited by in F6Publishing: 32] [Article Influence: 4.5] [Reference Citation Analysis]
446 Nagata Y, Kontani K, Enami T, Kataoka K, Ishii R, Totoki Y, Kataoka TR, Hirata M, Aoki K, Nakano K, Kitanaka A, Sakata-Yanagimoto M, Egami S, Shiraishi Y, Chiba K, Tanaka H, Shiozawa Y, Yoshizato T, Suzuki H, Kon A, Yoshida K, Sato Y, Sato-Otsubo A, Sanada M, Munakata W, Nakamura H, Hama N, Miyano S, Nureki O, Shibata T, Haga H, Shimoda K, Katada T, Chiba S, Watanabe T, Ogawa S. Variegated RHOA mutations in adult T-cell leukemia/lymphoma. Blood 2016;127:596-604. [PMID: 26574607 DOI: 10.1182/blood-2015-06-644948] [Cited by in Crossref: 68] [Cited by in F6Publishing: 63] [Article Influence: 9.7] [Reference Citation Analysis]
447 Giovannini C, Baglioni M, Baron Toaldo M, Ventrucci C, D'Adamo S, Cipone M, Chieco P, Gramantieri L, Bolondi L. Notch3 inhibition enhances sorafenib cytotoxic efficacy by promoting GSK3b phosphorylation and p21 down-regulation in hepatocellular carcinoma. Oncotarget 2013;4:1618-31. [PMID: 24113128 DOI: 10.18632/oncotarget.1221] [Cited by in Crossref: 30] [Cited by in F6Publishing: 33] [Article Influence: 3.8] [Reference Citation Analysis]
448 Okuyama R, Tagami H, Aiba S. Notch signaling: its role in epidermal homeostasis and in the pathogenesis of skin diseases. J Dermatol Sci 2008;49:187-94. [PMID: 17624739 DOI: 10.1016/j.jdermsci.2007.05.017] [Cited by in Crossref: 102] [Cited by in F6Publishing: 97] [Article Influence: 6.8] [Reference Citation Analysis]
449 Dang L, Fan X, Chaudhry A, Wang M, Gaiano N, Eberhart CG. Notch3 signaling initiates choroid plexus tumor formation. Oncogene 2006;25:487-91. [PMID: 16186803 DOI: 10.1038/sj.onc.1209074] [Cited by in Crossref: 51] [Cited by in F6Publishing: 46] [Article Influence: 3.2] [Reference Citation Analysis]
450 Kim BM, Hong Y, Lee S, Liu P, Lim JH, Lee YH, Lee TH, Chang KT, Hong Y. Therapeutic Implications for Overcoming Radiation Resistance in Cancer Therapy. Int J Mol Sci 2015;16:26880-913. [PMID: 26569225 DOI: 10.3390/ijms161125991] [Cited by in Crossref: 86] [Cited by in F6Publishing: 90] [Article Influence: 12.3] [Reference Citation Analysis]
451 Guarnaccia C, Pintar A, Pongor S. Exon 6 of human Jagged-1 encodes an autonomously folding unit. FEBS Letters 2004;574:156-60. [DOI: 10.1016/j.febslet.2004.08.022] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 0.6] [Reference Citation Analysis]
452 Zubeldía-Brenner L, De Winne C, Perrone S, Rodríguez-Seguí SA, Willems C, Ornstein AM, Lacau-Mengido I, Vankelecom H, Cristina C, Becu-Villalobos D. Inhibition of Notch signaling attenuates pituitary adenoma growth in Nude mice. Endocr Relat Cancer 2019;26:13-29. [PMID: 30121620 DOI: 10.1530/ERC-18-0337] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
453 Hassan WA, Yoshida R, Kudoh S, Kameyama H, Hasegawa K, Niimori-Kita K, Ito T. Notch1 controls cell chemoresistance in small cell lung carcinoma cells. Thorac Cancer 2016;7:123-8. [PMID: 26816546 DOI: 10.1111/1759-7714.12297] [Cited by in Crossref: 15] [Cited by in F6Publishing: 18] [Article Influence: 2.1] [Reference Citation Analysis]
454 Al Haddad AH, Adrian TE. Challenges and future directions in therapeutics for pancreatic ductal adenocarcinoma. Expert Opin Investig Drugs. 2014;23:1499-1515. [PMID: 25078674 DOI: 10.1517/13543784.2014.933206] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
455 Doi T, Tajimi M, Mori J, Asou H, Inoue K, Benhadji KA, Naito Y. A phase 1 study of crenigacestat (LY3039478), the Notch inhibitor, in Japanese patients with advanced solid tumors. Invest New Drugs 2021;39:469-76. [PMID: 32939607 DOI: 10.1007/s10637-020-01001-5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
456 Stockhausen MT, Kristoffersen K, Poulsen HS. Notch signaling and brain tumors. Adv Exp Med Biol 2012;727:289-304. [PMID: 22399356 DOI: 10.1007/978-1-4614-0899-4_22] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 1.4] [Reference Citation Analysis]
457 Reichrath J, Reichrath S. Notch-signaling and nonmelanoma skin cancer: an ancient friend, revisited. Adv Exp Med Biol 2012;727:265-71. [PMID: 22399354 DOI: 10.1007/978-1-4614-0899-4_20] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.1] [Reference Citation Analysis]
458 Lin NY, Distler A, Beyer C, Philipi-Schöbinger A, Breda S, Dees C, Stock M, Tomcik M, Niemeier A, Dell'Accio F, Gelse K, Mattson MP, Schett G, Distler JH. Inhibition of Notch1 promotes hedgehog signalling in a HES1-dependent manner in chondrocytes and exacerbates experimental osteoarthritis. Ann Rheum Dis 2016;75:2037-44. [PMID: 26851274 DOI: 10.1136/annrheumdis-2015-208420] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 2.3] [Reference Citation Analysis]
459 Kaur H, Li JJ, Bay BH, Yung LY. Investigating the antiproliferative activity of high affinity DNA aptamer on cancer cells. PLoS One 2013;8:e50964. [PMID: 23341879 DOI: 10.1371/journal.pone.0050964] [Cited by in Crossref: 25] [Cited by in F6Publishing: 24] [Article Influence: 2.8] [Reference Citation Analysis]
460 Vats A, Trejo-Cerro O, Thomas M, Banks L. Human papillomavirus E6 and E7: What remains? Tumour Virus Res 2021;11:200213. [PMID: 33716206 DOI: 10.1016/j.tvr.2021.200213] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 5.0] [Reference Citation Analysis]
461 Liu C, Li Z, Bi L, Li K, Zhou B, Xu C, Huang J, Xu K. NOTCH1 signaling promotes chemoresistance via regulating ABCC1 expression in prostate cancer stem cells. Mol Cell Biochem 2014;393:265-70. [PMID: 24782036 DOI: 10.1007/s11010-014-2069-4] [Cited by in Crossref: 31] [Cited by in F6Publishing: 30] [Article Influence: 3.9] [Reference Citation Analysis]
462 Chaffer CL, Thompson EW, Williams ED. Mesenchymal to epithelial transition in development and disease. Cells Tissues Organs 2007;185:7-19. [PMID: 17587803 DOI: 10.1159/000101298] [Cited by in Crossref: 218] [Cited by in F6Publishing: 202] [Article Influence: 14.5] [Reference Citation Analysis]
463 Gustafsson MV, Zheng X, Pereira T, Gradin K, Jin S, Lundkvist J, Ruas JL, Poellinger L, Lendahl U, Bondesson M. Hypoxia requires notch signaling to maintain the undifferentiated cell state. Dev Cell. 2005;9:617-628. [PMID: 16256737 DOI: 10.1016/j.devcel.2005.09.010] [Cited by in Crossref: 755] [Cited by in F6Publishing: 697] [Article Influence: 47.2] [Reference Citation Analysis]
464 Pietrafesa M, Maddalena F, Possidente L, Condelli V, Zoppoli P, Li Bergolis V, Rodriquenz MG, Aieta M, Vita G, Esposito F, Landriscina M. Gene Copy Number and Post-Transductional Mechanisms Regulate TRAP1 Expression in Human Colorectal Carcinomas. Int J Mol Sci 2019;21:E145. [PMID: 31878280 DOI: 10.3390/ijms21010145] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
465 Hass MR, Sato C, Kopan R, Zhao G. Presenilin: RIP and beyond. Semin Cell Dev Biol 2009;20:201-10. [PMID: 19073272 DOI: 10.1016/j.semcdb.2008.11.014] [Cited by in Crossref: 59] [Cited by in F6Publishing: 63] [Article Influence: 4.2] [Reference Citation Analysis]
466 Wu Q, Hou X, Xia J, Qian X, Miele L, Sarkar FH, Wang Z. Emerging roles of PDGF-D in EMT progression during tumorigenesis. Cancer Treat Rev. 2013;39:640-646. [PMID: 23261166 DOI: 10.1016/j.ctrv.2012.11.006] [Cited by in Crossref: 45] [Cited by in F6Publishing: 41] [Article Influence: 4.5] [Reference Citation Analysis]
467 Yousif NG, Sadiq AM, Yousif MG, Al-Mudhafar RH, Al-Baghdadi JJ, Hadi N. Notch1 ligand signaling pathway activated in cervical cancer: poor prognosis with high-level JAG1/Notch1. Arch Gynecol Obstet 2015;292:899-904. [PMID: 25842263 DOI: 10.1007/s00404-015-3694-1] [Cited by in Crossref: 17] [Cited by in F6Publishing: 19] [Article Influence: 2.4] [Reference Citation Analysis]
468 Berge E, Thompson C, Messersmith W. Development of Novel Targeted Agents in the Treatment of Metastatic Colorectal Cancer. Clinical Colorectal Cancer 2011;10:266-78. [DOI: 10.1016/j.clcc.2011.06.011] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
469 Pedrazzini T. Control of Cardiogenesis by the Notch Pathway. Trends in Cardiovascular Medicine 2007;17:83-90. [DOI: 10.1016/j.tcm.2007.01.003] [Cited by in Crossref: 16] [Cited by in F6Publishing: 18] [Article Influence: 1.1] [Reference Citation Analysis]
470 Shao N, Ma D, Wang J, Lu T, Guo Y, Ji C. Notch1 signaling is irresponsible to the anti-leukemic effect of HDACis in B-ALL Nalm-6 cells. Ann Hematol 2013;92:33-9. [PMID: 22968660 DOI: 10.1007/s00277-012-1561-8] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
471 Xu M, Morishima N, Mizoguchi I, Chiba Y, Fujita K, Kuroda M, Iwakura Y, Cua DJ, Yasutomo K, Mizuguchi J. Regulation of the development of acute hepatitis by IL-23 through IL-22 and IL-17 production. Eur J Immunol. 2011;41:2828-2839. [PMID: 21953641 DOI: 10.1002/eji.201141291] [Cited by in Crossref: 30] [Cited by in F6Publishing: 32] [Article Influence: 2.7] [Reference Citation Analysis]
472 Song J, Jie C, Polk P, Shridhar R, Clair T, Zhang J, Yin L, Keppler D. The candidate tumor suppressor CST6 alters the gene expression profile of human breast carcinoma cells: down-regulation of the potent mitogenic, motogenic, and angiogenic factor autotaxin. Biochem Biophys Res Commun 2006;340:175-82. [PMID: 16356477 DOI: 10.1016/j.bbrc.2005.11.171] [Cited by in Crossref: 18] [Cited by in F6Publishing: 20] [Article Influence: 1.1] [Reference Citation Analysis]
473 Engin F, Lee B. NOTCHing the bone: insights into multi-functionality. Bone. 2010;46:274-280. [PMID: 19520195 DOI: 10.1016/j.bone.2009.05.027] [Cited by in Crossref: 57] [Cited by in F6Publishing: 55] [Article Influence: 4.4] [Reference Citation Analysis]
474 Lino MM, Merlo A, Boulay JL. Notch signaling in glioblastoma: a developmental drug target? BMC Med. 2010;8:72. [PMID: 21078177 DOI: 10.1186/1741-7015-8-72] [Cited by in Crossref: 54] [Cited by in F6Publishing: 50] [Article Influence: 4.5] [Reference Citation Analysis]
475 Zeng C, Xing R, Liu J, Xing F. Role of CSL-dependent and independent Notch signaling pathways in cell apoptosis. Apoptosis 2016;21:1-12. [DOI: 10.1007/s10495-015-1188-z] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 2.6] [Reference Citation Analysis]
476 Dietrich J, Diamond EL, Kesari S. Glioma stem cell signaling: therapeutic opportunities and challenges. Expert Review of Anticancer Therapy 2014;10:709-22. [DOI: 10.1586/era.09.190] [Cited by in Crossref: 26] [Cited by in F6Publishing: 23] [Article Influence: 3.3] [Reference Citation Analysis]
477 Clark PA, Treisman DM, Ebben J, Kuo JS. Developmental signaling pathways in brain tumor-derived stem-like cells. Dev Dyn 2007;236:3297-308. [DOI: 10.1002/dvdy.21381] [Cited by in Crossref: 45] [Cited by in F6Publishing: 41] [Article Influence: 3.0] [Reference Citation Analysis]
478 Zhao D, Mo Y, Li MT, Zou SW, Cheng ZL, Sun YP, Xiong Y, Guan KL, Lei QY. NOTCH-induced aldehyde dehydrogenase 1A1 deacetylation promotes breast cancer stem cells. J Clin Invest. 2014;124:5453-5465. [PMID: 25384215 DOI: 10.1172/jci76611] [Cited by in Crossref: 89] [Cited by in F6Publishing: 63] [Article Influence: 11.1] [Reference Citation Analysis]
479 Landor SK, Mutvei AP, Mamaeva V, Jin S, Busk M, Borra R, Grönroos TJ, Kronqvist P, Lendahl U, Sahlgren CM. Hypo- and hyperactivated Notch signaling induce a glycolytic switch through distinct mechanisms. Proc Natl Acad Sci U S A 2011;108:18814-9. [PMID: 22065781 DOI: 10.1073/pnas.1104943108] [Cited by in Crossref: 70] [Cited by in F6Publishing: 67] [Article Influence: 6.4] [Reference Citation Analysis]
480 Liu ZJ, Li Y, Tan Y, Xiao M, Zhang J, Radtke F, Velazquez OC. Inhibition of fibroblast growth by Notch1 signaling is mediated by induction of Wnt11-dependent WISP-1. PLoS One 2012;7:e38811. [PMID: 22715413 DOI: 10.1371/journal.pone.0038811] [Cited by in Crossref: 11] [Cited by in F6Publishing: 14] [Article Influence: 1.1] [Reference Citation Analysis]
481 Mansouri M, Rose PP, Moses AV, Früh K. Remodeling of endothelial adherens junctions by Kaposi's sarcoma-associated herpesvirus. J Virol 2008;82:9615-28. [PMID: 18667499 DOI: 10.1128/JVI.02633-07] [Cited by in Crossref: 43] [Cited by in F6Publishing: 36] [Article Influence: 3.1] [Reference Citation Analysis]
482 Wang S, Cai L, Zhang F, Shang X, Xiao R, Zhou H. Inhibition of EZH2 Attenuates Sorafenib Resistance by Targeting NOTCH1 Activation-Dependent Liver Cancer Stem Cells via NOTCH1-Related MicroRNAs in Hepatocellular Carcinoma. Transl Oncol 2020;13:100741. [PMID: 32092673 DOI: 10.1016/j.tranon.2020.01.002] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 5.0] [Reference Citation Analysis]
483 Santini D, Pantano F, Vincenzi B, Tonini G, Bertoldo F. The role of bone microenvironment, vitamin D and calcium. Recent Results Cancer Res 2012;192:33-64. [PMID: 22307369 DOI: 10.1007/978-3-642-21892-7_2] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
484 Hsu KW, Hsieh RH, Lee YH, Chao CH, Wu KJ, Tseng MJ, Yeh TS. The activated Notch1 receptor cooperates with alpha-enolase and MBP-1 in modulating c-myc activity. Mol Cell Biol 2008;28:4829-42. [PMID: 18490439 DOI: 10.1128/MCB.00175-08] [Cited by in Crossref: 50] [Cited by in F6Publishing: 31] [Article Influence: 3.6] [Reference Citation Analysis]
485 Bolós V, Grego-Bessa J, de la Pompa JL. Notch signaling in development and cancer. Endocr Rev. 2007;28:339-363. [PMID: 17409286 DOI: 10.1210/er.2006-0046] [Cited by in Crossref: 369] [Cited by in F6Publishing: 349] [Article Influence: 24.6] [Reference Citation Analysis]
486 Nemir M, Croquelois A, Pedrazzini T, Radtke F. Induction of Cardiogenesis in Embryonic Stem Cells via Downregulation of Notch1 Signaling. Circulation Research 2006;98:1471-8. [DOI: 10.1161/01.res.0000226497.52052.2a] [Cited by in Crossref: 118] [Cited by in F6Publishing: 59] [Article Influence: 7.4] [Reference Citation Analysis]
487 Mittal S, Subramanyam D, Dey D, Kumar RV, Rangarajan A. Cooperation of Notch and Ras/MAPK signaling pathways in human breast carcinogenesis. Mol Cancer. 2009;8:128. [PMID: 20030805 DOI: 10.1186/1476-4598-8-128] [Cited by in Crossref: 93] [Cited by in F6Publishing: 86] [Article Influence: 7.2] [Reference Citation Analysis]
488 Huber MA, Kraut N, Beug H. Molecular requirements for epithelial-mesenchymal transition during tumor progression. Curr Opin Cell Biol. 2005;17:548-558. [PMID: 16098727 DOI: 10.1016/j.ceb.2005.08.001] [Cited by in Crossref: 1305] [Cited by in F6Publishing: 1236] [Article Influence: 76.8] [Reference Citation Analysis]
489 Wang L, Ye X, Liu Y, Wei W, Wang Z. Aberrant regulation of FBW7 in cancer. Oncotarget 2014;5:2000-15. [PMID: 24899581 DOI: 10.18632/oncotarget.1859] [Cited by in Crossref: 61] [Cited by in F6Publishing: 57] [Article Influence: 8.7] [Reference Citation Analysis]
490 Schaub MA, Henzinger TA, Fisher J. Qualitative networks: a symbolic approach to analyze biological signaling networks. BMC Syst Biol 2007;1:4. [PMID: 17408511 DOI: 10.1186/1752-0509-1-4] [Cited by in Crossref: 55] [Cited by in F6Publishing: 35] [Article Influence: 3.7] [Reference Citation Analysis]
491 Cascetta P, Cavaliere A, Piro G, Torroni L, Santoro R, Tortora G, Melisi D, Carbone C. Pancreatic Cancer and Obesity: Molecular Mechanisms of Cell Transformation and Chemoresistance. Int J Mol Sci 2018;19:E3331. [PMID: 30366466 DOI: 10.3390/ijms19113331] [Cited by in Crossref: 20] [Cited by in F6Publishing: 17] [Article Influence: 5.0] [Reference Citation Analysis]
492 Leon G, MacDonagh L, Finn SP, Cuffe S, Barr MP. Cancer stem cells in drug resistant lung cancer: Targeting cell surface markers and signaling pathways. Pharmacol Ther 2016;158:71-90. [PMID: 26706243 DOI: 10.1016/j.pharmthera.2015.12.001] [Cited by in Crossref: 76] [Cited by in F6Publishing: 89] [Article Influence: 10.9] [Reference Citation Analysis]
493 Xu Y, Zhu F, Xu S, Liu L. Anti-tumor effect of the extract from qingyihuaji formula on pancreatic cancer by down-regulating Notch-4 and Jagged-1. J Tradit Chin Med 2015;35:77-83. [PMID: 25842732 DOI: 10.1016/s0254-6272(15)30012-1] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
494 Rice SJ, Lai SC, Wood LW, Helsley KR, Runkle EA, Winslow MM, Mu D. MicroRNA-33a mediates the regulation of high mobility group AT-hook 2 gene (HMGA2) by thyroid transcription factor 1 (TTF-1/NKX2-1). J Biol Chem 2013;288:16348-60. [PMID: 23625920 DOI: 10.1074/jbc.M113.474643] [Cited by in Crossref: 45] [Cited by in F6Publishing: 34] [Article Influence: 5.0] [Reference Citation Analysis]
495 Yugawa T, Handa K, Narisawa-Saito M, Ohno S, Fujita M, Kiyono T. Regulation of Notch1 gene expression by p53 in epithelial cells. Mol Cell Biol 2007;27:3732-42. [PMID: 17353266 DOI: 10.1128/MCB.02119-06] [Cited by in Crossref: 124] [Cited by in F6Publishing: 87] [Article Influence: 8.3] [Reference Citation Analysis]
496 Youssef M, Cuddihy A, Darido C. Long-Lived Epidermal Cancer-Initiating Cells. Int J Mol Sci 2017;18:E1369. [PMID: 28654000 DOI: 10.3390/ijms18071369] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
497 Sharma A, Gadkari RA, Ramakanth SV, Padmanabhan K, Madhumathi DS, Devi L, Appaji L, Aster JC, Rangarajan A, Dighe RR. A novel Monoclonal Antibody against Notch1 Targets Leukemia-associated Mutant Notch1 and Depletes Therapy Resistant Cancer Stem Cells in Solid Tumors. Sci Rep 2015;5:11012. [PMID: 26046801 DOI: 10.1038/srep11012] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 2.9] [Reference Citation Analysis]
498 Lino M, Merlo A. Translating biology into clinic: the case of glioblastoma. Curr Opin Cell Biol 2009;21:311-6. [PMID: 19217766 DOI: 10.1016/j.ceb.2008.12.009] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 1.2] [Reference Citation Analysis]
499 Diab M, Azmi A, Mohammad R, Philip PA. Pharmacotherapeutic strategies for treating pancreatic cancer: advances and challenges. Expert Opin Pharmacother 2019;20:535-46. [PMID: 30592647 DOI: 10.1080/14656566.2018.1561869] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 3.0] [Reference Citation Analysis]
500 Belandia B, Powell SM, García-Pedrero JM, Walker MM, Bevan CL, Parker MG. Hey1, a mediator of notch signaling, is an androgen receptor corepressor. Mol Cell Biol 2005;25:1425-36. [PMID: 15684393 DOI: 10.1128/MCB.25.4.1425-1436.2005] [Cited by in Crossref: 92] [Cited by in F6Publishing: 63] [Article Influence: 5.4] [Reference Citation Analysis]
501 Hughes DP. How the NOTCH pathway contributes to the ability of osteosarcoma cells to metastasize. Cancer Treat Res 2009;152:479-96. [PMID: 20213410 DOI: 10.1007/978-1-4419-0284-9_28] [Cited by in Crossref: 68] [Cited by in F6Publishing: 70] [Article Influence: 5.7] [Reference Citation Analysis]
502 Röser K, Jäkel KT, Bullerdiek J, Löning T. [Significance of molecular-cytogenetic findings in mucoepidermoid carcinoma as an example of salivary gland tumors]. Pathologe 2005;26:359-66. [PMID: 16075259 DOI: 10.1007/s00292-005-0778-x] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
503 Bigas A, Espinosa L. Hematopoietic stem cells: to be or Notch to be. Blood. 2012;119:3226-3235. [PMID: 22308291 DOI: 10.1182/blood-2011-10-355826] [Cited by in Crossref: 90] [Cited by in F6Publishing: 82] [Article Influence: 9.0] [Reference Citation Analysis]
504 Ronchi CL, Sbiera S, Altieri B, Steinhauer S, Wild V, Bekteshi M, Kroiss M, Fassnacht M, Allolio B. Notch1 pathway in adrenocortical carcinomas: correlations with clinical outcome. Endocrine-Related Cancer 2015;22:531-43. [DOI: 10.1530/erc-15-0163] [Cited by in Crossref: 21] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
505 Gramantieri L, Giovannini C, Lanzi A, Chieco P, Ravaioli M, Venturi A, Grazi GL, Bolondi L. Aberrant Notch3 and Notch4 expression in human hepatocellular carcinoma. Liver Int. 2007;27:997-1007. [PMID: 17696940 DOI: 10.1111/j.1478-3231.2007.01544.x] [Cited by in Crossref: 73] [Cited by in F6Publishing: 70] [Article Influence: 4.9] [Reference Citation Analysis]
506 Roberts ML, Drosopoulos KG, Vasileiou I, Stricker M, Taoufik E, Maercker C, Guialis A, Alexis MN, Pintzas A. Microarray analysis of the differential transformation mediated by Kirsten and Harvey Ras oncogenes in a human colorectal adenocarcinoma cell line. Int J Cancer 2006;118:616-27. [PMID: 16152623 DOI: 10.1002/ijc.21386] [Cited by in Crossref: 30] [Cited by in F6Publishing: 29] [Article Influence: 1.9] [Reference Citation Analysis]
507 Guo J, Tong J, Zheng J. Circular RNAs: A Promising Biomarker for Endometrial Cancer. Cancer Manag Res 2021;13:1651-65. [PMID: 33633465 DOI: 10.2147/CMAR.S290975] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
508 Ferrer-Lorente R, Bejar MT, Tous M, Vilahur G, Badimon L. Systems biology approach to identify alterations in the stem cell reservoir of subcutaneous adipose tissue in a rat model of diabetes: effects on differentiation potential and function. Diabetologia. 2014;57:246-256. [PMID: 24132782 DOI: 10.1007/s00125-013-3081-z] [Cited by in Crossref: 48] [Cited by in F6Publishing: 45] [Article Influence: 5.3] [Reference Citation Analysis]
509 Tagami S, Okochi M, Yanagida K, Ikuta A, Fukumori A, Matsumoto N, Ishizuka-Katsura Y, Nakayama T, Itoh N, Jiang J, Nishitomi K, Kamino K, Morihara T, Hashimoto R, Tanaka T, Kudo T, Chiba S, Takeda M. Regulation of Notch signaling by dynamic changes in the precision of S3 cleavage of Notch-1. Mol Cell Biol 2008;28:165-76. [PMID: 17967888 DOI: 10.1128/MCB.00863-07] [Cited by in Crossref: 82] [Cited by in F6Publishing: 51] [Article Influence: 5.5] [Reference Citation Analysis]
510 Zhu G, Yi X, Haferkamp S, Hesbacher S, Li C, Goebeler M, Gao T, Houben R, Schrama D. Combination with γ-secretase inhibitor prolongs treatment efficacy of BRAF inhibitor in BRAF-mutated melanoma cells. Cancer Lett 2016;376:43-52. [PMID: 27000992 DOI: 10.1016/j.canlet.2016.03.028] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
511 Guo S, Liu M, Gonzalez-Perez RR. Role of Notch and its oncogenic signaling crosstalk in breast cancer. Biochim Biophys Acta. 2011;1815:197-213. [PMID: 21193018 DOI: 10.1016/j.bbcan.2010.12.002] [Cited by in Crossref: 47] [Cited by in F6Publishing: 116] [Article Influence: 3.9] [Reference Citation Analysis]
512 Pallavi SK, Ho DM, Hicks C, Miele L, Artavanis-Tsakonas S. Notch and Mef2 synergize to promote proliferation and metastasis through JNK signal activation in Drosophila. EMBO J 2012;31:2895-907. [PMID: 22580825 DOI: 10.1038/emboj.2012.129] [Cited by in Crossref: 53] [Cited by in F6Publishing: 54] [Article Influence: 5.3] [Reference Citation Analysis]
513 Bouras T, Pal B, Vaillant F, Harburg G, Asselin-labat M, Oakes SR, Lindeman GJ, Visvader JE. Notch Signaling Regulates Mammary Stem Cell Function and Luminal Cell-Fate Commitment. Cell Stem Cell 2008;3:429-41. [DOI: 10.1016/j.stem.2008.08.001] [Cited by in Crossref: 316] [Cited by in F6Publishing: 301] [Article Influence: 22.6] [Reference Citation Analysis]
514 Groot AJ, Vooijs MA. The role of Adams in Notch signaling. Adv Exp Med Biol 2012;727:15-36. [PMID: 22399336 DOI: 10.1007/978-1-4614-0899-4_2] [Cited by in Crossref: 42] [Cited by in F6Publishing: 44] [Article Influence: 4.2] [Reference Citation Analysis]
515 Heffernan C, Liu J, Sumer H, Malaver-Ortega LF, Verma R, Carvalho E, Verma PJ. Induction of pluripotency. Adv Exp Med Biol 2013;786:5-25. [PMID: 23696349 DOI: 10.1007/978-94-007-6621-1_2] [Reference Citation Analysis]
516 Axelson H. Eyeing tumorigenesis: Notch signaling and epigenetic silencing ofRb inDrosophila. Bioessays 2006;28:692-5. [DOI: 10.1002/bies.20428] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.1] [Reference Citation Analysis]
517 Mazurek M, Rola R. The implications of nitric oxide metabolism in the treatment of glial tumors. Neurochem Int 2021;150:105172. [PMID: 34461111 DOI: 10.1016/j.neuint.2021.105172] [Reference Citation Analysis]
518 Harbuzariu A, Gonzalez-Perez RR. Leptin-Notch axis impairs 5-fluorouracil effects on pancreatic cancer. Oncotarget. 2018;9:18239-18253. [PMID: 29719602 DOI: 10.18632/oncotarget.24435] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 5.0] [Reference Citation Analysis]
519 Colvin EK, Scarlett CJ. A historical perspective of pancreatic cancer mouse models. Semin Cell Dev Biol 2014;27:96-105. [PMID: 24685616 DOI: 10.1016/j.semcdb.2014.03.025] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 2.4] [Reference Citation Analysis]
520 Doucas H, Mann CD, Sutton CD, Garcea G, Neal CP, Berry DP, Manson MM. Expression of nuclear Notch3 in pancreatic adenocarcinomas is associated with adverse clinical features, and correlates with the expression of STAT3 and phosphorylated Akt. J Surg Oncol. 2008;97:63-68. [PMID: 17918209 DOI: 10.1002/jso.20894] [Cited by in Crossref: 56] [Cited by in F6Publishing: 47] [Article Influence: 4.0] [Reference Citation Analysis]
521 Pandya C, Uzilov AV, Bellizzi J, Lau CY, Moe AS, Strahl M, Hamou W, Newman LC, Fink MY, Antipin Y, Yu W, Stevenson M, Cavaco BM, Teh BT, Thakker RV, Morreau H, Schadt EE, Sebra R, Li SD, Arnold A, Chen R. Genomic profiling reveals mutational landscape in parathyroid carcinomas. JCI Insight 2017;2:e92061. [PMID: 28352668 DOI: 10.1172/jci.insight.92061] [Cited by in Crossref: 38] [Cited by in F6Publishing: 28] [Article Influence: 7.6] [Reference Citation Analysis]
522 Deonarain MP, Kousparou CA, Epenetos AA. Antibodies targeting cancer stem cells: a new paradigm in immunotherapy? MAbs. 2009;1:12-25. [PMID: 20046569 DOI: 10.4161/mabs.1.1.7347] [Cited by in Crossref: 107] [Cited by in F6Publishing: 97] [Article Influence: 8.9] [Reference Citation Analysis]
523 Garg P, Sarma D, Jeppsson S, Patel NR, Gewirtz AT, Merlin D, Sitaraman SV. Matrix metalloproteinase-9 functions as a tumor suppressor in colitis-associated cancer. Cancer Res 2010;70:792-801. [PMID: 20068187 DOI: 10.1158/0008-5472.CAN-09-3166] [Cited by in Crossref: 59] [Cited by in F6Publishing: 31] [Article Influence: 4.9] [Reference Citation Analysis]
524 Mapelli P, Aboagye EO, Stebbing J, Sharma R. Epigenetic changes in gastroenteropancreatic neuroendocrine tumours. Oncogene 2015;34:4439-47. [DOI: 10.1038/onc.2014.379] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
525 Sanders PG, Muñoz-Descalzo S, Balayo T, Wirtz-Peitz F, Hayward P, Arias AM. Ligand-independent traffic of Notch buffers activated Armadillo in Drosophila. PLoS Biol 2009;7:e1000169. [PMID: 19668359 DOI: 10.1371/journal.pbio.1000169] [Cited by in Crossref: 43] [Cited by in F6Publishing: 43] [Article Influence: 3.3] [Reference Citation Analysis]
526 Pant S, Jones SF, Kurkjian CD, Infante JR, Moore KN, Burris HA, McMeekin DS, Benhadji KA, Patel BKR, Frenzel MJ, Kursar JD, Zamek-Gliszczynski MJ, Yuen ESM, Chan EM, Bendell JC. A first-in-human phase I study of the oral Notch inhibitor, LY900009, in patients with advanced cancer. Eur J Cancer. 2016;56:1-9. [PMID: 26798966 DOI: 10.1016/j.ejca.2015.11.021] [Cited by in Crossref: 48] [Cited by in F6Publishing: 37] [Article Influence: 8.0] [Reference Citation Analysis]
527 Park HS, Jung CK, Lee SH, Chae BJ, Lim DJ, Park WC, Song BJ, Kim JS, Jung SS, Bae JS. Notch1 receptor as a marker of lymph node metastases in papillary thyroid cancer. Cancer Sci 2012;103:305-9. [PMID: 22118425 DOI: 10.1111/j.1349-7006.2011.02161.x] [Cited by in Crossref: 17] [Cited by in F6Publishing: 21] [Article Influence: 1.7] [Reference Citation Analysis]
528 Zeng JS, Zhang ZD, Pei L, Bai ZZ, Yang Y, Yang H, Tian QH. CBX4 exhibits oncogenic activities in breast cancer via Notch1 signaling. Int J Biochem Cell Biol 2018;95:1-8. [PMID: 29229426 DOI: 10.1016/j.biocel.2017.12.006] [Cited by in Crossref: 22] [Cited by in F6Publishing: 25] [Article Influence: 4.4] [Reference Citation Analysis]
529 Bray SJ. Notch signalling: a simple pathway becomes complex. Nat Rev Mol Cell Biol. 2006;7:678-689. [PMID: 16921404 DOI: 10.1038/nrm2009] [Cited by in Crossref: 1664] [Cited by in F6Publishing: 1615] [Article Influence: 104.0] [Reference Citation Analysis]
530 Torrente L, Sanchez C, Moreno R, Chowdhry S, Cabello P, Isono K, Koseki H, Honda T, Hayes JD, Dinkova-Kostova AT, de la Vega L. Crosstalk between NRF2 and HIPK2 shapes cytoprotective responses. Oncogene 2017;36:6204-12. [PMID: 28692050 DOI: 10.1038/onc.2017.221] [Cited by in Crossref: 44] [Cited by in F6Publishing: 38] [Article Influence: 8.8] [Reference Citation Analysis]
531 Wang AM, Ku HH, Liang YC, Chen YC, Hwu YM, Yeh TS. The autonomous notch signal pathway is activated by baicalin and baicalein but is suppressed by niclosamide in K562 cells. J Cell Biochem 2009;106:682-92. [PMID: 19160421 DOI: 10.1002/jcb.22065] [Cited by in Crossref: 73] [Cited by in F6Publishing: 66] [Article Influence: 5.6] [Reference Citation Analysis]